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Proopiomelanocortin expression and processing in the
ovine pars intermedia
In the sheep, peripheral blood plasma concentrations of alpha melanocyte
stimulating hormone (aMSH) undergo marked seasonal fluctuations and are
maximal in late summer and autumn. The pituitary pars intermedia is believed to
be the principle source of this circulating aMSH which is synthesised from the
proopiomelanocortin (POMC) precursor through the proteolytic action of the
prohormone convertases, PCI and PC2. This thesis describes studies into the
effect of season and photoperiod on the aMSH-synthetic activity of the pars
intermedia in the highly photoperiodically-responsive Soay sheep. The influence
of the hypothalamus and dopaminergic inhibition was also studied. The
localisation and expression of POMC mRNA, POMC-derived peptides and both
PCI and PC2 mRNAs and proteins were measured by in situ hybridisation,
RNase protection assay and immunocytochemistry; specific riboprobes were
developed for the project. The presence of the cellular proliferation marker,
PCNA, was used as an index of cellular proliferation.
In the first study, the general anatomy of the ovine pituitary gland was
investigated using the new methodology. POMC mRNA was highly expressed in
melanotrophs in the pars intermedia and in the corticotrophs dispersed in the pars
distalis. The POMC-derived peptides, ACTH and aMSH both occurred in the
pars intermedia while in the pars distalis ACTH predominated while aMSH was
only weakly expressed. PCI mRNA and protein was also expressed both in the
pars distalis and the pars intermedia with a distribution similar to that of POMC,
as well as in the pars nervosa. PC2 mRNA was expressed in the pars intermedia
while PC2 protein occurred principally in the pars intermedia and pars nervosa.
Like aMSH, PC2 protein was expressed weakly in the pars distalis. The second
study investigated the changing activity of the pars intermedia at four seasonal
time points in Soay ewes living outdoors and exposed to natural photoperiod
(n=5/group). Expression of POMC and PCI mRNA was significantly greater in
the summer and autumn compared to the winter and spring. The autumnal
increase in pars intermedia activity was also characterised by an increase in
cellular proliferative activity and hypertrophy of melanotrophs. The effect of
photoperiod on the activity of the pars intermedia was investigated in the third
xii
Abstract xin
study in which Soay rams were exposed to an artificial lighting regimen of
alternating 16-weekly periods of long days (LD, 16L 8D) and short days (SD, 8L
16D) designed to entrain the seasonal aMSH cycle and were killed following
treatment under LD and SD (n=4-5/group). Expression of POMC, PCI and PC2
mRNA was enhanced in the SD group although this was statistically significant
only for PCI due to large individual variation.
The fourth study investigated the role of the hypothalamus in the photoperiodic
regulation of the pars intermedia in control and long term hypothalamo-pituitary
disconnected (HPD) Soay rams (n=8/group) exposed to an artificial lighting
regimen (as above) for 80 weeks, a subset of which were later killed under long
days (n=3/group). In control rams, circulating aMSH concentrations varied
markedly with photoperiod with a 10-fold increase from the minimum under LD
to the maximum under SD. In HPD rams aMSH concentrations increased
following surgery (significantly above control values) and then declined in the
longer term; there were no cyclical changes associated with the switches in
photoperiod. The expression of POMC, PCI and PC2 mRNA in the pars
intermedia tended to be reduced in the long term HPD rams compared with
controls exposed to short days, although this was statistically significant only for
PCI. The pars intermedia was enlarged in size in HPD rams.
In the final study, the potential importance of dopamine (DA) as an inhibitory
regulator of the pars intermedia was investigated in Soay rams living outdoors
under natural photoperiod. Animals were treated chronically with a long term
DA agonist (parlodel LA, 16.7mg/animal iv every 5-7 days for 40 days) in July
and August at the time of the seasonal maximum in aMSH secretion. Untreated
rams were used as controls (n=3/group). Treatment with the DA agonist resulted
in sustained (70%) reduction in circulating concentrations of aMSH. This was
associated with a significant reduction in the expression of POMC, PCI and PC2
mRNA in the pars intermedia and a decrease in cell proliferation and cell size.
Overall, the results support the conclusion that the seasonal cycle in blood plasma
concentrations of aMSH in sheep are mediated by the photoperiodic co-
regulation of POMC, PCI and PC2 gene expression which dictates the rate of
synthesis of aMSH by the pars intermedia. This photoperiodic regulation is
transduced through direct hypothalamic innervation of which dopaminergic
inhibitory control is likely to predominate. Thus, the ovine pars intermedia is a
seasonally dynamic tissue with potentially important roles established previously
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The ability to respond to changes in the external environment is one of the
fundamental requirements of all living organisms. Mammals living in cold and
temperate climates experience substantial and predictable variations in
environmental conditions such as temperature and food availability and show
marked adaptive seasonal cycles in reproduction, growth and pelage. The
endocrine control of these adaptive characteristics is under physiological regulation
by the hypothalamus, which receives, integrates and conveys information about
external factors to the pituitary gland. The pituitary gland amplifies these
hypothalamic responses and generates conspicuous circulating humoral signals
which temporally co-ordinate the peripheral physiological systems. Thus the
ability of the hypothalamo-pituitary axis to respond to environmental cues is central
in physiological and behavioural adaptations to seasonal climates.
The sheep is a well studied example of a mammal adapted to living in such
seasonal environments. Seasonal changes in food availability, with abundant food
in summer and food shortages in winter exert considerable selective pressure to
accumulate fat reserves before the winter and to restrict the mating season to the
autumn. The hypothalamo-pituitary axis is central in the physiological systems
controlling such seasonal adaptations. There are pronounced seasonal cycles in the
secretion of hormones from the pituitary gland such as luteinising hormone (LH),
follicle-stimulating hormone (FSH) and prolactin and these are involved in the
regulation of reproduction and pelage growth (Lincoln and Short, 1980). While
there has been extensive research conducted to understand the seasonal regulation
of the reproductive axis, there is a rather smaller body of literature on the
physiological regulation of the seasonal cycle in growth and metabolism (Bronson,
1989). Conspicuous seasonal cycles in circulating alpha-melanocyte-stimulating
hormone (aMSH) and beta-endorphin ((3END) are observed in the sheep which
correlate closely with the seasonal changes in voluntary food intake and body
weight (Ebling and Lincoln, 1987). Both of these peptides are co-secreted from
the pituitary gland and are derived from a single precursor, proopiomelanocortin
(POMC). The POMC protein is cleaved into smaller peptides by the
endoproteolytic action of the prohormone convertases PCI and PC2 and these
1
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peptides are further modified by other processing enzymes before being secreted.
The post-translational processing of POMC is tissue specific and results in the
biosynthesis of a combination of several different peptides. Thus the bioactivity of
the products of the POMC precursor are governed by the processing activity of a
particular tissue. The cellular events governing the processing of POMC are
therefore as important as POMC gene expression itself in generating bioactive
peptides such as aMSH and (SEND. In the sheep it is believed that most circulating
aMSH is derived from the pituitary pars intermedia (Engler et al., 1989). This
thesis aims to investigate the seasonal regulation of POMC gene expression and the
processing of the POMC precursor protein in the pars intermedia of the highly
photoperiodically responsive Soay sheep.
To provide an introduction to the subject of this thesis in the next section the
literature concerning the anatomy of the pars intermedia, the precise nature of the
regulation of its activity and the synthesis of its principle products will be
reviewed.
1.2 Neuroendocrine control of pars intermedia POMC
expression and secretion
1.2.1 General anatomy of the ovine pituitary gland
The pituitary gland is the principle source of POMC-derived peptides present in the
peripheral blood (Autelitano et al., 1989; Lundblad and Roberts, 1988) and
expresses POMC mRNA at a level 1000-fold greater than the hypothalamus (Smith
and Funder, 1988). All vertebrate species possess a pituitary gland (Wingstrand,
1966) and within the mammals the pituitary gland is composed of a consistent
number of tissues of different developmental origins. These tissues, of which the
pars intermedia is one, have distinct structural and functional properties in the adult
pituitary gland (Figure 1.1). The pituitary gland is developmentally derived in part
from the brain and in part from the oral fossa (Figure 1.2). The region derived
from the oral fossa develops into the pars intermedia and anterior lobe. The
anterior lobe, sometimes called the glandular lobe, has an endocrinologically active
and heterologous cell population and is divided functionally and histologically into
the pars tuberalis, the zona tuberalis and the pars distalis. The region derived from
the brain forms the remaining part of the posterior lobe comprised of the pars
nervosa and median eminence (Atwell, 1918). The grouping of the pars intermedia
into the posterior lobe reflects its close physical association with the pars nervosa
but does not reflect its developmental origin.
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1.2.2 Development of the ovine pituitary gland
The anterior and posterior lobes of the pituitary gland are formed by the folding and
migration of two distinct tissue layers derived from the brain and the oral fossa.
The part derived from the oral fossa is initially formed from a shallow infolding
anterior to the oral plate towards the brain and this gives rise to Rathke's pouch
(Figure 1.2). Rathke's pouch becomes more closely associated with the neural
lobe and the remaining connection to the oral cavity, the hypophyseal stalk,
becomes more constricted and is eventually lost (Atwell, 1918). In the sheep this
occurs by day 31 of gestation (Perry et al., 1982). The developmental fate of the
cells forming Rathke's pouch is probably already determined before the pouch is
formed since homeobox genes associated with the structure are expressed long
before it forms (Treier and Rosenfeld, 1996). The distinct distribution of particular
types of secretory cells of the pars distalis is likely to result from a complex
transcriptional-cascade in development, where developmental fate tends to be
influenced by relative position (Treier and Rosenfeld, 1996), although there are no
clear boundaries between functional cell types in the pars distalis. Factors released
from the floor of the primitive diencephalon are also thought to influence pituitary
cell differentiation (Lamonerie et al., 1996).
The part of the developing pituitary gland derived from the brain forms the
pars nervosa which remains attached to the brain. This also is derived from a
pouch-like structure, an outgrowth of the third ventricle, but the lumen of the pars
nervosa is obliterated by numerous foldings early in pituitary gland development
(Atwell, 1918). Functionally the pars nervosa is an outgrowth of the
hypothalamus, containing numerous nerve fibres and terminals from neurons
originating in the hypothalamus. Rathke's pouch pushes up against the neural lobe
which projects down ventrally. The position of the neural lobe changes throughout
pituitary gland development so that it projects posteriorly and lies flat underneath
the brain wall in the adult gland (Atwell, 1918). The tissue forming Rathke's
pouch develops into the pars intermedia at its neural aspect and into the anterior
lobe at the anterior aspect. The lumen of this pouch separates the anterior lobe
from the pars intermedia and through embryonic development undergoes a degree
of regression but survives as the hypophyseal cleft or hypophyseal vesicles in the
adult gland. Ultrastructural analysis suggests that the residual cleft is empty in the
ovine fetal pituitary but in the adult contains a colloid like material acquired soon
after birth (Perry et al., 1982). In the sheep the posterior aspect of Rathke's
pouch, which gives rise to the pars intermedia, is still undifferentiated at day 26 of
gestation. By day 40, only the cells lining the residual cleft, which are not fully
differentiated melanotrophs, show any sign of differentiation, and differentiation of
the rest of the tissue is not observed until day 50. While corticotrophs are present
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at day 95 of gestation (Challis and Brooks, 1989), the fully functional melanotroph
is not observed until day 100 (Perry et al., 1982). Follicles, common in adult pars
intermedia, are not seen until 120 days of gestation (Perry et al., 1982). The pars
intermedia of the new-born lamb is approximately ten cells deep and increases to
about 15 cells in the adult. Furthermore the perinatal pars intermedia is more richly
vascularised than in the adult and these blood vessels occur from gestational day
100 onwards (Perry et al., 1982).
There are reports suggesting that the corticotroph population changes
morphologically through the development of the ovine pars distalis. The
predominant fetal corticotroph phenotype is large and columnar while the adult
phenotype is stellate and darker. It may be that the processing of the POMC
molecule is less extensive in the fetal type so explaining the incidence of high
molecular weight POMC peptides in fetal circulation which appear to antagonise the
effects of ACTH on the adrenal cortex. The gradual change from fetal to adult
phenotype can be reversed by adrenalectomy, suggesting that glucocorticoids
promote this change (Challis and Brooks, 1989). The distribution of ACTH-
immunoreactive corticotrophs also tends to shift from the superior part of the pars
distalis, adjacent to the pars tuberalis, to the inferior pars distalis from day 60 to
parturition (Matthews et al., 1994).
The pars tuberalis, the most anterior and dorsal part of the anterior lobe is
thought to be derived from lateral outgrowths of Rathke's pouch which migrate up
to and from processes that surround and fuse enclosing the median eminence (see
Figure 1.2) (Atwell, 1918). This part of the anterior lobe is functionally and
histologically distinct from the pars distalis.
1.2.2.1 Blood supply to the pituitary gland.
The anterior and posterior lobes of the pituitary gland are vascularised from two
sources, both of which ultimately arise from the internal carotid artery. The
anterior lobe is richly vascularised by capillaries arising from the anterior
hypophyseal artery as well as from the portal vessels which run through the median
eminence and into the zona tuberalis (Green and Harris, 1947; Harris, 1947). The
blood supply from the anterior hypophyseal artery first runs through the pars
tuberalis before joining the portal vessels (Fitzgerald, 1979) which are observed
from gestational day 45 in the sheep (Challis and Brooks, 1989).
The posterior lobe is vascularised by the posterior hypophyseal artery and
thus it is unlikely that the posterior lobe receives any portal blood from the median
eminence (Harris, 1947). The rat pars intermedia is reported to be poorly
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vascularised but the literature suggests that this is less the case in the sheep (Perry
et al., 1981).
1.2.2.2 The development of the pars intermedia innervation
The activity of the pars intermedia is believed to be regulated by direct
hypothalamic innervation from the hypothalamus. In development, regulatory
neurons migrate towards the pars intermedia from the hypothalamus. In the adult
gland there is a very close association between the pars intermedia and pars nervosa
which becomes apparent if attempts are made to separate the two tissues. In the
developing rabbit fetus, pronounced projections invading the pars intermedia from
the pars nervosa have long been reported (Atwell, 1918). In the sheep,
anterograde tracers show that tyrosine hydroxylase (the rate limiting enzyme in
dopamine synthesis) -expressing neurons originate at least in part from the A15
nucleus in the retrochiasmatic area of the hypothalamus. Dopaminergic neurons
from the A15 also project nerve fibres into the median eminence and pars nervosa
(Gayrard et al., 1995). In the rat, aMSH promotes the outgrowth and expression
of tyrosine hydroxylase in cultured fetal neurons, suggesting that aMSH itself acts
as a neurotrophic factor, promoting differentiation of the dopaminergic neurons and
innervation of the melanotrophs (Egles et al., 1998). The development of this
innervation extends into the perinatal period in the rat (Chronwall et al., 1998).
In the sheep, the innervation of the pars intermedia is already partially
developed by 125 days of gestation since the pars intermedia is capable of
responding to stress induced as a result of hypoxemia by decreased POMC mRNA
expression. The response to hypoxemia by the pars intermedia becomes more
pronounced in older fetuses (Braems et al., 1996) implying that development of the
system regulating the activity of the pars intermedia is still ongoing at this stage.
D2 dopamine receptors are expressed by day 130 of gestation in the fetal sheep
pars intermedia since POMC mRNA is reduced to half pretreatment levels by
chronic treatment with the dopamine agonist, bromocriptine (Matthews et al.,
1996).
1.2.3 Anatomy of the adult pituitary gland
1.2.3.1 The pars intermedia
The ovine pars intermedia is a lobular tissue with a cell population predominantly
composed of polyhedral melanotrophs with uniform ovoid nuclei. Compared to
the pars distalis, the pars intermedia is relatively poorly vascularised and is often
separated from the pars distalis by a prominent hypophyseal cleft, although in
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places the pars intermedia and pars distalis fuse with no clear boundary between the
two tissues (Perry et al., 1981). The boundary between the pars intermedia and
pars tuberalis is also rather poorly defined (Dawson, 1937). In some species the
pars intermedia is reported to enclose the pars nervosa, particularly close to the
infundibular stalk (Atwell, 1918; Dawson, 1937). In the sheep the pars intermedia
forms a layer of melanotrophs approximately 15-20 cells thick. Melanotrophs are
rich in granular endoplasmic reticulum and secretory granules, reflecting their
endocrine function, although the number of granules varies considerably from cell
to cell (Perry et al., 1981). A significant degree of cell proliferation in the pars
intermedia is a normal feature of development and may also occur in the adult sheep
since pars intermedia hypertrophy is observed after removal of hypothalamic
influence (Clarke et al., 1983) and cell proliferation has been observed in the adult
rat pars intermedia (Horiuchi et al., 1994). In the developing ovine pars
intermedia, mitosis has been observed in apparently endocrinologically active
melanotrophs containing secretory granules at 100 gestational days (Perry et al.,
1982).
In addition to the melanotroph, four additional cell types occur in the ovine
pars intermedia. These are described as pars distalis-like glandular cells, interstitial
cells, follicular cells and cleft lining cells (Perry et al., 1981). The pars distalis-like
cells, representing less than 5% of total pars intermedia cells, were characterised
using electron microscopy rather than by any endocrine or functional aspect. There
are, however, immunocytochemical reports of a few gonadotrophs invading the
pars intermedia from the pars distalis in the mouse and rat (Stoeckel and Porte,
1984). The interstitial cells of the pars intermedia are characterised by elongated
indented nuclei and the absence of granular endoplasmic reticulum, suggesting a
non secretory role for these cells.
Follicles sometimes containing acellular colloid-like material are often
observed in the ovine pars intermedia, usually close to the margin with the pars
nervosa. These are lined by follicular cells which ultrastructurally resemble
interstitial cells and together with them represent less than 5% of the cells of the
pars intermedia (Perry et al., 1981).
The hypophyseal cleft is lined by a mixed cell population on the pars
intermedia side, mainly triangular cells, tapered basally and bearing microvilli
extending into the cleft. Another epithelial cell type is commonly observed which
occurs in clusters and is ciliated at the cleft aspect (Perry et al., 1981).
1.2.3.2 The pars nervosa
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The pars nervosa is made up of neuronal axons which project into this tissue from
the hypothalamus. The principle types of neurons are those which produce
vasopressin and those which produce oxytocin. In addition a newly discovered
neuropeptide, secretoneurin, is synthesised by the bovine pars nervosa and, like
POMC, is produced from a larger precursor, secretogranin II (Egger et al., 1994).
The pars nervosa also contains a number of neurons whose function is to regulate
the activity of the pars intermedia. These are principally dopaminergic, GABAergic
and (^-adrenergic (Chronwall et al., 1998).
1.2.3.3 The median eminence
The median eminence is also structurally a part of the hypothalamus containing
many neuroendocrine synapses which secrete hypothalamic peptides into a rich
vascular system which supplies the pars distalis. Essentially, the median eminence
is formed from an outfolding of the post-optic hypothalamus along the route of the
portal blood system (Wingstrand, 1966) It is enclosed by the pars tuberalis and
contains the axons of neurons projecting from the hypothalamus into the pars
nervosa. Unusually for a central tissue, the median eminence lacks a blood-brain
barrier (Garcia de Yebenes et al., 1997), suggesting that it may be possible for
pituitary factors to influence this tissue.
1.2.3.4 The pars tuberalis
The pars tuberalis is present in all mammals with a few exceptions, and lies at the
most anterio-dorsal part of the pituitary gland within the pia mater of the brain,
posterior to the optic chiasm (Atwell, 1918). In the rat, the pars tuberalis may be
the first part of the pituitary gland to become functionally active (Fitzgerald, 1979).
The pars tuberalis forms a collar several cells deep around the median eminence.
These cells are of a mixed secretory and non-secretory population and are thought
to include some endocrine cells usually associated with the pars distalis,
particularly migrating gonadotrophs which are most abundant towards the pars
distalis (Fitzgerald, 1979). These gonadotrophs become more abundant in the rat
after removal of the rest of the pituitary gland (Stoeckel and Porte, 1984). The pars
tuberalis is the most richly vascularised part of the pituitary gland (Fitzgerald,
1979). Cerebrospinal fluid is thought to be able to gain access to the cells of the
pars tuberalis through cellular cords distributed widely through the tissue (Stoeckel
and Porte, 1984). Abundant melatonin receptors are expressed in the pars tuberalis
and zona tuberalis, but are absent elsewhere in the ovine pituitary gland. These are
involved in the seasonal control of prolactin secretion in the sheep since this is the











Figure 1.1. Photograph of the ovine pituitary gland and hypothalamus in sagittal
plane (top) and schematic diagram showing the differential processing of POMC in
the two POMC-expressing pituitary cell types (bottom). MB- mediobasal
hypothalamus, ME- median eminence, OC- optic chiasma, PD- pars distalis, PI-
pars intermedia, PN- pars nervosa, PT- pars tuberalis, 3V- third ventricle.
Adapted from Clarke et al. (1983) Neuroendocrinology 36: 376.
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PD
3v - 3rd Ventricle
PN - Pars Nervosa
RP - Rathke's Pouch
LL - Lateral Lobes
OC - Optic Chiasm
PT - Pars Tuberaiis
PI - Pars Intermedia
PD - Pars Distalis
HS - Hypophyseal Stalk
Figure 1.2. General anatomy of the developing (a) and adult (b) mammalian
pituitary gland, both in sagittal section.
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is disconnected from the hypothalamus (Lincoln and Clarke, 1995). Reported
photoperiodic and seasonal changes in secretory cell morphology in species other
than the sheep further implicate the pars tuberalis as a modulator of pars distalis
function (Rutten et al., 1988; Wittkowski et al., 1984).
•
1.2.3.5 The zona tuberalis
The zona tuberalis was first identified and considered as separate from the pars
distalis on the basis of a lack of eosinophillic cells (Dawson, 1937). The zona
tuberalis lies at the anterior pole of the pituitary gland and seems to form an
extension of the pars tuberalis adjoining the pars distalis. There is no clear
boundary between the zona tuberalis and the pars tuberalis or pars distalis
(Dawson, 1937). This tissue contains many blood vessels and sinusoids (Harris,
1947) and is reported to contain a large proportion of gonadotrophs in the sheep
(Skinner and Robinson, 1995).
1.2.3.6 The pars distalis
The pars distalis contains the majority of endocrinologically active cells in the ovine
pituitary, including ACTH-secreting corticotrophs, prolactin-secreting lactotrophs,
LH and FSH-secreting gonadotrophs, growth hormone-secreting somatotrophs
and thyroid-stimulating hormone-secreting thyrotrophs. Immunocytochemical
studies of these cell types has revealed that each show a unique pattern of
distribution and some of these cell types are also present in the zona tuberalis
(Girod et al., 1982; Girod et al., 1983; Girod et al., 1985; Girod et al., 1986;
Sasaki et al., 1992; Skinner and Robinson, 1995). Follicular-stellate cells, whose
function is not clear, also occur extensively in the pars distalis (Jabbour et al.,
1997; Mendez et al., 1998).
1.2.4 Regulation of POMC-derived peptide expression and
secretion
1.2.4.1 Pituitary gland POMC expression
Within the pituitary gland, POMC is expressed both by the pars distalis of the
anterior lobe and the pars intermedia of the posterior lobe. It is generally accepted
that the pars intermedia is the source of most of the peripheral circulating pEND and
aMSH in the sheep and this is substantiated by several lines of evidence. First, in
the seasonal cycle in plasma aMSH and pEND concentration in sheep, aMSH
concentrations correlate closely with pEND levels with a molar ratio between the
two hormones close to 1:1 (Lincoln and Baker, 1995). This suggests that these
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two POMC-derived products are co-secreted from the same tissue and are subject
to the same regulatory mechanism.
Secondly, ACTH, which is an intermediate in the processing of aMSH from
the precursor, POMC, is also secreted into the circulation from the pituitary gland.
It is thought that the corticotrophs of the pars distalis secrete most of this circulating
ACTH in response to hypothalamically-derived humoral releasing factors (Smith
and Funder, 1988). Plasma ACTH correlates poorly with photoperiod and does
not correlate well with aMSH in the long term, suggesting that the observed
changes in aMSH and pEND are due to the secretory activity of a cell type other
than the corticotroph, specifically the pars intermedia melanotroph (Lincoln and
Baker, 1995). Moreover, circulating Cortisol, which is secreted in response to
ACTH, is also not clearly affected by photoperiod (Brunet and Sebastian, 1991;
Ebling and Lincoln, 1987). Ultradian fluctuations in ACTH with a frequency of
minutes, correlate only partially with fluctuations in aMSH secretion in the sheep
(Engler et al., 1989; Hagan and Brooks, 1996). Such secretion of ACTH with
aMSH has also been demonstrated in ovine fetal melanotrophs in vitro (Fora et al.,
1996). Since ACTH is also produced by the pars intermedia as an intermediate in
aMSH biosynthesis, the partial correlation of such short term fluctuations of
aMSH to ACTH is consistent with the hypothesis that the pars distalis is the source
of most circulating ACTH while the pars intermedia secretes most circulating
aMSH with a small quantity of ACTH.
Thirdly, glucocorticoid receptors are expressed by corticotrophs but are not
usually expressed in the pars intermedia (Autelitano et al., 1989). Dexamethasone,
a synthetic glucocorticoid receptor agonist, inhibits the secretion of ACTH, but not
aMSH, in the sheep (Engler et al., 1989) providing further evidence that the pars
distalis is not a significant source of circulating aMSH. Most pEND is likely to be
also derived from the pars intermedia although since dexamethasone is able to
partially suppress pEND there may be some secretion of this peptide by the pars
distalis (Ssewannyana et al., 1989).
Further evidence supporting the concept that the pars intermedia is the major
source of aMSH and pEND cosecretion is provided by the suppression of secretion
of both peptides, but not ACTH, by the dopamine D2 receptor agonist
bromocriptine (Engler et al., 1989). Moreover, circulating aMSH and pEND are
dramatically increased after hypothalamo-pituitary disconnection without a
corresponding increase in circulating ACTH (Clarke et al., 1986). This suggests
that the secretion of these peptides is under inhibitory hypothalamic regulation in
the intact animal and is consistent with the model of tonic inhibitory dopaminergic
control of the pars intermedia established in other species (Oyarce et al., 1996).
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1.2.4.2 Ontogeny of POMC expression in the ovine pituitary
gland
POMC mRNA expression is first seen in the fetal sheep pars distalis at day 60
(Yang et al., 1991) and increases to parturition (Challis and Brooks, 1989). Some
workers report a decrease in POMC mRNA expression in the last three weeks of
gestation and this may reflect increased glucocorticoid feedback from the
developing adrenal cortex (Merei et al., 1993). The corticotroph may be
unresponsive to glucocorticoids before this stage of development since where the
hypothalamus is surgically disconnected from the pituitary in the 100 day fetal
sheep, POMC mRNA is unaltered by exogenous Cortisol. ACTH storage is
increased in the pituitary gland of the sheep nearer parturition and this increased
storage may be due to increased negative feedback by Cortisol (Challis and Brooks,
1989). However, circulating levels of ACTH increase by more than two fold from
110 days to 147 days of gestation in the fetal sheep (Saphier et al., 1993) in spite
of a 20 fold increase in circulating Cortisol (Challis and Brooks, 1989) in a similar
time frame. This dramatic increase in circulating Cortisol suggests increased
sensitivity of the adrenal cortex to ACTH and this is confirmed by studies on the
fetal sheep demonstrating that the adrenal cortex does indeed become more
responsive to ACTH and aMSH and increases in weight exponentially at this stage
of development (Hagan and Brooks, 1996). Furthermore the ratio of mature
ACTH (1-39) to larger immunoreactive forms, which are thought to be antagonistic
to ACTH at the adrenal cortex, increases to parturition (Saoud and Wood, 1996).
The expression of circulating ACTH correlates well with the expression of POMC
mRNA. In the sheep, parturition is believed to be dependant on increased fetal
circulating ACTH and Cortisol immediately prepartum (Challis and Brooks, 1989).
Increased ACTH near to term stimulates increased circulating Cortisol which in the
sheep acts at the placenta to increase the production of estrogens and uterine
smooth muscle activity (Liggins, 1974; Saoud and Wood, 1996). The corticotroph
secretes ACTH in response to CRF by day 110 of gestation (Challis and Brooks,
1989). Postnatally, pars distalis POMC mRNA expression decreases from the
neonate to the adult.
POMC expression in the pars intermedia is detected at a later stage than in the
pars distalis. In the pars intermedia ultrastructural evidence for biosynthetic activity
is reported by day 70 of gestation (Perry et al., 1982). Soon afterwards, D2
dopamine receptors are expressed and the ovine melanotroph responds to the
dopamine agonist, bromocriptine with a two fold decrease in POMC mRNA
expression and decreased circulating aMSH by 130 days of gestation (Hagan and
Brooks, 1996; Matthews et al., 1996). A corresponding response in the secretion
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of ACTH to dopamine agonists and antagonists suggests that the fetal pars
intermedia secretes a significant amount of ACTH (Hagan and Brooks, 1996). The
pars intermedia may, therefore, have a significant role in the induction of
parturition in the sheep.
In the rat, the development of corticotroph and melanotroph function follows
a similar temporal order. Expression of POMC mRNA is first detected in the
ventral aspect of Rathke's pouch, which becomes the pars distalis at embryonic day
13, two days before it is expressed in the presumptive pars intermedia (Lugo et al.,
1989). The rat corticotroph expresses receptors for and is sensitive to stimulation
by CRF at embryonic day 15 (Scott and Pintar, 1993). This just precedes the
invasion of the median eminence by CRF neuron terminals at embryonic day 16
(Lugo et al., 1989). Soon afterwards the corticotroph begins to process the POMC
precursor. The processing enzyme PC2 is abundantly expressed in the
corticotroph of the fetal and neonatal rat (Mains and Eipper, 1990) and mouse
(Marcinkiewicz et al., 1993) suggesting that processing of POMC by the neonatal
corticotroph is more extensive where it occurs, producing POMC products more
chacteristic of the melanotroph, during fetal and neonatal life. PC2 expression in
the pars distalis is negligable in the adult and the loss of PC2 activity may be
associated with suppression by glucocorticoids (Mains and Eipper, 1990). In spite
of the more extensive nature of POMC-processing in the fetal compared to the adult
corticotroph, efficient processing of POMC does not seem to occur in the rat until
late in development. In the neonate only 50% of pars distalis POMC is processed
compared to over 90% in the adult (Mains and Eipper, 1990).
In the rat, immunoreactive aMSH is detected in the pars distalis before
POMC mRNA is expressed in the pars intermedia (Lugo et al., 1989). In the pars
intermedia, the expression of POMC mRNA is first detected at about embryonic
day 15, increases steadily to birth and subsequently increases a further four fold to
weaning (Hindelang et al., 1990; Lugo et al., 1989). The processing enzymes
PCI and PC2 are first detected in the pars intermedia of the mouse one day after
POMC mRNA is first expressed (Marcinkiewicz et al., 1993). In the rat, aMSH is
not detected in the pars intermedia until day 19, some time after POMC mRNA
expression is first detected (Allen et al., 1984). The neonatal pars intermedia
seems to be sensitive to glucocorticoids in the rat, since dexamethasone inhibits the
expression of POMC mRNA one day after birth but has no effect ten days later
(Scott and Pintar, 1993).
1.2.4.3 Direct innervation and regulation of the pars intermedia
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The pars intermedia is much more closely associated with the pars nervosa than
with the pars distalis from which it is separated by the residual lumen of Rathke's
pouch (Wingstrand, 1966). The melanotrophs are therefore in direct contact with
neurons of the hypothalamus which extend nerve terminals into the pars nervosa
and regulate the activity of the pars intermedia (Chronwall et al., 1998). Direct
innervation of the pars intermedia was first observed in the rabbit (Atwell, 1918)
and occurs in many species including the sheep (Chronwall et al., 1998; Danger et
al., 1989; Perry et al., 1981). In the rat direct contacts to melanotrophs by
dopaminergic and GABAergic neurons have been observed and the degree of
individual melanotroph innervation has been implicated in apparent heterogeneity in
melanotroph activity (Chronwall et al., 1998).
The nerve terminals of the mammalian pars nervosa exert a regulatory control
over the pars intermedia which is principally inhibitory. In the sheep,
hypothalamo-pituitary disconnection, which also results in atrophy of the pars
nervosa results in increased circulating aMSH (Clarke et al., 1986). Similarly,
posterior pituitary denervation in the rat, which abolishes tyrosine hydroxylase
activity in the posterior lobe and results in polyurea due to the loss of vasopressin,
increases circulating aMSH by two fold (Vecsernyes et al., 1997).
1.2.4.4 Dopaminergic innervation
In the sheep dopaminergic neurons, originating at least partly in the hypothalamic
A15 nucleus, infiltrate the pars intermedia and make direct synaptic contacts with
individual melanotrophs. Tyrosine hydroxylase immunoreactive neurons are also
observed in the pars intermedia and pars nervosa of the porcine pituitary gland
(Leshin et al., 1996). Similarly in the rat the pars intermedia is innervated by
dopaminergic neurons originating at least partially in the periventricular region of
the hypothalamus (Goudreau et al., 1992), specifically the A14 nucleus (Goudreau
et al., 1995). The pars intermedia is under tonic inhibitory control by dopamine
secreted by these neurons, which acts in the rat by decreasing the responsiveness to
(3-adrenergic input through specific G-protein negatively-coupled D2 dopamine
receptors (Cote et al., 1981; Cote et al., 1982b). The stimulation of these receptors
blocks the activity of adenylate cyclase and so reduces intracellular cAMP levels.
Dopamine seems to exert the principle role in the regulation of pars intermedia
activity in most species studied (Oyarce et al., 1996; Ssewannyana and Lincoln,
1990). The only mammalian exception to this pattern of dopaminergic innervation
and inhibitory control documented to date is the rabbit in which glucocorticoids
appear to exert the major inhibitory control over the pars intermedia
(Schimchowitsch et al., 1994).
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In the rat, chronic treatment with the dopamine agonist, bromocriptine,
decreases mRNA levels for POMC two to four-fold (Lundblad and Roberts, 1988)
and mRNA for many of the enzymes involved in the processing of POMC
including PC2, CPE and PAM by approximately two-fold (Bloomquist et al.,
1991; Oyarce et al., 1996). Moreover, chronic treatment with haloperidol, a
dopamine antagonist, results in an increase in mRNA expression for these enzymes
(Bloomquist et al., 1991; Chronwall et al., 1987; Oyarce et al., 1996) while POMC
mRNA is increased two to seven-fold (Chen et al., 1983; Hollt et al., 1982a;
Lundblad and Roberts, 1988). Circulating (3END is increased by up to five fold
after such treatment (Hollt and Bergmann, 1982b). POMC and PC2 mRNA levels
generally show a greater sensitivity to dopamine than PCI, CPE and PAM (Oyarce
et al., 1996). Moreover N-acetyl-transferase activity may also be regulated by
dopamine since it is found that cultured rat melanotrophs secrete a greater ratio of
acetylated (3END to non acetylated forms when treated with haloperidol (Ham et al.,
1984). Since the processing enzymes are expressed at a level much lower than that
of POMC, the regulation of their expression by dopamine may have a large impact
on the synthesis of mature POMC-derived peptides (Oyarce et al., 1996).
Biosynthetic rates of POMC-derived peptides were found to change even more
markedly than mRNA levels in response to such treatments suggesting that
dopamine may also exert an inhibitory translational effect (Oyarce et al., 1996).
Dopamine antagonists seem to exert a short term biphasic effect where peptide
secretion alone is initially increased and then later gene expression is also increased
so that stored peptide is replenished. In the longer term regression in the murine
pars intermedia is noted after long term treatment with bromocriptine (Beaulieu et
al., 1984). Chronic treatment with bromocriptine and haloperidol (over 12 days)
were found to have an influence on DNA synthesis (decreased and increased
respectively, measured by [3H]thymidine incorporation) suggesting that dopamine
suppresses cell proliferation in the rat pars intermedia (Chronwall et al., 1987). In
this study a change in the gross morphology of the pars intermedia was noted as a
result of changes in the number of melanotrophs due to proliferation. The response
to these treatments in POMC expression was more rapid (significant within a few
hours) than the proliferative response. Proliferation of melanotrophs has been
observed by other workers in the adult rat (Saland, 1981) and immature mice
(Llanos et al., 1987).
1.2.4.5 p-Adrenergic innervation
Melanotrophs secrete POMC-derived peptides in response to (3-adrenergic input
through specific G-protein coupled receptors (Cote et al., 1982a) which are
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expressed in the pars intermedia of the rat (Chronwall et al., 1998) and are
mediated by increased intracellular calcium (Nemethy et al., 1998). This response
is biphasic and is proceeded by a small decrease in calcium (Nemethy et al., 1998).
Noradrenaline, the endogenous ligand for (5-adrenergic receptors, is synthesised by
the enzyme dopamine (S-hydroxylase and this enzyme is present in the pars nervosa
(Chronwall et al., 1998). Alternatively peripherally circulating catecholamines
such as epinephrine from the adrenal medulla may stimulate the secretion of aMSH
from the pars intermedia, p-adrenergic receptors also seem to mediate increased
aMSH secretion in response to histamine since the p-adrenergic receptor antagonist
propanolol abolishes this response (Kjaer et al., 1995; Knigge et al., 1991).
1.2.4.6 GABAergic innervation
The murine pars intermedia, as well as the pars nervosa and median eminence, is
also directly innervated by GABA neurons which originate in the hypothalamus
(Vincent et al., 1982). The influence of GABA on the melanotroph of the rat is
generally inhibitory although there is evidence to suggest that GABA can in the
short term actually stimulate aMSH secretion from the melanotroph in vitro
(Loeffler et al., 1986; Tomiko et al., 1983) before exerting an inhibitory action.
The GABA agonist, muscimol, stimulates the secretion of aMSH in vitro in the
short term while GABA inhibits the increased secretion of aMSH resulting from
increased potassium ions (Tomiko et al., 1983). The rat pars intermedia expresses
the GABAa receptor which is activated by not only GABA, but also endozepines
(natural analogues of benzodiazepines), steroids and barbiturates, although these
other ligands bind at different parts of the receptor structure. GABAa receptor
activation by administration of benzodiazepines causes a 25% reduction in pars
intermedia POMC mRNA (Garcia de Yebenes et al., 1997).
1.2.4.7 Serotoninergic innervation
In the rat the pars intermedia is innervated by neurons with serotonin
immunoreactivity (Autelitano et al., 1989), expresses serotonin receptors and
responds with increased aMSH secretion to serotonin (Chronwall et al., 1998;
Randle et al., 1983). Where serotonin is experimentally depleted with a
neurotoxin, POMC mRNA is increased in the murine pars intermedia and the
increase in POMC mRNA associated with stress is abolished (Garcia-Garcia et al.,
1997). The possibility exists that serotonin may be principally exerting an effect on
the corticotroph since the secretion of (SEND is more sensitive to stimulation than
that of aMSH after treatment with serotonin agonists or the serotonin reuptake
inhibitor, fluoxetine (Carr et al., 1991). Serotonin may be more relevant to the
Chapter 1 Literature Review 17
CRF neuroendocrine system than the pars intermedia, since serotonin stimulates
the secretion of CRF from cultured rat hypothalamic neurons in vitro (Hillhouse
and Milton, 1989). Furthermore, the immunoreactivity in the pars nervosa of the
rat is abolished by fluoxetine, suggesting that serotonin is not synthesised but is
internalised by neurons of the pars intermedia (Saland et al., 1987), possibly
through a dopamine reuptake mechanism (Chronwall et al., 1998). Moreover the
effects of the serotonin agonist, MK-212 on aMSH, but not (3END secretion can be
blocked by pretreatment with the dopamine agonist apomorphine (Carr et al., 1991)
suggesting that the pars intermedia response to serotonin is likely to be mediated by
dopamine. Taken together these reports suggest that while melanotrophs may be
capable of responding to serotonin, it is unlikely that serotonin plays a significant
part in the direct regulation of pars intermedia activity.
1.2.4.8 Neuropeptide Y (NPY) innervation
There is evidence that NPY neurons innervate the pars intermedia in some species.
This is well recognised in some lower vertebrates (Danger et al., 1989) and NPY
binding sites are found in follicular-stellate cells of the amphibian pars intermedia
(De Rijk et al., 1991). While some reports suggest NPY neurons also occur in the
rat pars nervosa and occasionally the pars intermedia (Vanhatalo and Soinila,
1996), other workers have failed to confirm such innervation (Chronwall et al.,
1998). It is likely that NPY is less relevant to the mammalian pars intermedia than
in the lower vertebrates and that NPY neurons in the pars nervosa, if present, may
have a role unrelated to pars intermedia function.
1.2.4.9 Regulation of the pars intermedia by CRF and AVP
The pars intermedia of the sheep, rat and frog responds to CRF with increased
secretion of POMC-derived peptides (Fora et al., 1996; Kraicer et al., 1985;
Verburg-van Kemenade et al., 1987), and CRF receptors have been localised to
murine melanotrophs. However, the murine pars nervosa contains no CRF
neurons (Chronwall et al., 1998). It is conceivable that small quantities of CRF
may reach the pars intermedia through its vasculature, though this seems unlikely
to represent a significant regulatory system since in most species the pars
intermedia is poorly vascularised and is not supplied with blood from the portal
vessels. The ovine pars intermedia is, however, more vascularised than that of the
rat and it is reported that the fetal pars intermedia secretes increased ACTH in
response to AVP and CRF (Fora et al., 1996). The expression of the CRF-like
peptide, urocortin (Vaughan et al., 1995) has been reported in the pituitary gland of
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the rat (Wong et al., 1996), raising the possibility of paracrine stimulation of the
secretion of POMC-products through a CRF receptor mediated mechanism.
1.2.5 Peripheral and auto-regulation of pituitary gland POMC
expression
1.2.5.1 Glucocorticoid negative feedback
Glucocorticoids reduce the expression and secretion of POMC-derived peptides
from the rat corticotroph (Gagner and Drouin, 1985) and the glucocorticoid
receptor-ligand complex may act as a trans-acting factor in the inhibition of gene
transcription (Autelitano et al., 1989). Additionally glucocorticoids also act in the
hypothalamic paraventricular nucleus to reduce the expression of CRF in the ovine
fetus (Myers et al., 1992) implicating a negative feedback effect at both
hypothalamic and pituitary levels. Glucocorticoids reduce the expression of POMC
and secretion of POMC-derived peptides both in the pars distalis and in cultured
ovine corticotrophs (Levin et al., 1993). The glucocorticoid receptor is not
normally expressed in the mammalian pars intermedia in vivo (Antakly and Eisen,
1984) except in the rabbit (Schimchowitsch et al., 1994). This is confirmed by the
observation in the rat that while adrenalectomy increases POMC mRNA expression
in the pars distalis, it has no such effect in the pars intermedia (Schacter et al.,
1982). However, where rat melanotrophs are isolated from the hypothalamus by
autotransplantation to the kidney capsule, they respond to stress with a decrease in
POMC gene expression (Iturriza, 1989). This seems to suggest that
glucocorticoids can act directly on melanotrophs in isolation from the hypothalamus
and this is substantiated by the finding that where the pars intermedia of the rat is
isolated from hypothalamic input, glucocorticoid receptor expression develops
(Antakly et al., 1985; Seger et al., 1988). This can be reversed by treatment with
bromocriptine and dopamine itself suggesting that hypothalamic dopamine
suppresses the expression of glucocorticoid receptor in the pars intermedia of this
species (Antakly et al., 1987). Moreover the rabbit pars intermedia, the one known
mammalian example in which the glucocorticoid receptor is normally expressed,
lacks pars intermedia responsiveness to dopamine and possibly even lacks
dopamine innervation (Schimchowitsch et al., 1994). There are, however, reports
of the presence of immunoreactivity to glucocorticoid receptor in the rat pars
intermedia, which is mostly cytosolic, suggesting that the receptor is in an inactive
form (Bertini et al., 1989). Since glucocorticoid sensitivity occurs in the pars
intermedia of the rat after treatment with the inhibitor of protein synthesis,
puromycin, it has been suggested that glucocorticoid receptors are present in the
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pars intermedia of the rat under normal circumstances in a form
immunocytochemically masked by an endogenous protein inhibitor. It is possible
that where glucocorticoid receptors are inactive or inhibited, their conformation
does not allow exposure of the DNA-binding motifs of the receptor, to which most
antibodies have been raised (Cidlowski et al., 1990). The ovine pars intermedia,
however, does not respond to dexamethasone with any change in POMC mRNA
expression where hypothalamic influence is removed from the pars intermedia in
the HPD sheep (Mercer et al., 1989), thus it is unlikely that glucocorticoid receptor
is expressed in the ovine pars intermedia even in the absence of hypothalamic
influence.
1.2.5.2 Melanotroph infra-cellular response to stimulation
Melanotrophs of the pars intermedia secrete stored POMC-derived products such as
aMSH, in a high frequency pulsatile fashion (Engler et al., 1989; Hagan and
Brooks, 1996) in response to cAMP-mediated secretogogues such as noradrenaline
(Cote et al., 1982b; Miyazaki et al., 1984). The identity of the specific substrate
phosophorylated by cAMP-dependant protein kinase activity and which is
responsible for the exocytosis of the secretory granule in the melanotroph has not
been identified. There is some evidence that these events are mediated by
intracellular calcium signalling since removal of calcium prevents secretion and the
calcium ionophore A23187 stimulates secretion without affecting cAMP
concentrations (Miyazaki et al., 1984).
Basal aMSH secretion is generally maintained at a high default level but is
tonically suppressed by dopamine which exerts its effect through D2 dopamine
receptors (Ssewannyana and A, 1990) which are G-protein negatively coupled
(Cote et al., 1982b). When stimulated they block the action of adenylate cyclase in
catalysing the synthesis of cAMP (Lundblad and Roberts, 1988). A decrease in
sensitivity to p-adrenergic stimulation after exposure to dopamine agonists has also
been reported (Cote et al., 1981) .
The full cellular repertoire of POMC-derived peptides are likely to be present
within the same secretory granules and cosecreted in response to secretagogues
although there are reports of differential secretion of particular POMC-products
(Randle et al., 1983). Since many POMC-derived peptides are synthesised and
mature in the secretory vesicle (Milgram and Mains, 1994) such differential
regulation seems unlikely.
1.3 POMC and its products
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1.3.1 The POMC molecule
ACTH and aMSH were long known to be produced from a single precursor
protein and it was subsequently discovered that (3LPH and (3END, which
colocalised to the same pituitary cell types, were also produced from the same
precursor (Mains et al., 1977). This precursor, POMC, is a 265 amino acid
prohormone expressed in both the anterior and the posterior lobes of the ovine
pituitary gland and is cleaved into a number of smaller biologically active peptides
by the prohormone convertase enzymes in a tissue-specific manner (Figure 1.1).
In the pars distalis, POMC is expressed only by a proportion of cells, the
corticotrophs. The principle products of POMC processing in these cells are
ACTH and pLPH. In the pars intermedia POMC is expressed at a very high level,
its mRNA being 10% of all mRNA (Oyarce et al., 1996) produced, by
melanotrophs which are the principle cell type of this tissue. There are estimated to
be between 20000 and 50000 transcripts for POMC present in the average murine
melanotroph (Lundblad and Roberts, 1988; Oyarce et al., 1996). Subsequent
processing of POMC by the prohormone convertases in the melanotroph is more
extensive than in the corticotroph and (3END, aMSH, CLIP and (3CT are among the
products of POMC processing in the pars intermedia (Figure 1.3). POMC is
expressed in a great many other tissues including the hypothalamus, the amygdala
(Garcia-Garcia et al., 1997), pigment cells of the skin and the pancreatic islets of
Langerhans where POMC-derived peptides can stimulate insulin secretion through
a paracrine action (Borelli et al., 1996). The widespread pattern of POMC
expression may reflect that the products of the POMC protein are pleiotrophic in
their physiological effects. Extrapituitary POMC is also expressed in immune cells
and both leydig and germ cells in the testis where in the rat a mRNA transcript for
POMC is produced that is 250bp smaller than the llOObp transcript expressed in
the rat pituitary gland (Autelitano et al., 1989; Smith and Funder, 1988). Similarly
in the sheep a 1200bp transcript is detected in the pituitary gland compared to a
transcript 100-200bp smaller in the testis, ovary and placenta (Yang et al., 1991).
POMC is widely phylogenetically conserved and it is expressed throughout the
vertebrates and some invertebrate phyla such as the annelida (Salzet et al., 1997).
The murine, porcine, bovine and human POMC genes contain three exons
separated by two large introns in the 5' untranslated region and the N-terminal
fragment, which are rapidly removed from the primary RNA transcript in the
nucleus before transport to the cytoplasm (Castro and Morrison, 1997). Changes
in the expression of the primary RNA transcript, because of its transient nature are
detectable before changes in mRNA and this phenomenon has been utilised in
studies on the temporal nature of POMC gene expression in response to dopamine
antagonists. The expression of the primary POMC transcript is increased within
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Figure 1.3 The endoproteolytic processing of POMC by PCI (top) and PC2
(bottom)





















Figure 1.4. Summary diagram illustrating the way in which the hypothalamus
may mediate the effects of photoperiod to regulate POMC expression and
processing in the melanotrophs of the pars intermedia to dictate the seasonal cycle
in aMSH secretion in the sheep.
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one hour of haloperidol administration in the rat (Lundblad and Roberts, 1988).
Studies on the rat POMC gene in which its 5' untranslated regulatory sequence is
fused to a CAT reporter gene reveal that relative to the start of translation site the
start of transcription occurs at -95 nucleotides and suppressive regulatory sites
occur between -59 and -35. Promoter sequence occurs from -35 to -21 nucleotides
(Lundblad and Roberts, 1988). The rat POMC promoter contains at least nine
regulatory elements and the synergistic action of all these elements determine the
level of POMC gene expression (Castro and Morrison, 1997). Only one POMC
gene occurs in all species studied except for a murine pseudogene which is not
expressed and probably arose through transposon activity (Lundblad and Roberts,
1988). Moreover, the porcine pars distalis and pars intermedia express identical
POMC mRNA transcripts (Gen et al., 1994). Thus, the tissue-specific regulation
and processing of POMC is not likely to result from multiple gene copies, rather
POMC is processed in a tissue-specific way to yield a number of biologically active
products. The nature of these products is determined by the nature and extent of
POMC-processing and modification (Eipper and Mains, 1980).
1.3.2 The POMC-derived peptides
1.3.2.1 Adrenocorticotrophic hormone (ACTH)
ACTH is one of the principle secreted products of the corticotroph but is also
produced in the pars intermedia as an intermediate in aMSH synthesis. ACTH acts
principally on the adrenal cortex where it stimulates the secretion of Cortisol. It is
thought to be essential in the maturation of the adrenal cortex in the sheep, since
hypophysectomy results in adrenal cortical hypotrophy. ACTH induces the
prepartum Cortisol surge which causes parturition and synchronises the maturation
of tissues such as the lungs in preparation for birth (Challis and Brooks, 1989).
ACTH may also be an immunomodulator and its secretion is affected by immune
status through circulating cytokines (Rivier, 1995) including leukaemia inhibitory
factor (Ray et al., 1996). ACTH and glucocorticoids are particularly increased in
rats in response to stress such as hypoxia, restraint (Gaillard and Al-Damluji,
1987), pain (Smith and Funder, 1988) and dietary protein deficiency (Jacobson et
al., 1997).
1.3.2.2 (3-Lipotrophin ((3LPH)
There is little literature on the biological actions of (3LPH, although it is known to
stimulate the production and secretion of steroids such as Cortisol and aldosterone
from the adrenal gland (Matsuoka et al., 1981; O'Connel et al., 1996).
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1.3.2.3 a-Melanocortin (aMSH)
aMSH is a basic 13 amino-acid peptide with a molecular weight of 1663Da.
aMSH is derived from ACTH peptide sequence (1-13) through endoproteolytic
cleavage of the prohormone and subsequent acetylation at the N-terminal serine
residue in the N- and 0- positions (Castro and Morrison, 1997). In the ovine pars
intermedia, mono-acetylated, diacetylated and des-acetylated aMSH occur in
approximately similar amounts (Smith and Funder, 1988). As well as in the
pituitary pars intermedia and pars distalis, aMSH occurs in the hypothalamus,
thalamus, midbrain, amygdala, the brain stem and peripherally the skin, gut,
placenta, testis, ovary and the adrenal medulla (Catania and Lipton, 1993).
aMSH and ACTH exert their biological effects through a number of recently
cloned receptors. Five subtypes of the melanocortin receptor have been cloned to
date and the tissue distribution and ligand specificity of each is unique (Mountjoy
and Wong, 1997). The expression of the type one melanocortin receptor (MC1-R)
occurs in adipose tissue, the melanocytes and melanomas of the skin and in
macrophages (Mountjoy and Wong, 1997). MC1-R is involved in pigmentation in
melanocytes and its primary ligand is aMSH. An endogenous antagonist, the
agouti protein, occurs in the mouse which regulates the balance between the
production of two melanin pigments, the black eumelanin and yellow
phaeomelanin. Inappropriate central expression of agouti coupled with
overexpression in the melanocyte results in the abnormalities seen in the yellow
obese mouse which has a yellow coat colour and an obese, insulin-resistant
phenotype (Lu et al., 1994). The second receptor type (MC2-R) is the classic
ACTH receptor, which has a low affinity for aMSH and is involved in the HPA
axis. This receptor is expressed in adipose tissue as well as the adrenal gland
(Mountjoy and Wong, 1997). The type three receptor (MC3-R) is expressed
centrally as well as in placenta, duodenum, the pancreas and the stomach
(Mountjoy and Wong, 1997). MC3-R acts as a receptor for yMSH as well as
aMSH (Catania and Lipton, 1993).
The type four receptor (MC4-R) is expressed centrally in the brain, spinal
cord, sympathetic nervous system and muscle (Mountjoy and Wong, 1997). This
receptor subtype is implicated in the central control of appetite since its inactivation
in the mouse results in hyperphagia and obesity (Huszar et al., 1997). aMSH and
desacetyl-MSH have potent effects in promoting weight gain in white and brown
adipose tissue, and muscle in the mouse (Shimizu et al., 1989). However, intra-
cerebroventricular administration of aMSH is also reported to reduce food intake in
rats while attenuating CRF-induced anorexia (Oohara et al., 1993). This
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inconsistency in the response in voluntary food intake to aMSH is complicated by
the fact that acetylated and des-acetylated forms appear to have antagonistic effects,
acetylated forms having an inhibitory and des-acetylated forms having a stimulatory
effect on food intake (Mountjoy and Wong, 1997). In the rat, pars intermedia
aMSH is generally acetylated to a greater degree than hypothalamic aMSH (Castro
and Morrison, 1997).
The fifth receptor (MC5-R) is expressed in the brain and spinal cord, in skin,
exocrine glands, prostate gland, adrenal cortex, spleen, thymus, lymphoid tissues,
bone marrow, pituitary gland, testis, ovary, skeletal muscle and adipose tissue
(Mountjoy and Wong, 1997; van der Kraan et al., 1998). MC5-R has a more
widespread pattern of peripheral expression than any of the other melanocortin
receptor subtypes and is particularly highly expressed in the lacrimal gland,
preputial gland and harderian gland (van der Kraan et al., 1998).
aMSH stimulates the excretion of sodium ions from the kidney through the
increased secretion of atrial natriuretic peptide in the rat (Castro and Morrison,
1997). The genetically spontaneously-hypertensive rat has a phenotype which
includes increased pars intermedia POMC gene expression, alterations in central
dopaminergic activity and reduced pituitary dopamine content (Autelitano and van
den Buuse, 1997). This is consistent with pars intermedia hyperactivity associated
with reduced dopaminergic tonic inhibition. Furthermore, chronic salt-loading
decreases POMC mRNA levels and causes regression of the pars intermedia of rats
(Sharma et al., 1997). These data suggest a role for aMSH in sodium balance and
hypertension in the rat. Other MSH peptides such as (3MSH and yMSH which
occur as a result of specific cleavages of different regions of the POMC molecule
(the (3LPH(4i-58) and N-terminal regions respectively) also have natriuretic
properties (Valentin et al., 1993), as described for aMSH.
aMSH has potent antipyretic properties when administered centrally or
peripherally and endogenous aMSH may play a role in the regulation of fever.
aMSH content in certain brain regions increases in fever and circulating aMSH
also increases in response to pyrexia (Catania and Lipton, 1993). aMSH is
capable of suppressing local inflammation and hypersensitivity reactions (Catania
and Lipton, 1993; Tatro, 1996). This immunoregulatory role of aMSH is
probably its most phylogenetically ancient function. POMC is expressed by
invertebrate immunocytes (Salzet et al., 1997) and has immunoregulatory
properties in invertebrates (Tatro, 1996).
In the human, circulating aMSH decreases after birth probably because of the
dramatic involution of the pars intermedia after which only a few isolated aMSH
immunopositive cells remain in the adult (Mauri et al., 1993).
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1.3.2.4 (3-Endorphin ((3END)
(3END is one of the three endogenous opioid receptor ligands, which also include
enkephalin and dynorphin. The opioid receptors, specifically p, 8 and k (Morley
and Levine, 1983) were identified before their ligands as the binding sites for
exogenous opioids such as morphine. Like morphine, endogenous opioids have
powerful analgesic properties.
For some years there has been interest in (3END as a potential factor
governing food intake and metabolism. There is good evidence in both rodents and
humans that altered central and peripheral levels of pEND are associated with
obesity, eating disorders and stress (Mercer and Holder, 1997). Genetically obese
mice (ob/ob) and rats (fa/fa) are found to have a higher pituitary content of (3END
than lean strains (Margules et al., 1978). Furthermore, periods of increased food
intake in rats correlate with increased circulating immunoreactive pEND (Davis et
al., 1983). There is some evidence that pEND acts as an insulin secretagogue in
the pancreas (Ipp et al., 1978; Reid and Yen, 1981), although a role for pEND on
insulin secretion is not consistently observed (Fatouros et al., 1995). Circulating
PEND is correlated negatively with circulating glucose concentrations, but not with
circulating insulin, suggesting that pEND is involved with glucose metabolism and
regulation in an insulin independent way (Fatouros et al., 1995).
In humans, elevated basal levels of circulating pEND are associated with
obesity (Balon-Perin et al., 1991; Genazzani et al., 1986; Giugliano and Lefebvre,
1991) and pancreatic p-cell response to pEND is increased in such subjects
(Cozzolino et al., 1995; Giugliano and Lefebvre, 1991). Since the adult human
pituitary does not contain a distinct neuro-intermediate lobe, and this elevated
PEND level is not abolished by dexamethasone, it is unclear whether this plasma
pEND is derived from the pituitary.
In the sheep, where hypoglycaemia is induced by an insulin bolus, ACTH,
PEND and aMSH are secreted into the peripheral blood. The delay in this response
suggests that insulin is not having a direct effect on the secretion of POMC-derived
peptides from the pituitary gland (Engler et al., 1988) and that hypoglycaemic
stress itself may be the major stimulator to POMC-derived peptide secretion.
Most of the pEND produced by the ovine pars intermedia is of an acetylated
form (mostly acetylated pEND(i_27)) (Smith and Funder, 1988), compared to only
25% acetylation in the ovine pars distalis (mostly pEND(i_3i)) (Castro and
Morrison, 1997). Acetylated pEND is thought to be inactive as an opioid receptor
ligand (Smith and Funder, 1988). Furthermore it is unlikely that peripheral pEND
can cross the blood brain barrier (Mercer and Holder, 1997). It may be that altered
levels of peripheral pEND reflect altered central levels and are altered in concert
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with bioactive aMSH. It is possible that the secretion of (3END by the pars
intermedia is of secondary importance to the cosecretion of aMSH.
1.3.2.5 Corticotrophin-like intermediate lobe peptide (CLIP)
CLIP is a peptide derived from the C-terminal portion of ACTH by endoproteolytic
processing in the pars intermedia (Figure 1.3) and its name reflects the fact that the
shared peptide sequence often results in cross-reaction with antisera directed
against ACTH. CLIP can be extensively modified by post-translational
exopeptidase activity, glycosylation and phosphorylation. In the rat many forms of
CLIP occur due to the occurrence of different combinations of these modifications
(Smith and Funder, 1988). The biological significance of the many forms of CLIP
is not well understood.
1.3.2.6 (3-Cell tropin (pCT)
PCT, like CLIP, is derived from the processing of ACTH in the pars intermedia.
This peptide was first isolated from the plasma of genetically obese (ob/ob) mice
and is secreted by the pars intermedia. In studies on perfused pancreas, pCT
appears to be an insulin secretagogue in the mouse and rat (Beloff-Chain et ai,
1983; Billingham et al., 1982) and has been shown to have insulin-like lipogenic
properties in adipose tissue (Watkinson and Beloff-Chain, 1984). Plasma pCT
levels have been found to be higher in certain genetically obese strains of mice and
rats when compared to lean animals (Morton et al., 1991). This peptide is also
detected in human plasma (Salvatoni et al., 1986).
POMC-derived peptides are expressed within the pancreatic islets and their
secretion is stimulated by glucose at high concentrations (Borelli et al., 1996). It is
therefore possible that pituitary-derived pCT is not directly involved in the control
of pancreatic function, but that its effects on the pancreas may implicate the
existence of a paracrine mechanism controlling insulin secretion which is mediated
by locally synthesised POMC-derived peptides.
1.3.2.7 Other POMC-derived peptides
In addition to the previously-described peptides, the cleavage of POMC in the pars
intermedia yields other peptides whose physiological function is obscure, including
the 74 amino-acid residue N-terminal fragment which is cleaved to produce yMSH,
C-terminal amidated joining-peptide and a smaller 49 amino-acid N-terminal
fragment (Smith and Funder, 1988) (Figure 1.3).
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1.4 POMC processing and secretion
During POMC translation, the signal peptide at the N-terminus directs POMC to the
lumen of the endoplasmic reticulum where the signal sequence is rapidly removed.
The nascent POMC peptide is then transported to the golgi stack where it is
glycosylated and phosphorylated at specific sites (Smith and Funder, 1988). It is
here and subsequently in the immature secretory granule that the endoproteolytic
processing of POMC occurs. The endoproteolytic processing of POMC
determines the combination of biologically active products liberated from the
prohormone and is catalysed by the prohormone convertases, specifically PCI and
PC2 in the melanotroph (Benjannet et al., 1991; Thomas et al., 1991) (Figure 1.3).
A similar pattern of POMC processing to that of the pars intermedia is also
observed in the hypothalamic arcuate nucleus (Smith and Funder, 1988). PCI and
PC2 are ubiquitous enzymes involved in the processing of a large number of other
prohormones (Castro and Morrison, 1997; Smeekens et al., 1992). These include
POMC, prorenin, proinsulin, proenkephalin, prosomatostatin, proglucagon,
proparathyroid hormone, progastrin, procalcitonin, proCRF and proneurotensin
(Castro and Morrison, 1997). The prohormone convertases are part of a large
family of subtilisin-like endoproteases expressed throughout the animal kingdom
and in yeasts. This family includes yeast Kex2 (Mizuno and Matsuo, 1984), the
constitutive mammalian endoprotease Furin (Bresnahan et al., 1990), PC4 and
PC5 which are expressed in the testis and ovary respectively (Seidah and Chretien,
1994), PC7, expressed in the colon and lymphoid tissues (Seidah et al., 1996) and
PACE4, expressed by somatotrophs, lactotrophs and corticotrophs in the rat
(Johnson et al., 1994).
These proteases, while more substrate-specific (Lindberg, 1991), share
functional and sequence homology to bacterial subtilisin-like enzymes (Seidah and
Chretien, 1994), from which they are likely to be phylogenetically derived. Kex2
was the first characterised of these enzymes, and is a membrane-anchored calcium-
dependent endoprotease which produces the yeast a-mating factor from a precursor
and possesses a distinct catalytic domain containing a Asp-Ser-His amino acid
sequence common to all the prohormone convertases (Castro and Morrison, 1997).
All known mammalian prohormone convertases possess an RGD (Arg-Gly-Asn)
motif which is a recognition sequence for proteins of the extracellular matrix,
although the significance of this motif to the prohormone convertases is unknown
(Seidah and Chretien, 1994). The catalytic domain is invariably followed C-
terminally by a P-domain without which the enzyme fails to mature and may be
important in conformational stabilisation (Lindberg, 1991). At the C-terminus each
prohormone convertase has a unique sequence, including in Kex2 the trans-
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membrane domain (Seidah and Chretien, 1994). PCI and PC2 differ from Kex2
in not usually being membrane-bound, although there are reports of some
membrane bound forms occurring in the secretory granules of the mouse and the
cow (Kirchmair et al., 1992). Different immunoreactive forms of PCI and
PC2 are detected by immunoprecipitation and these are likely to represent
endoproteases at different stages of maturation.
All prohormone convertases cleave proteins at specific paired basic amino
acid residues, and possibly at single arginine residues, in common with related
enzymes (Benjannet et al., 1991; Seidah and Chretien, 1994). Prohormone
sequence at sites other than paired basic amino acid residues are also relevant to
endoproteolytic cleavages since protein conformation may make these residues
more or less stearically exposed to prohormone convertase activity (Jung et al.,
1993). PCI and PC2 are active only late in the secretory pathway and are
dependent on acid pH for maximal activity (Jean et al., 1993; Shennan et al.,
1991). PCI activity is likely to precede PC2 activity in the secretory pathway,
since it is less sensitive to low temperature which inhibits vesicle transport of
secretory products to later stages of the pathway (Milgram and Mains, 1994;
Paquet et al., 1996). Endoproteolytic processing is followed by exoproteolytic
removal of amino acid residues, a-amidation and acetylation. These modifications,
while apparently more subtle than those of the prohormone convertases, have
profound effects on the biological potency of the mature peptide. a-Amidation of
aMSH, for example, which reduces the C-terminal glycine residue to an amide
group, is necessary for biological activity and prevents intracellular degradation
(Smith and Funder, 1988).
PCI and PC2 are restricted to neuroendocrine and endocrine tissues and are
expressed in bovine (Kirchmair et al., 1992), murine (Benjannet et al., 1991) and
amphibian pituitaries (Kurabuchi and Tanaka, 1997). In the rat and mouse, PCI
occurs in the pituitary pars distalis and the pars intermedia whereas PC2 is mainly
confined to the pars intermedia (Benjannet et al., 1991). Similarly in the frog, PCI
and PC2 have been localised at the ultrastructural level in the pituitary gland where
PCI occurs mainly in the corticotrophs of the pars distalis while PC2 is mostly
expressed in the amphibian pars intermedia and pars nervosa. PCI
immunoreactivity colocalises with secretory granules containing ACTH
immunoreactivity, whereas PC2 colocalises down to the ultrastructural level with
aMSH in the pars intermedia (Kurabuchi and Tanaka, 1997). The dependence on
PC2 for aMSH biosynthesis is further strengthened by the observation that PC2 is
localised to human anterior pituitary tumours producing CLIP (Vieau et al., 1994),
which is cosynthesised with aMSH.
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1.4.1 The secretion of POMC-derived peptides
The events that occur in the processing and secretion of POMC rely on a complex
molecular machinery acting in concert. Two modes of exocytotic secretion are
observed. In the first secretory products are constitutively synthesised and secreted
and hence this is known as the constitutive secretory pathway. The products of
POMC-processing are secreted via the second mode of secretion, the regulated
secretory pathway, which involves the concentration of secretory products into
specialised vesicles or secretory granules. These granules store the secretory
products, often for long periods of time, until their release following intracellular
second messenger mediated hormonal stimulation (Burgess and Kelly, 1987). The
processing of POMC is Ca2+ and acidic pH dependant, limiting POMC processing
to the trans-golgi network and secretory granules (Jean et al., 1993; Shennan et al.,
1991). The secretory pathway occurs over a pH gradient, a total decrease of about
lpH unit across the golgi stack (Halban and Irminger, 1994), which is probably
important for transport and sorting of secretory products. Associated with
maturation of secretory granules, there is a concentration of secretory products,
often into an electron-dense inert aggregate and further acidification of the granular
contents occurs (Halban and Irminger, 1994). The concentration of secretory
products in the secretory granule is estimated to be 20-200 fold that of the golgi
(Burgess and Kelly, 1987). These granules are subject to long term storage, and
experiments on (3-cell insulin secretion suggest that more recently formed granules
are preferentially secreted before older ones (Rhodes et al., 1987), although the
functional significance of this mechanism is unclear. In the sheep (3END and
aMSH seem to be cosecreted suggesting a common secretory granule (Lincoln and
Baker, 1995).
1.4.2 PCI
PCI is involved in the processing of several proproteins including POMC. The
mouse PCI gene contains 14 introns and shares considerable homology to PC2 in
the protein level, particularly in the N-terminal catalytic region (Lindberg, 1991).
From N-terminal to C-terminal, the proPCl peptide sequence consists of a pro-
region removed during PCI maturation, a catalytic domain containing the
characteristic Asp-Ser-His amino acid triplet, a P-domain containing the
characteristic RGD sequence, the unique C-terminal sequence and finally a region
of amphipathic helices which may be involved in membrane anchorage (Jung et al.,
1993). PCI commonly cleaves peptides at Arg-Arg, Lys-Arg (to produce ACTH
and (3LPH and weakly to cleave pLPH to produce pEND, (Benjannet et al., 1991;
Jung et al., 1993; Smith and Funder, 1988). PCI is calcium-dependent and is
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optimally active at pH 5.5-6.0 (Jean et al., 1993; Rufaut et al., 1993; Seidah and
Chretien, 1994; Zhou and Lindberg, 1993). The acid pH and calcium requirements
are consistent with the observation by that most PCI mediated endoproteolytic
activity occurs in immature secretory granules (Tanaka et al., 1997).
The prohormone convertases are themselves produced as proenzymes or
zymogens. The maturation of the prohormone convertases is likely to provide an
important mechanism ensuring that these enzymes are activated at an appropriate
stage of the secretory pathway. Like POMC, the endoproteases PCI and PC2 both
contain internal dibasic paired amino acids which act as sites for internal cleavage
autocatalysis. PCI catalyses the removal of its own proregion in the endoplasmic
reticulum (Goodman and Gorman, 1994; Kirchmair et al., 1992; Rufaut et al.,
1993) and is then glycosylated in the golgi stack (Lindberg, 1991), conferring
stability to the enzyme (Benjannet et al., 1993). PCI is further modified in the
golgi stack increasing the activity of the enzyme (Jutras et al., 1997; Lindberg,
1991).
1.4.3 PC2
The human PC2 gene contains 11 introns and is similar at the peptide level to PCI
but possesses a unique C-terminal region, after the P-domain (Lindberg, 1991).
As in proPCl, proPC2 possesses a region of amphipathic loops at its C-terminal
which may be involved in membrane anchorage (Jung et al., 1993). PC2 catalyses
the cleavage of ACTH at the Lys-Lys cleavage site to produce aMSH and CLIP
(Friedman et al., 1996; Smith and Funder, 1988). PC2 is calcium-dependent and
is most active at pH5.5 when transiently expressed in Xenopus oocytes (Lamango
et al., 1996; Shennan et al., 1991). The slightly lower pH optimum for PC2
compared to PCI is consistent with an activity later in the secretory pathway. PC2
matures via an autocatalytic mechanism (Shennan et al., 1995). Autocatalysis of
PC2 requires low pH and is effectively blocked by low temperature, suggesting
maturation in a later secretory compartment than PCI (Milgram and Mains, 1994).
The slower and later maturation of PC2 (Seidah and Chretien, 1994; Shennan et
al., 1995; Zhou and Mains, 1994) may ensure the sequential processing of POMC
in the pars intermedia. The maturation and activity of PC2 is thought to be
regulated by the action of its binding protein, 7B2. This protein bears homology to
both chaperonins and bacterial subtilisin inhibitors (Benjannet et al., 1995; Braks
and Martens, 1994).
1.5 Predictions and aims of this study
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1.5.1 Seasonal cycle in aMSH in the sheep
The seasonal cycle in circulating aMSH in the sheep results from the long term
activation and inactivation of the pars intermedia as an adaptation to life in a
seasonal environment. A generalised model for the way in which the environment
acting through sensory cues may regulate the pars intermedia is illustrated in Figure
1.4. This proposed that cues, particularly photoperiod acting through melatonin,
dictate the functional activity of neural networks in the hypothalamus which govern
the synthesis and secretion of POMC-derived products from the pars intermedia.
Since the pars intermedia is under predominant inhibitory tone through dopamine,
it is presumed that exposure to long days enhances dopamine activity to suppress
the secretion of aMSH as observed in spring and summer, while exposure to short
days reduces dopamine activity to promote the secretion of aMSH as observed in
autumn. These changes in aMSH act in turn on the multiple target tissues
(adipose, pancreas, melanocytes) to induce the seasonal responses.
1.5.2 Model of coordinated control
The cycle in the adult sheep provides a novel model in which to study the dynamic
regulation of POMC expression and processing in the pars intermedia. There have
been no studies of the cellular events associated with this cycle. Consequently, the
aim of the studies presented in this thesis was to investigate the changes in POMC
expression and processing in relation to various physiological treatments and
manipulations- season, photoperiod, hypothalamic disconnection and treatment
with dopamine. Most of the material was collected from Soay sheep which express
a particularly marked seasonal cycle in pars intermedia activity similar to the
ancestral Mouflon. The prediction was as follows:
Long term changes in the secretion of POMC-derived peptides in the adult
sheep will be the result of coordinated regulation of POMC, PCI and PC2 gene
expression.
1.5.3 Layout of the thesis
The thesis begins with a description of general methods used in the studies
including the development of specific molecular probes (Chapter 2). The general
anatomy of the pituitary gland in the Soay sheep is presented for comparison with
other breeds of sheep and with particular emphasis on the cell types expressing
POMC, PCI and PC2 (Chapter 3). The data with respect to season, photoperiod
and hypothalamic control, and influence of dopamine are presented in chapters 4 to
6 respectively. The final chapter aims to integrate the results.
Chapter 2
General Materials and Methods.
2.1. Animals and treatments
2.1.1. Animals
Animals used for the experiments were adult Soay sheep bred in Fife, Scotland
(56°N), and housed outdoors in Fife or indoors in the Marshall Building in Roslin,
Midlothian. Originating from St Kilda in the North Atlantic, the Soay sheep is a
feral breed similar to the wild Mouflon sheep from which all domesticated sheep
are derived. Like the wild sheep the Soay displays pronounced seasonally-
regulated changes in pelage and food intake as well as reproduction (Argo and
Smith, 1983; Lincoln, 1991). Seasonal cycles in aMSH and pEND are well
characterised in the Soay sheep (Ebling and Lincoln, 1987) and as such this breed
is an appropriate experimental model in which to study the seasonal regulation of
the POMC-processing and secretory system. At the end of each experimental
regime, animals were killed by sodium pentobarbitone intravenous overdose. For
the Northern analyses and to validate some of the methods, material was also
obtained from adult Scottish Blackface sheep held at the Moredun Research
Institute, Midlothian.
2.1.2. Treatments
The specific experimental treatments are described in more detail in the relevant
chapters. Generally, where housed indoors, animals were maintained under an
alternating artificial lighting regimen of 16 weekly periods of long (16L: 8D) and
short (8L: 16D) days. During the light phase, light intensity was maintained at 160
lux at the animals head level. Light intensity during the dark phase was maintained
at less than 5 lux by dim red lighting. Such alternating photoperiods are able to
induce and entrain long term cycles in reproductive activity, food intake and pelage
growth similar to those seen in animals living outdoors (Lincoln and Baker, 1995;
Lincoln and Clarke, 1994). Animals maintained indoors were penned individually
with visual and tactile contact between neighbours and were fed on a constant diet
of dried grass nuts with hay and water ad libitum. Where animals lived outdoors
they were maintained in grass paddocks under natural photoperiod and received
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supplementary feeding of commercial sheep nuts and hay during the winter
(December to April). Animals were allowed free access to food and water
throughout all experimental regimes.
2.2. Chemicals and suppliers
Molecular biology grade chemicals were obtained from Sigma, (Poole, UK) and
IBI, (Cambridge, UK). All radiolabelled nucleotides were obtained from Dupont
NEN, (Stevenage, UK). Enzymes were purchased from Boehringer Mannheim,
(Buckinghamshire, UK) or Promega, (Southampton, UK). Phenol/chloroform
was purchased from Camlab, (Cambridge, UK) and was pre-buffered with Tris,
pH 8.0. Autoradiography products were obtained from Eastman Kodak
(Rochester, NY, USA), supplied by Sigma.
2.3. RNA extraction and separation
2.3.1. Dissection of tissue
The pituitary gland and basal hypothalamus were removed shortly after the sheep
were culled. The rostral part of the pituitary gland was fixed in Bouins reagent for
five hours and then transferred to 70% ethanol before paraffin embedding for
histology. The caudal part of the pituitary gland was used for RNA extraction.
Within this more distal portion, the pars intermedia and pars nervosa were
dissected from the pars distalis and both were snap frozen on dry ice and stored at
-70°C until RNA extraction as described below. In some animals, the medio-basal
hypothalamus posterior to the optic chiasm and anterior to the mammilary bodies,
the latero-ventral hippocampus and cerebellum was snap-frozen for RNA extraction
as described for the pituitary gland.
2.3.2. Extraction of RNA from fresh tissue
RNA was extracted using a commercially available guanidinium thiocyanate-based
extraction reagent (Chomczynski and Sacchi, 1987), Tri-reagent (Sigma),
according to manufacturers instructions, with appropriate adjustment of volumes.
The tissue in Tri-reagent was homogenised for approximately 30 seconds until
completely dissociated allowing approximately 10ml Tri-reagent per gram of tissue.
To this homogenate, 0.2 volumes of chloroform was added and the mixture shaken
vigorously for 15 seconds. The mixture was allowed to stand at room temperature
and then centrifuged at 12000g for 20 minutes at 4°C. The upper aqueous layer
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containing the RNA was transferred to a fresh tube and the RNA was precipitated
with 1 volume of cold (-20°C) isopropanol. The RNA was then pelleted by
centrifugation at 12000g for 20 minutes at 4°C. Following removal of the
supernatant, the RNA pellet was washed in 75% ethanol and then dissolved in
RNase-free water by warming to 65°C for lOmin. RNA isolated in this way was
then stored at -70°C.
RNA was scanned at 260 and 280nm on a spectrophotometer. The 260:280
ratio for each sample was calculated to give an estimation of the purity of the RNA.
A ratio of 1.6-1.8 was taken to be pure. The concentration of the RNA was
calculated from the 260nm value where an optical density of 1.0 is equal to
40pg/ml RNA.
2.4. Tissue fixation and processing
2.4.1. Fixation
Fixation of the tissue was achieved by submersion in Bouins reagent (Appendix I).
The tissue was fixed in Bouins' fluid for 5 hours and transferred to 70% ethanol
for storage before processing and wax-embedding, as described below, for
immunocytochemistry and in situ hybridisation.
2.4.2. Processing and sectioning of tissue
Tissue was processed through a graded series of alcohols in an automatic 2LE
Processor (Shandon Scientific Limited, Cheshire, UK) using a standard 20 hour
cycle and embedded in paraffin wax. Glass microscope slides to be used for in situ
hybridisation were washed, dried and baked at 300°C for 8 hours to remove latent
RNase activity. All slides were subsequently washed in a 0.25% solution of 3-
aminopropyl triethoxysilane (TESPA, Sigma) in acetone (BDH Ltd, Poole, UK),
followed by a wash in acetone and finally rinsed in filtered distilled water and
dried. Paraffin wax embedded tissue was sectioned to a thickness of 5pm for in
situ hybridisation, and 3pm for immunocytochemistry using a hand operated "820"
Spencer Microtome (American Optical Corporation) and a D-profile knife. Sections
were floated on water, RNase-free for in situ hybridisation, transferred onto the
treated slides and dried overnight before use.
2.4.3. Histological staining of sections
Haematoxylin and eosin staining (Bancroft and Stevens, 1982) was used for
general histological characterisation of the pituitary gland. Briefly, sections were
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cleared in histoclear (National Diagnostics, Manville, NJ, U.S.A.) and rehydrated
in a decreasing series of alcohols. Sections were stained with haematoxylin
(BDH), differentiated in acid-alcohol and blued in Scott's tap water. Finally,
sections were dehydrated, cleared in xylene and coverslips were mounted with
pertex (Cellpath, Hemel Hempstead, UK).
Tissue sections subjected to immunocytochemistry and in situ hybridisation
were counterstained using haematoxylin alone after the procedure, differentiated in
acid-alcohol and blued in Scott's tap water. Finally, sections were dehydrated,
cleared in xylene and mounted as above.
2.5. Immunohistochemistry
2.5.1. Tissue pretreatment and primary antibody
Tissue sections prepared as described in section 2.4 and mounted onto glass slides
were cleared in histoclear for approximately 10 minutes and rehydrated in
decreasing concentrations of alcohol (100%, 96% and 70% respectively). The
tissue sections were placed in 3% hydrogen peroxide in methanol for 30 minutes to
reduce endogenous peroxidase activity where a peroxidase detection method was
used. Where the alkaline phosphatase detection system was used this step was
omitted. Slides were then washed in Tris-buffered saline (TBS) pH7.4 for 5
minutes and the tissue sections incubated with normal serum from the species in
which the secondary antibody was raised (usually swine or rabbit), diluted 1:5 in
TBS for 30 minutes at room temperature. After this incubation, the normal serum
was removed carefully from the sections with a tissue and replaced with diluted
primary antibody (in 1:5 normal swine serum: TBS). The slides were covered with
Gelbond film (Flowgen, Rockland, ME, USA), hydrophilic side down and tissue
was then incubated with the antibody overnight at 4°C in a humidified chamber.
The following day, excess antibody was removed by two 5 minute washes with
TBS.
2.5.2. Secondary antibody and Horseradish Peroxidase detection
system
Secondary antibodies for immunocytochemistry were obtained from Dako
(Glostrup, Denmark). Immunocytochemistry used the horseradish peroxidase
detection system using a kit purchased from Dako. The secondary antibody for the
horseradish peroxidase detection system was biotinylated for subsequent
conjugation to avidin-linked peroxidase enzyme complex. Secondary antibody was
diluted 1:500 in TBS and incubated on the tissue sections for 30 minutes. Excess
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antibody was again removed by 2x 5 minute washes with TBS. Sections were
incubated in the presence of avidin-horseradish peroxidase complex (Dako,
Glostrup, Denmark) for 30 minutes. This bound the biotinylated secondary
antibody and formed a complex which served to amplify the signal obtained from
the primary antibody by acting on a substrate (DAB and hydrogen peroxide,
Sigma) which was subsequently applied to the sections and produced a coloured
product. The horseradish peroxidase complex solution was prepared according to
the suppliers instructions (Dako) in 0.05M Tris/HCl pH7.6 at least 20 minutes
before use. Excess AB complex was removed by 2x 5 minute TBS washes before
bound antibody was visualised with a solution of 225pM DAB in 0.05M Tris/HCl,
pH7.6 containing 0.01% hydrogen peroxide.
After development of the colour reaction sections were washed in water,
stained with haematoxylin, dehydrated and mounted with coverslips. Where
attempts to quantify immunocytochemical staining intensity were made, sections
were examined without prior knowledge of treatment group and staining intensity
was graded from zero (antigen not detectable) to five (heavy immunostaining).
2.5.3 Double immunocytochemical staining for ACTH and LH(3
Double immunocytochemistry on single tissue sections was carried out to visualise
the spatial relationship between two secretory cell types, specifically corticotrophs
and gonadotrophs. Immunocytochemistry for LH(3 was performed using the
horseradish peroxidase detection system as previously described but was
immediately followed by immunocytochemistry for ACTH using an alkaline
phosphatase procedure illustrated in Figure 2.1 (right). The secondary antibody
for this procedure was non-biotinylated sheep anti rabbit immunoglobulins (SAR;
Sigma). SAR was diluted 1:60 in TBS and incubated on the sections for 30
minutes. This was followed by 2x 5 minute washes with TBS to remove excess,
unbound antibody. Sections were incubated for 30 minutes in rabbit alkaline
phosphatase anti-alkaline phosphatase (APAAP, Dako) diluted 1:60 in TBS
followed by 2x 5 minute washes in TBS. Sections were then equilibrated in buffer
containing 0.1M Tris pH9.5, 0.1M NaCl and 50mM MgCl2, for 2 minutes.
Detection of antigen was then achieved using the fast blue substrate (Sigma)
according to the manufacturers instructions.
After development of the colour reaction sections were washed in water and
mounted with an aqueous mounting medium since fast blue is soluble in alcohol.
Sections treated in this way were not counterstained.


















Figure 2.1 Immunocytochemical techniques, standard avidin-biotin HRP or AP
procedure (left) and APAAP procedure (right).
2.5.4 Antisera
Specific antibodies were used to identify cell types and tissues within the pituitary
gland and access cell proliferation by detection of specific cell proliferation
markers. Anti-C-terminal ovine aMSH rabbit polyclonal antibody (provided by Dr
Brigette Baker, University of Bath, UK) was used to identify melanotrophs and the
pars intermedia at a dilution of 1:1000. The aMSH antibody crossreacts at 70%
with ovine des-acetylated aMSH and 0.15% with ACTH. A polyclonal rabbit
antibody against ovine CLIP was used for the detection of ACTH (provided by
Professor Leslie Rees, St Bartholomews Hospital, London, UK) and was used at a
dilution of 1:500. Since this antibody was raised against the N-terminal of CLIP
which is also the N-terminal of ACTH, it is 100% cross-reactive with ACTH.
Rabbit polyclonal anti-ovine LHp antibody (provided by NIDDK) was used to
identify gonadotrophs at a dilution of 1:3000. Rabbit polyclonal anti-ovine
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prolactin antibody (provided by NIDDK) was used to identify lactotrophs at a
dilution of 1:5000.
Rabbit polyclonal anti-mouse PCI antibody (raised against C-terminal
segment 629-726) was used at a dilution of 1:600 and rabbit polyclonal anti-mouse
PC2 antibody (Raised against mouse PC2 segment 529-637) was used at a dilution
of 1:1000 to localise these enzymes to specific cell types. Both the PCI and PC2
antisera were provided by Dr Mieczyslaw Marcinkiewicz (IRCM, Montreal,
Canada). These antisera have been validated in immunocytochemistry on mouse
tissue by preabsorbtion with synthetic antigenic peptides (Marcinkiewicz et al.,
1993).
The antibody used to identify proliferating cells was monoclonal anti-PCNA
(Novacastra, Newcastle upon Tyne, UK) at a dilution of 1:100. PCNA is a 36kDa
protein which is highly conserved between species. Since this antibody was raised
against mouse PCNA the affinity of the antibody for the sheep protein was tested
by preliminary immunocytochemistry in sheep testis. Since spermatogenesis
involves repeated meiotic divisions this tissue was used as a positive control.
Immunocytochemistry for both these antigens revealed abundant proliferative
activity in the sheep testis, as expected.
2.5.5 Control of antibody specificity
Since synthetic antigen was not generally available, non immune serum of the same
species in which the primary antibody was raised was used, at equivalent dilutions,
in TBS to check antibody specificity. Controls of this type are illustrated in
Figures 2.2 and 2.3.
2.6 Reverse transcription polymerase chain reaction (RT-
PCR)
2.6.1 Synthesis of oligonucleotide primers
Oligonucleotides (17-24mers) were synthesised using phosphoramadite chemistry
on a model 381 DNA synthesiser (Applied Biosystems (ABI), Warrington, UK) or
ordered commercially from Genosys (Pampisford, UK). Where synthesised
within the laboratory, oligonucleotides were recovered into 1ml of pure ammonia,
deprotected by incubating overnight at 55°C, recovered by two rounds of ethanol
precipitation and resuspended in TE buffer (Appendix I). The concentration of
oligonucleotide was assessed by spectrophotometry at 260nm where an optical
density of 1.0 is equal to a concentration of 20|ag/ml.
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Figure 2.2 Control of antibody specificity. Positively-staining cells in the pars
intermedia (aMSH, ACTH) and pars distalis (LHp, PRL- prolactin) are shown on
the left with equivalent controls for antibody specificity (primary antibody replaced
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Figure 2.3 Control of antibody specificity. Positively-staining cells in the pars
distalis (PCI) and pars intermedia (PC2, PCNA) are shown on the left with
equivalent controls for antibody specificity (primary antibody replaced with
equivalent dilution of host-species serum) shown on the right.
PC1
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2.6.2 RT-PCR Reaction
Partial cDNAs to ovine PCI and PC2 mRNA were generated using an RT-PCR
approach. Reverse transcription was undertaken using 250-500ng of total RNA in
20gl volume containing lOmM Tris-HCl pH 8.3, 90mM KC1, ImM MnC^,
200pM each dNTP, 5U superscript reverse transcriptase enzyme (Gibco BRL,
Paisley, UK) and 75mM of appropriate downstream 3' antisense primer or oligo
dT primer (Gibco BRL) to reverse transcribe mRNA species possessing a polyT
sequence at their 3' end. The conditions used for the reverse transcription were
denaturation of both RNA and primer at 65°C for 5 minutes followed by immediate
annealing on ice for 5 minutes. Reverse transcriptase enzyme was then added to
the reaction mixture and this was incubated at 37°C for 1 hour. The reverse
transcription reaction was terminated by heating to 95°C for 5 minutes. After the
reverse transcription to generate the first cDNA strand was completed, PCR was
undertaken on a diluted product of reverse transcription (typically 1:50) in order to
amplify the products. The products of reverse transcription were diluted in a buffer
containing 1.5mM MgCl2, 40% glycerol, lOmM Tris-HCl pH 8.3, 890mM KC1,
6mM EGTA (to chelate MnCl2 present in the reverse transcription reaction mixture)
and 0.4% Tween 20. This buffer maximised the efficiency of the Taq DNA
polymerase in the PCR reaction. 5' and 3' primers for DNA synthesis were added
at a final concentration of 0.15pM.
2.6.3 Cloning of amplified cDNAs
Where RT-PCR reactions were conducted for obtaining probes for in situ
hybridisation and/or RNase protection assay reactions, the amplified DNA
fragments were subcloned into appropriate plasmid vectors containing SP6 and T7
RNA polymerase promoters. The vectors used were the TA cloning vectors,
pCRII (Invitrogen, Abingdon, UK) illustrated in Figure 2.4 and pGEM-T easy
vector, illustrated in Figure 2.5 (Promega, Southampton, UK). Ovine POMC
cDNA was provided by Dr Iain Clarke (Prince Henry's Medical School, Victoria,
Australia) in the bluescript pSK~ vector (Stratagene, Cambridge, UK), illustrated in
Figure 2.6. Amplification of the cDNA was followed by ligation of the PCR
product and plasmid at appropriate molar ratios (3:1 respectively) with T4 DNA
ligase (supplied by plasmid supplier). The concentration of PCR product was
assessed by comparison with known standards on an agarose gel and was added to
the ligation mixture such that there was a 1:3 molar ratio of plasmid to PCR
product. 25ng plasmid vector and 1U T4 DNA ligase (as supplied by plasmid
supplier) were mixed with 75ng of PCR product, lgl lOx ligation buffer (contains
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60mM Tris-HCl pH 7.5, 60mM MgCl2, 50mM NaCl, lmg/ml BSA, 70mM (3-
mercaptoethanol, ImM ATP, 20mM DTT and lOmM spermidine, pCRII vector or
300mM Tris-HCl pH 7.8, lOOmM MgCl2, lOOmM DTT And lOmM ATP, pGEM-
T easy vector) and made up to a volume of 10gl with water.
Following ligation, transformation of competent TOPI OF' (pCRII vector) or
JM109 (pGEM-T easy vector) E.Coli cells was conducted by mixing with lpl of
ligation mixture as described above. For pGEM-T easy vector, 2pl of 0.5M (3-
mercaptoethanol was also added to this mixture. The mixture was incubated on ice
for 30 minutes, heat-shocked by incubating at 42°C for 30 seconds (pCRII) or 45
seconds (pGEM-T) and then placed on ice for 2 minutes. Thereafter 450pl SOC
medium (2% Bacto tryptone, 0.5% Bacto yeast extract, lOmM NaCl, 2.5mM KC1,
lOmM MgCl2, lOmM MgS04 and 20mM glucose) prewarmed to 37°C was added
to the cells which were then incubated at 37°C on a shaker at 225rpm for 1 hour.
Aliquots (50gl and 200gl) were plated onto Euria Bertani (LB) agar plates
(Appendix I) containing 50pg/ml ampicillin, 50gl 50gg/ml X-gal and lOOgl lOOmM
IPTG (pCRII) or lOOgg/ml ampicillin, 50gl 50gg/ml X-gal and lOOgl lOOmM
IPTG (pGEM-T) with a bent glass rod. Plates were incubated inverted overnight at
37°C. Identification of colonies transformed with plasmid containing the cDNA
insert was based on the lac Z blue/white selection. Both pCRII and pGEM-T easy
vectors contain the lac Z gene in their polylinker region (Figures 2.4 and 2.5). Lac
Z gene expression was induced by IPTG to express the product (3-galactosidase.
This acted on the substrate X-gal, which p-galactosidase converted into a blue
coloured end product. The lac Z gene was disrupted by the insertion of the cDNA
sequence into the vector by ligation. Therefore bacterial colonies that contained
plasmid without the cDNA insert had a functional lac Z gene and were blue
whereas those colonies which were successfully transformed with recombinant
plasmid were white. White bacterial colonies were restreaked on LB agar plates
which were again incubated inverted overnight at 37°C. Individual bacterial
colonies containing cloned plasmid were then picked into LB broth (Appendix I)
and were propagated overnight at 37°C in LB broth containing 50pg/ml ampicillin
in a shaker at 225 rpm. Plasmid DNA was then isolated for analysis from bacterial
cultures by the alkaline lysis method using the Wizard Minipreps DNA purification
system (Promega), according to the manufacturers instructions. Briefly, bacterial
suspensions were pelleted by centrifugation at 1600g, the supernatant discarded,
cells resuspended in buffer containing 50mM Tris/HCl, pH 7.5, lOmM EDTA and
lOOpg/ml RNase and mixed with an equal volume of 0.2M NaOH containing 1%
SDS. The resulting solution containing lysed bacterial cells was neutralised by the
addition of 2.25M potassium acetate. The resulting suspension was centrifuged at
12000g to sediment the majority of bacterial genomic DNA. The supernatant
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(approximately 600pl) was removed, mixed with a 1ml suspension of DNA
purification resin and passed through a miniprep column which retained the
plasmid DNA bound to the resin. The plasmid DNA was then eluted into a sterile
tube by the addition of 50gl pure water and subsequent centrifugation at 12000g for
20 seconds. The presence of cDNA insert of appropriate size was confirmed by
restriction digestion with the endonuclease EcoRI and electrophoresis of digestion
products on an agarose gel prior to definitive analysis by DNA sequencing.
2.7 Plasmid recovery and analysis
2.7.1. Plasmid preparation from bacterial cultures
Large plasmid preparations were recovered from bacterial cultures using the Wizard
Maxiprep DNA purification system (Promega), according to the manufacturers
instructions. Briefly, 500ml bacterial cultures were pelleted by centrifugation at
5000g, the supernatant discarded and cells resuspended in buffer containing 50mM
Tris/HCl, pH 7.5, lOmM EDTA and 100pg/ml RNase. The suspension was then
mixed with an equal volume of 0.2M NaOH containing 1% SDS. The resulting
solution containing lysed bacterial cells was neutralised by the addition of 2.25M
potassium acetate. The resulting suspension was centrifuged at 14000g to
sediment the majority of bacterial genomic DNA. The supernatant (approximately
600pl) was removed and filtered. The plasmid DNA in the filtrate was then
precipitated by the addition of 0.5 volumes of isopropanol and centrifuged at
14000g. The DNA pellet was then resuspended in 2ml TE buffer. This was then
mixed with a 10ml suspension of DNA purification resin and passed through a
maxiprep column which retained the plasmid DNA. The plasmid DNA was then
eluted into a sterile tube by the addition of 1.5ml pure water and subsequent
centrifugation at 14000g for 5 minutes.
2.7.2. Analysis of plasmid DNA quality
The approximate concentration of plasmid DNA was determined by scanning at
260nm on a spectrophotometer. The concentration of the DNA was calculated
from the 260nm value given that an optical density of 1.0 is equal to 50p.g/ml
DNA.
Purity of plasmid DNA was determined by analysis on a 1.0% agarose
minigel (Sambrook et al., 1989). This was prepared using Seakem agarose
dissolved in 0.5x TBE buffer (appendix I). The agarose was melted and
approximately 200gg/ml ethidium bromide was added for visualisation of DNA.
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M13 Reverse Primer
CAG GAA ACA GOT ATG AC C ATG ATT ACG CCA AGC T
GTC CTT TGT CGA TAC TG G TAC TAA TGC GGTT TCG A
Sp6 Promoter
AT TTA GST GAC ACT ATA. GAA
TA AAT CCA CTG TGA TAT CTT
Nsil Hindlll Kpnl Sacl BamH I Spel
TAC TCA AGC TAT GCA TCA AGC TTG GTA CCG AGC TCG GAT CCA CTA GTA ACG GCC
ATG AGT TCG ATA CGT AGT TCG AAC CAT GGC TCG AGC CTA G3T GAT CAT TGC CGG
BstXI EcoRI
GCC AGT GTG CTG GAA TTC GGC TT
CGG TCA CAC GAC CTT AAG CCG
EcoRI EcoRV
A GCC GAA TTC TGC AGA TAT
TT COG CTT AAG ACG TCT ATA
Aval
PaeR7l
BstXI Notl Xhol Nsil Xbal Apal
CCA TCA CAC TGG CGG CCG CTC GAG CAT GCA TCT AGA GGG CCC AAT TCG
GGT AGT GTG ACC GCC GGC GAG CTC GTA CGT AGA TCT CCC GGG TTA AGC
CCC TAT
GGG ATA
Figure 2.4 pCRII TA cloning vector.
catalogue.
Adapted from Invitrogen product
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Figure 2.5 pGEM-T Easy vector. Adapted from Promega product catalogue.
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pBluescript SK (+/-)
2958 bp
Figure 2.6 Bluescript SK" vector. Adaptedfrom Stratagene product catalogue.
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The gel was poured into a 7cm by 10cm gel tray containing an 8 well comb and
submerged in 0.5 x TBE buffer in a midigel cell (Hybaid). Plasmid DNA (lOpl)
was run in a sample solution containing 2pl loading buffer (contained 30% w/v
glycerol, 0.25% w/v bromophenol blue, 0.25% w/v xylene cyanol FF and 0.5M
EDTA at pH7.0) and 8pl water. Samples were separated in parallel with KB
Ladder DNA markers (range 72-23130bp, Gibco BRL) by electrophoresis at 100V
for 1-2 hours in 0.5x TBE, viewed under UV light and photographed.
2.8. DNA sequencing
2.8.1. Automatic sequencing
Automatic sequencing reactions were carried out using the Taq DyeDeoxy
Terminator Cycle Sequencing kit (Applied Biosystems) and were run on the
Applied Biosystems Model 373A DNA sequencing system.
2.8.1.1. Sequencing reactions
A reaction premix was prepared containing 4pl 5x TACS buffer (400mM Tris/HCl,
lOmM MgCl2 and lOOmM (NH4)2S04 pH9.0), lpl dNTP mix (containing 150pM
each dATP, dGTP, dTTP and dCTP), lpl each ddATP, ddTTP, ddCTP and
ddGTP terminators and 0.5-lpl AmpliTaq DNA polymerase for each sequencing
reaction to be performed. A total of 11.5gl (PCR template) or 9.5pl (plasmid DNA
template) of the reaction premix was added to separate tubes containing 3.2 pmol
primer and 5|il template DNA, the total volume adjusted to 20|il with water and
overlaid with mineral oil.
Tubes were placed in a Perkin Elmer Cetus Model 480 thermal cycler
preheated to 96°C and 25 cycles of thermal cycling carried out as follows; rapid
thermal ramp to 96°C, 96°C for 30 seconds, rapid thermal ramp to 50°C, 50°C for
15 seconds, rapid thermal ramp to 60°C and 60°C for 4 minutes.
On completion of the sequencing reaction, the samples were extracted twice
with water saturated phenokchloroform and precipitated with 15pl 2M sodium
acetate pH4.5 and 300pil cold ethanol to remove unincorporated labelled
terminators. Labelled DNA was pelleted by centrifugation, the supernatant
discarded and the DNA washed using 70% ethanol, air dried and resuspended in
formamide/EDTA buffer (5gl formamide, lpl 50mM EDTA, pH8.0) just before
loading onto the gel.
2.8.3.2. Automatic sequencing gel
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A sequencing gel mix containing 50g urea, 15ml 40% acrylamide and water made
up to a final volume of 80ml was prepared. Amberlite resin (Sigma) was added to
remove acrylamide free acid and the mixture was stirred and heated until the urea
had dissolved, the solution was filtered and 10ml lOx TBE added. The gel mix
was polymerised using 45pl TEMED and 500pl 10% ammonium persulphate and
poured carefully between clean glass plates.
The gel was prerun for 30 minutes at 30W. Samples resuspended in buffer
were heated to 95°C for 5 minutes before loading onto the gel. The gel was run
overnight using the automatic data collection and analysis programs. The
following cDNA probes, sequenced in this way, were used in the studies described
in this thesis.
2.8.2. Ovine POMC cDNA probe
The sequence of the ovine POMC cDNA probe (provided by Dr Iain Clarke) used
in this study is shown in Figure 2.7. This sequence codes for a portion of the
POMC peptide at the C-terminal, including |3END, and continues into the 3'
untranslated region.
2.8.3 Ovine PCI probe
The novel ovine PCI cDNA probe used in this study was generated by an
RT-PCR approach using primers GAGATAACTGTGACTGTGAT (5') and
TCGGCTGTTCACCATCAAGCC (3'-reverse), based on nucleotide sequences
occurring at 1162 and 1514bp of the rat PCI cDNA sequence (accession number
M76705, (Bloomquist et al., 1991)). A 374bp fragment was generated with 88%
homology to the rat and 95% homology to the porcine (accession number U20545,
(Dai et al., 1995)) nucleotide sequences between the primer sequences (Figure
2.6). The predicted ovine peptide sequence was identical to the predicted rat
peptide. The ovine PCI nucleotide sequence had less than 50% homology with
published PC2 or any other endoprotease sequences. This cDNA was subcloned
into the pCRII vector, sequenced and deposited on the NIH genbank database,
accession number AF063110.
2.8.4 Ovine PC2 probe
The novel ovine PC2 cDNA probe used in this study was generated by an RT-PCR
approach using primers GATGACTGGTTCAACAGCCAT (5') and
GCCGTCACAGTTGCAGTCATC (3'-reverse), based on nucleotide sequences
occurring at 923 and 1262bp of the rat PC2 cDNA sequence (accession number
M76706, (Bloomquist et al., 1991). A 360bp fragment was generated with 88%
homology to the rat and 91% homology to the porcine (accession number X68603,
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I I I I I I I
CTGAGGCGGCCGAGAAGAAGGACTCGGGGCCCTATAAGATGGAACACTTCCGCTGGGGCAGCCCGCCCAAGGACAAG
CTGAGGCGGCCGAGAAGAAGGACTCGGGGCCCTATAAGATGGAACACTTCCGCTGGGGCAGCCCGCCCAAGGACAAG
I I I I I I I I
620 630 640 650 660 670 680 690
90 100 110 120 130 140 150 160
I I I I I I I I
CGCTACGGCGGGTTCATGACCTCGGAGAAGAGCCAAACGCCCCTTGTCACGCTGTTCAAAAACGCCATCATCAAGAA
CGCTACGGOSGGTTCATGACCTCGGAGAAGAGCCAAACGCCCKTITGTCACGCTGTTCAAAAACGCCATCATCAAGAA
I I I I I I I I
700 710 720 730 740 750 760 770
170 180 190 200 210 220 230 240
I I I I I I I I
CGCCCACAAGAAGGGCCAGTGAGGGCGCAGCGGGCAGGGGCCTCTCTCCGCGGAAGGTTGACCCCGAAGGCCTCTCT
CGCCCACAAGAAGGGCCAGTGAGGGCGCAGCGGGCAGGGGCCTCTCTCCGCGGAAGGTTGACCCCGAAGGCCTCTCT
I I I I I I I
780 790 800 810 820 830 840
250 260 270 280 290 300 310
I I I I I I I
TCTGTCCTCCTGTCGCCTCGCAGCCCGGGTGAGGACTTGCCCAGGCAGTGATGGCGCCAGGTATCCCGACTCTTAAA
TCTGTCCTCCTGTCGCCTCGCAGCCCGGGTGAGGACTTGCCCAGGCAGTGATGGCGCCAGGTATCCCGACTCTTAAA
I I I I I I I I
850 860 870 880 890 900 910 920
320 330 340 350 360
I I I I I
GCTGTCTGTAGTTAAGAAATAAAACCTTTCAAGTTTCACGAAAAA
GCTGTCTGTAGTTAAGAAATAAAACCTTTCAAGTTTCACGAAAAA
I I I I
930 940 950 960
Figure 2.7 POMC cDNA probe sequence. The cDNA used in this study is
shown (top) with part of the full ovine POMC cDNA (bottom). Numbers refer to
bases from the 5' end of the probe (top) or from the start of translation site in the
full sequence (bottom).
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10 20 30 40 50 60
I I I I I I
GAGATAACTGTGACTGTGATGGGTACACGGACAGCATCTACACCATCTCCATCAGCAGTGC
GAGATAACTGTGACTGTGATGGCTACACAGACAGCATTTACACCATCTCTATCAGCAGTGC
I I I I I I
940 950 960 970 980 990
70 80 90 100 110 120 130
i I I I I I I
CTCGCAGCAAGGCCTATCCCCCTGGTACGCAGAGAAGTGCTCCTCCACGCTGGCCACCTCGTACAGCAGCGGGGACT
• •• ••••• ••••• • • •••••••• ••••#•••••• •••••••• ••••••••••• •••••••• • • •• •
CTCCCAGCAGGGCCTGTCACCCTGGTATGCAGAGAAGTGTTCCTCCACACTGGGCACCTCCTACAGCAGTGGTGATT
I I I I I I I
1010 1020 1030 1040 1050 1060 1070
140 150 160 170 180 190 200 210
I I I I I I I I
ACACTGACCAGCGAATTACGAGCGCTGACCTGCACAACGACTGCACGGAGACCCACACGGGCACCTCAGCCTCTGCA
ACACAGACCAACGAATAACTAGTGCGGACCTGCACAATGACTGCACAGAGACCCACACAGGCACCTCAGCTTCTGCA
I I I I I I I I
1080 1090 1100 1110 1120 1130 1140 1150
220 230 240 250 260 270 280 290
I II I I I I I
CCCCTGGCCGCGGGCATCTTCGCTCTAGCCCTGGAAGCAAATCCAAATCTCACCTGGCGAGATATGCAGCACTTGGT
CCTCTGGCTGCTGGCATCTTTGCTCTAGCCTTGGAAGCAAACCCAAATCTCACCTGGCGAGATATGCAGCATCTGGT
I I I I I I I I
1160 1170 1180 1190 1200 1210 1220 1230
300 310 320 330 340 350 360
I I I I I I I
TGTATGGACCTCTGAGTATGACCCACTGGCCAATAACCCCGGATGGAAAAAGAACGGAGCAGGCTTGATGGTGAACA
TGTCTGGACCTCTGAGTATGACCCATTGGCCAATAACCCAGGTTGGAAAAAGAATGGAGCGGGCTTGATGGTGAACA
I I I I I I I
1240 1250 1260 1270 1280 1290 1300
370
GCCGA




Figure 2.8 PCI cDNA probe sequence. The cDNA used in this study is shown
(top) with part of the rat PCI cDNA (bottom). Numbers refer to bases from the 5'
end (ovine cDNA) or from the start of translation site (rat sequence). Rat primer
sequence is underlined.







20 30 40 50 60 70 80 90
I I I I I I I I
GCCATGGGACGAGATGTGCCGGGGAGGTCTCTGCGGCTGCCAACAATAACATCTGCGGGGTCGGCGTGGCCTACGGC
• •••••• •• •• ••••• •• •• •• • • • « • • •••• ••• •• ••••• • • ••••• •• • • ••• •
GCCATGGAACCAGGTGTGCAGGAGAAGTTTCCGCTGCAGCCAGCAACAATATCTGTGGAGTCGGTGTAGCATACAAC
I I I I I I I I
620 630 640 650 660 670 680 690
100 110 120 130 140 150 160 170
I I I I I I I I
TCCAAGGTCGCAGGTATCCGGATGCTGGACCAGCCCTTCATGACGGACATCATCGAGGCTTCCTCCATCAGCCACAT
TCCAAGGTGGCAGGTATCCGGATGCTGGACCAGCCCTTTATGACTGACATCATCGAGGCCTCCTCCATCAGCCACAT
I I I I I I I I
700 710 720 730 740 750 760 770
180 190 200 210 220 230 240
I I I I I i I
GCCTCAGCTGATGGACATCTACAGCGCCAGCTGGGGCCCCACCGACAACGGGAAGACGGTGGATGGGCCCCGGGAGC
GCCTCAACTGATCGACATCTACAGTGCAAGCTGGGGCCCCACAGACAACGGGAAGACAGTTGATGGGCCCCGAGAGC
I I I I I I I
780 790 800 810 820 830 840
250 260 270 280 290 300 310 320
I I I I I 1 I I
TCACGCTCCAAGCGATGGCGGATGGCGTGAACAAGGGCCGCGGGGGCAAAGGCAGCATCTACGTGTGGGCCTCGGGC
TCACGCTCCAGGCCATGGCTGATGGTGTGAACAAGGGCCGTGGGGGCAAAGGCAGCATCTATGTGTGGGCCTCCGGG
I I I I I I I I
850 860 870
. 880 890 900 910 920
330 340 350 360
I I I I
GACGGCGGCAGCTACGATGACTGCAACTGTGACGGC
GACGGTGGCAGCTACGATGACTGCAACTGTGACGGC
I I I I
930 940 950 960
Figure 2.9 PC2 cDNA probe sequence. The cDNA used in this study is shown
(top) with part of the rat PC2 cDNA (bottom). Numbers refer to bases from the 5'
end (ovine cDNA) or from the start of translation site (rat sequence). Rat primer
sequence is underlined.
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(Seidah et al., 1992) sequence between the primer sequences (Figure 2.7). The
predicted peptide sequence was 98% homologous to the predicted rat peptide. The
nucleotide sequence had less than 50% homology with published PCI sequences,
although it shared approximately 60% homology to the human PACE4 and rat PC5
sequences (Johnson et al., 1994; Seidah and Chretien, 1994). This level of
homology is unlikely to interfere with any of the detection techniques subsequently
used given that hybridisation and post-hybridisation conditions were kept relatively
stringent. This cDNA was subcloned into the pGEM-T vector. The nucleotide
sequence was deposited on the NIH genbank database, accession number
AF063108.
2.9. Preparation of radiolabeled probes for Northern blot
analysis
2.9.1. Preparation of template DNA for radiolabelling
Double stranded DNA for radiolabelling was prepared by excision of the cloned
cDNA insert from the plasmid vector by enzymatic digestion and separation on a
1.0% low melt agarose (Seakem, UK) gel. The appropriately sized DNA fragment
was cut out of the gel, melted at 65°C and this was diluted 1:5 in pure water to
prevent re-solidification. The presence of agarose at this concentration did not
appear to interfere with the random labelling procedure. The quantity of excised
cDNA was estimated by comparison with a known concentration of KB Ladder.
2.9.2. Radiolabelling double stranded DNA
Double stranded cDNA was used to produce radiolabelled cDNA using the random
primer method (Feinberg and Vogelstein, 1983) and an Amersham 'Rediprime' kit
according to the manufacturers instructions (Amersham). Briefly, DNA (2.5-
25ng) was denatured at 98°C for 5 minutes. DNA was labelled with 50gCi of 32P-
[oc]-dCTP in a reaction containing 5(il primer solution of random hexanucleotides,
lOmM each dATP, dGTP and dTTP, and 5pl reaction buffer containing Tris/HCl
pH7.8, MgCl2 and 2-mercaptoethanol. The labelling reaction was catalysed by
addition of 2U Klenow enzyme and incubation was for 30 minutes at 37°C.
Labelled DNA was denatured with 5N NaOH (100pl), neutralised with 1M Tris,
pH7.6 (600ql) and IN HC1 (375pl) and added to the hybridisation mixture (section
3.7).
The generation of high specific activity cDNA probes was confirmed by
pipetting 1 jlxI of the newly synthesised probe on glass fibre filter paper (Whatman
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GF, Whatman, Maidstone, UK). This was washed for three times two minutes in
5% Trichloroacetic acid (TCA) then in 70% ethanol and finally rinsed with 95%
ethanol and air dried before analysis in a beta counter.
2.10. Northern blot analysis
2.10.1. Separation of RNA on denaturing agarose gels
RNA was separated on 1.0% denaturing agarose gels both for assessment of RNA
quality and prior to blotting onto nitrocellulose membranes for northern analysis
(section 2.10). The gel was prepared by melting l.lg Seakem agarose (FMC
supplied by Flowgen, Sittingbourne, UK) in 70ml DEPC-treated water. This was
cooled to about 60°C and 20ml of lOx northern running buffer (containing 200mM
MOPS, lOmM EDTA and 50mM sodium acetate at pH7.0) plus 22ml 37%
formaldehyde were added. The solution was mixed gently and poured into a gel
tray (15 x 20cm) containing a 12 well comb in a fume hood. After setting, the
comb was removed and the gel submerged in lx northern running buffer in a
midigel electrophoresis cell (Hybaid, Ashford, UK).
RNA (5pg) in a volume of no greater than 4.5pl was prepared by adding
2.0pil lOx MOPS northern-running buffer (Appendix I), 4.5pl of formaldehyde and
lOpl deionised formamide and heating at 60°C for 5 minutes. After heating, 2pl of
northern-loading buffer (contains 50% w/v glycerol, 0.25% w/v bromophenol
blue, 0.25% w/v xylene cyanol and 0.5M EDTA at pFI7.0) and lgl of lmg/ml
ethidium bromide was added to each sample. RNA was loaded into individual
wells of the gel and separated by running for approximately 6 hours at 60V. An
RNA ladder (Gibco BRL) was run with the RNA so that RNA transcript size could
be accessed.
2.10.2. RNA transfer to membrane
RNA separated on a denaturing gel was transferred to nylon membrane (Hybond-
N; Amersham) by capillary blotting as shown in Figure 2.10. The nylon
membrane was prewetted with pure RNase-free water followed by 20x SSC before
placing carefully on the gel. Transfer using 20x SSC proceeded for a minimum of
12 hours. After transfer the position of the gel wells were marked on the
membrane and RNA was bound by UV crosslinkage.











Figure 2.10 Northern blotting. Schematic drawing of the apparatus used for
the transfer of RNA from a denaturing agarose gel to Hybond-N nylon membrane
(black) by capillary action.
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2.10.3. Hybridisation of radiolabeled probe to membrane
Membranes were prehybridised at 65°C for 2-4 hours in buffer containing 20%
formamide, 5x Denhardt's solution (Appendix I), 5x SSPE buffer (Appendix I),
0.1% SDS, 0. lmg/ml denatured salmon sperm DNA (Sigma), lpg/ml polyA
(Sigma) and 6% dextran sulphate (Sigma). Radiolabelled probe was added to the
prehybridisation mix to give a final activity of 0.5 - lxlO6 cpm/ml buffer.
Hybridisation was allowed to proceed for 24-48 hours at 65°C.
2.10.4. Post-hybridisation washes
Membranes were washed with 2x SSC, then lx SSC, 0.5x SSC or 0.2x SSC for
15 minutes each at 55°C.
2.10.5. Development of signal
After washing, membranes were wrapped in clingfilm and exposed to X-ray film
(X-OMAT AR or LS; Kodak, supplied by Sigma) in cassettes at -70°C. After an
appropriate exposure time the signal was developed using LX 24 developer
(Kodak) and fixed using FX 40 fixative (Kodak) according to the suppliers
recommendations.
2.11. Radioactive in situ hybridisation
2.11.1 Preparation of radiolabelled cRNA probes.
2.11.1.1. Template cDNA preparation
Plasmid DNA (lpg) prepared as described previously in section 3.7 was linearised
in reaction buffer (contains 10-50mmol/l Tris/HCl, 5-10 mmol/1 MgC^, 50-
lOOmmol/1 NaCl and lmmol/1 DTT, DTE or 6-mercaptoethanol) with 10U
restriction enzyme and made up to a volume of lOpil with pure water. The enzyme
and buffer used was dependent on the plasmid vector being digested and the
direction of synthesis of the riboprobe. These are given in Table 2.1. The reaction
was incubated at 37°C for 2-4 hours. Digested DNA was then extracted once with
tris-buffered phenokchloroform, once with chloroform alone and then precipitated
with 0.1 volumes 3M sodium acetate (pH5.5) and 2.5 volumes absolute ethanol
overnight at -20°C. Linearised DNA was pelleted, dried and resuspended in 9pl
pure water. Thereafter, lgl of reaction mix was run on a minigel (1.0% agarose)
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and compared to an uncut sample of the same plasmid run in a parallel lane to
assess the efficiency of digestion.
Table 2.1. Restriction Endonucleases used to linearise plasmids for use as
riboprobe synthesis templates and RNA polymerases used to synthesise probes.
AS, Antisense, S, Sense. *18S for use in RNase protection assay as supplied
prelinearised by Ambion (Austin, TX, USA).
cDNA Plasmid Orientation Endonuclease
POMC Bluescript AS (T7) BamHI
POMC Bluescript S (T3) Hind III
PCI pCRII AS (SP6) Xba I
PCI pCRII S (T7) BamHI
PC2 pGEM-T AS (T7) Nde I
PC2 pGEM-T S (SP6) Nco I
18S* pTRI AS (T7) -
2.11.2. In vitro synthesis of cRNA probes
Synthesis of riboprobes was carried out using lgg linearised plasmid template in a
reaction mix containing 4mM DTT, 40U RNase inhibitor, 0.4mM each rATP,
rCTP and rGTP, 8pM rUTP, lx transcription buffer (lx transcription buffer
contains 40mM Tris/HCl, pH7.9, 6mM MgCl2, 2mM spermidine and lOmM
NaCl) and 50pCi 33P-UTP. The reaction was catalysed by addition of 20U of the
appropriate RNA polymerase (T3, T7 or SP6) and incubated at 37°C for
approximately 1.5 hours. The DNA template was then removed by digestion with
10U RNase-free DNase for 15 minutes at 37°C. 20gg of tRNA (from bakers
yeast, Sigma) was added to assist in precipitation pellet formation. Enzymes and
salts were removed by phenol/chloroform and chloroform extractions and RNA
was precipitated with sodium acetate and ethanol for at least 1 hour at -70°C and
recovered by centrifugation as above.
Radiolabeled RNA was air dried, resuspended in 50gl pure water and the
activity of 2x lpl aliquots was determined by liquid scintillation spectroscopy. The
average activity of the two samples was calculated and the volume of probe
necessary to give 1 x 106 cpm was determined.
2.11.3. Pretreatment of tissue
Paraffin wax embedded tissue was cleared in histoclear for 10 minutes and
rehydrated in a series of alcohols of decreasing concentrations. Tissue was placed
in 0.2N HC1 for 20 minutes followed by two 5 minutes washes in distilled water.
Chapter 2 General Methods 58
Sections were then treated with 2gg/ml proteinase K (Sigma) in buffer containing
lOOmM Tris/HCl pH7.8 and 50mM EDTA at 37°C for 20 minutes followed by
distilled water for 2 minutes. Sections were washed briefly in 0.1M
triethanolamine (TEA) pH8.0 and acetylated in 0.25% acetic anhydride in 0.1M
TEA pH8.0 for 10 minutes. Finally, sections were rinsed in distilled water and
prehybridised in buffer containing 4 x STE buffer (Appendix I), 1 x Denhardt's
solution, lOmM DTT, 125pg/ml salmon sperm DNA, 125gg/ml yeast transfer
RNA in 50% deionised formamide for 2-4 hours at probe Tm-25°C.
2.11.4. Hybridisation of probe to tissue
Hybridisation was conducted overnight using hybridisation buffer (as
prehybridisation buffer with 10% dextran sulphate) containing radiolabeled probe
at 1 x 106 cpm in 40gl buffer/slide. The incubation was carried out under
coverslips prepared from Gelbond film (Flowgen), hydrophilic side towards the
tissue, in a humidified chamber at Tm-25°C where Tm was calculated individually
for each probe according to the equation:
Tm = 79.8 + 58.4 (FGC) + 11.8 (FGC)2 + 18.5 log(M) - 820/L - 0.35 (%F) -
(%M)
where:
FGc = mole fraction of GC content of probe, usually about 0.45
M = monovalent cation concentration (molarity of salt in hybridisation
buffer)
L = length of duplexes formed during hybridisation (probe length)
%F = percentage of formamide in buffer
2.11.5. Post hybridisation washes
After incubation sections were washed in two changes of 4x SSC for 10 minutes
each to remove the coverslip and treated with RNase A (Sigma) at a concentration
of 20(ig/ml in 0.5M NaCl, lOmM Tris pH8.0 and ImM EDTA for 30 minutes at
37°C. Sections were washed in RNase buffer alone for 30 minutes at 37°C
followed by 30 minute washes in 4x SSC and 2x SSC at room temperature and a
final wash in 0.1 x SSC at 55°C for 30 minutes. Sections were then dehydrated in
alcohols of increasing concentration all containing 300mM ammonium acetate.
2.11.6. Development of in situ hybridisation
After air drying, slides were warmed to 45°C and dipped in prewarmed NTB3
photographic emulsion (Kodak) at 45°C in the dark. Emulsion coated slides were
stored in a humidified, lightproof box overnight before transfer to a lightproof
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polyacetyl black trough (Lamb's laboratory supplies, London, UK) containing
silica gel and stored at 4°C for 1-2 days (POMC) or six weeks (PCI and PC2).
Silver grains formed by reaction of the hybridised, radiolabeled probe with
the emulsion were developed using Kodak D19 developer. Briefly, in the dark,
slides were placed in developer cooled to 15°C for 4 minutes, followed by a 20
second wash in pure water, then fixation by incubation for 10 minutes in Kodak
polymax at 14°C. Sections were washed in pure water for 20 minutes, rinsed in
running tap water for 20 minutes, stained with haematoxylin, dehydrated and
mounted in Pertex (O.Kindler GmbH & Co. supplied by Laboratory Sales Ltd.,
Rochdale, England).
Slides were analysed under dark field using an Olympus BH2 microscope
(Leitz, Wetzlar, Germany) to visualise the silver grains indicating areas of
hybridisation. Silver grain density was analysed using image analysis software
(Image proplus, Media Cybernetics, Silver Springs, MD, USA). Bright field
microscopy was used to examine the morphology of the pituitary gland sections
and to allow identification of the pars intermedia, nervosa and distalis.
2.12 Ribonuclease (RNase) protection assay.
2.12.1 Preparation of radiolabeled cRNA probes
Radiolabeled antisense cRNA probes were prepared as described in section 2.11
except that 32P-[a]-UTP was used in place of 33P-UTP and no cold rUTP was
added to the in vitro transcription reaction in the preparation of PCI and PC2
antisense cRNA probes. As a control for sample RNA loading, 18S antisense
RNA probe (Ambion, supplied by AMS Biotechnology (UK), Witney, UK) was
prepared according to the manufacturers instructions. In order to purify full length
cRNA transcripts, radiolabeled RNA probes were gel-purified. RNA probes were
mixed with gel loading buffer II (Ambion, contains 95% formamide, 0.025%
xylene cyanol, 0.025% bromophenol blue, 0.5mM EDTA, 0.025% SDS), heated
at 95°C for 3 minutes and loaded onto a 6% denaturing polyacrylamide gel and
separated by electrophoresis at 300V for 2 hours. After electrophoresis, the gel
was wrapped in cling film and exposed briefly (1-2 minutes) to an autoradiographic
film (X-OMAT AR, Kodak). The portion of the gel containing the full length
transcript was excised and the probe was eluted in elution buffer (Ambion, contains
0.5M ammonium acetate, ImM EDTA, 0.025% SDS) at 37°C overnight. The
activity of two lgl aliquots of the probe in elution buffer was then measured by
liquid scintillation spectroscopy and from the average of these the volume of probe
having an activity of 2x 105 cpm was determined (2x 104 for 18S control probe).
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2.12.2 RNase protection assay reaction
Reagents used in RNase protection assay were supplied by Ambion. Total RNA
extracted as described in section 3.3 was mixed with 2xl05 cpm of radiolabeled
cRNA and 5xl04 cpm of 18S antisense probe. These were coprecipitated with 0.1
volumes 5M ammonium acetate and 2.5 volumes absolute ethanol, resuspended,
denatured at 95°C for 3 minutes and hybridised overnight in 20ml hybridisation
buffer (contains 80% deionised formamide, lOOmM sodium citrate pH 6.4,
300mM sodium acetate pH 6.4 and ImM EDTA) at 44°C. After hybridisation of
probes to RNA, non-hybridised single-stranded RNA was selectively digested by
the addition of 5U RNase A and 200U RNase T1 (Ambion) in RNase buffer at
37°C for 40 minutes. The reactions were then precipitated in the presence of 0.3M
sodium acetate and absolute ethanol for 30 minutes at -20°C and centrifuged at
13000g for 20 minutes at 4°C. The supernatant was carefully removed and the
pellet redissolved in 8gl gel loading buffer, heated to 95°C for 3 minutes and
loaded onto a 6% denaturing acrylamide gel prepared as described below.
Undigested and unprotected controls were included to check for full RNase
digestion. The sizes of the protected fragments was accessed by running
radiolabeled RNA size standards on the gel. These were prepared from
prelinearised plasmids by in vitro transcription according to the manufacturers
instructions (RNA Century Marker Plus template set, Ambion). Samples were run
for 2 to 3 hours at 200V before drying the gel at 80°C and exposing to either an
autoradiographic film (Kodak) or a phosphorescent screen for quantification with a
phosphorimager (Storm, Molecular Dynamics, Sunnyvale, CA, USA). The
relative optical density of the cDNA probe-protected and 18S ribosomal standard
were determined on a phosphorimager and the 18S ribosomal standard was used to
correct for loading variations in the RNA between treatments.
2.12.3 Denaturing acrylamide RNase protection assay gel
A gel mix containing 14.4g urea, 3.8ml 40% acrylamide (19:1 acrylamide:
bisacrylamide) and 3ml lOx TBE made up to a final volume of 30ml was prepared
and the mixture was stirred and heated until the urea had dissolved. The gel mix
was polymerised using 32gl TEMED and 240pl fresh 10% ammonium persulphate
and before complete polymerisation was poured carefully between clean glass
plates. A comb was inserted to form wells for sample loading. The gel was run in
lx TBE buffer.
2.13 Radioimmunoassay
Chapter 2 General Methods 61
In selected experiments, circulating concentrations of aMSH, prolactin and FSH
were determined in single radioimmunoassays using methods validated for sheep
plasma (aMSH, (Lincoln and Baker, 1995); prolactin, (McNeilly and Andrews,
1974); and FSH, (McNeilly et al, 1986)). For the aMSH assay, the aMSH
antibody used crossreacted at 0.15% with ovine ACTH and 70%with ovine
desacetylated aMSH. The lower limit of detection (10% decrease in binding
relative to B0) was 22.5 pmol/litre and the intra-assay coefficient of variation was
16%. The corresponding values for the prolactin assay were 0.5 pg NIH prolactin
S 13/litre and 6.0%. For the FSH assay these were 0.2 pg/NIDDK-FSH-RP2/litre
and 9.3%
2.14 Statistical analyses
Differences between the relative density in the different treatment groups were
evaluated using ANOVA. Comparisons between individual groups were carried
out using the unpaired student t-test. Where standard deviations differed between
treatments, the natural logarithms of data were used for parametric comparisons.
Results both in histograms and in the text are presented as mean±the standard error
of the mean (SEM).
Chapter 3
The anatomy of the Soay ram pituitary gland
3.1 Introduction
The general anatomy of the sheep pituitary gland is well described. The pituitary
gland is divided into anterior and posterior lobes with a clearly defined pars
intermedia. The pars intermedia develops in fetal life and remains a major part of
the pituitary gland throughout adult life. The tissue is closely associated with the
pars nervosa and forms a layer of approximately 15-20 cells thick between the pars
nervosa and pars distalis. The ovine pars intermedia is a lobular tissue with a cell
population predominantly composed of a single endocrine cell type, the
melanotroph (Perry et al., 1981). POMC gene expression in the pars intermedia is
detected by Day 70 of fetal life and is the predominant gene expressed in the
melanotrophs in the adult. POMC is also expressed by the corticotrophs dispersed
throughout the pars distalis (Castro and Morrison, 1997; Smith and Funder, 1988).
The aim of this study was to characterise the anatomy of the Soay sheep
pituitary gland using immunocytochemistry. In particular, the localisation of the
POMC products aMSH and ACTH and the localisation of the associated
endoproteolytic POMC-processing enzymes PCI and PC2. The prediction was that
cell types expressing aMSH would be characterised by the expression of both PCI
and PC2 while the cells expressing predominantly ACTH would express PCI
alone. Additionally, the distribution of two other cell types, gonadotrophs and
lactotrophs was characterised as markers of the pars distalis (Polkowska et al.,
1980; Skinner and Robinson, 1995).
3.2 Experimental procedures
3.2.1 Animals and collection of tissues
Pituitary glands were collected from adult Soay rams maintained indoors under
mixed artificial photoperiodic conditions as described in section 2.1.2. Animals
were housed in individual pens and fed on a constant diet of dried grass nuts with
hay and water ad libitum. Animals were killed and immediately after death, the
pituitary gland was removed, weighed and promptly fixed for five hours in Bouins
reagent and processed for histology as described in section 2.4.
62
Chapter 3 Anatomy of the Soay ram pituitary gland 63
3.2.2 Immunocytochemistry
Immunocytochemical staining for aMSH, ACTH, PCI, PC2, LHp and prolactin
was carried out on 3pm coronal sections of the pituitary gland (Section 2.5.4). A
polyclonal rabbit antibody against ovine CLIP was used for the detection of
ACTH. Anti-C-terminal ovine aMSH rabbit polyclonal antibody was used to
identify the melanotrophs and rabbit polyclonal anti-ovine LHp antibody to identify
the gonadotrophs. Rabbit polyclonal anti-ovine prolactin antibody was used to
identify the lactotrophs. Rabbit polyclonal anti-mouse PCI and rabbit polyclonal
anti-mouse PC2 antibodies were used to localise the site of expression of the
processing enzymes. Immunocytochemistry utilised the avidin-biotin horse radish
peroxidase complex (Section 2.5.2). Where double immunocytochemistry was
employed both the horse radish peroxidase and the alkaline phosphatase anti-
alkaline phosphatase methods were employed simultaneously (Section 2.5.3).
Control sections were incubated with non-immune serum from the species in which
the respective primary antibody was raised (Section 2.5.5).
The relative size of the different compartments of the pituitary gland were
measured in cross section using an image analysis program (Proplus software).
Cell frequency as a percentage of total cells within a tissue was calculated by
counting total and positively-staining cells within ten graticule units (Graticules
Ltd, Tonbridge, UK) in ten different areas of the tissue (total area in which cells
were counted was 0.032mm2).
3.3 Results
3.3.1 General anatomy of the Soay sheep pituitary gland
The average pituitary gland weight of the adult Soay rams (average body weight
36.0±1.5kg) was 595±39mg (mean±SEM, n=14). Of the pituitary gland caudal to
the pars tuberalis, the pars distalis/zona tuberalis, pars intermedia and pars nervosa
comprised on average 90%, 6.5% and 3.5% respectively of the entire pituitary
gland.
The distribution of the various components of the pituitary gland is illustrated
in Figures 3.1 and 3.2 in which sagittal and coronal sections of the rostral pituitary
gland were stained for aMSH, ACTH, LHp and prolactin. The general
organisation of the pars intermedia is represented schematically in Figure 3.3. The
pars intermedia extended into the midline of the dorsal face of the pars distalis and
stained heavily for both aMSH and ACTH. ACTH expression was localised in
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scattered cells of the pars distalis which were presumed to be corticotrophs. The
pars intermedia and the pars distalis were largely separated by the residual lumen of
Rathke's pouch, but frequent direct contacts between these two tissues were also
observed. The pars intermedia adhered closely to the pars nervosa. At the rostral
end, the pars intermedia was detached from the median eminence. LH(3-
expressing gonadotrophs were scattered throughout the pars distalis, zona tuberalis
and the pars tuberalis. By contrast, prolactin staining was restricted to the pars
distalis. Within the pars distalis, lactotrophs were the most abundant cell type
comprising 50%-60% compared with 7%-8% corticotrophs and 5%-8%
gonadotrophs.
3.3.2 Cellular organisation of the pars intermedia and pars distalis
The appearance of the pars intermedia at high magnification is illustrated in Figure
3.4 and 3.5. Figure 3.4 demonstrates the close association between the pars
intermedia and pars nervosa as well as the dissociation of the pars intermedia from
the pars distalis. Figure 3.5 shows an area of direct contact between these tissues.
The pars intermedia had a lobular organisation and contained finger like projections
from the pars nervosa. The lining of the residual lumen on the side of the pars
distalis contained a remarkable concentration of gonadotrophs (Figure 3.4b).
Occasional gonadotrophs were also present in the pars intermedia while in the pars
distalis the gonadotrophs had a particularly scattered distribution compared with the
lobular association of the lactotrophs. The zona tuberalis was richly vascularised
whereas by comparison scattered small blood vessels were observed in the pars
intermedia.
3.3.2 Localisation of the site of expression of PCI and PC2.
Immunocytochemical staining for PCI and PC2 in the pars intermedia is illustrated
in Figure 3.6. Low level of expression of PCI was detected in a high population
of the cells within the pars intermedia. By comparison, PC2 was more heavily
expressed by the majority of the cells within the pars intermedia. For both
enzymes, the staining was localised within the cytoplasmic compartment.
Moreover, both aMSH and ACTH were detected in this tissue.
The pattern of expression of PCI and PC2 in the pars distalis is illustrated in
Figure 3.7. Immunostaining for PCI and PC2 was detectable in a small and
scattered population of cells within the pars distalis. PC2 staining in the pars
distalis was weaker than that observed in the pars intermedia. ACTH was heavily
expressed in a proportion of the pars distalis cells whereas only weak expression of
aMSH was detected in this tissue.
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3.4 Discussion
This immunohistological study has allowed the identification of several distinct
tissues and mapped the distribution of many endocrine cell types by their secretory
products in the Soay ram pituitary gland. This study identified five specific
compartments within the pituitary gland of the Soay ram based on the distribution
of endocrine cell types. These compartments were the pars tuberalis, the zona
tuberalis, the pars distalis, the pars intermedia and the pars nervosa. These
compartments are as described in other sheep breeds (Perry et al., 1981;
Polkowska et al., 1980; Skinner and Robinson, 1995) and are conserved in many
other mammalian species (Atwell, 1918; Harris, 1947; Wingstrand, 1966). As
with other sheep breeds, the pars intermedia persists as a major pituitary gland
tissue in the adult (Perry et al., 1981).
Within the Soay pituitary gland, POMC-derived peptides were expressed in
two pituitary tissues. These were the pars intermedia in which aMSH-expressing
melanotrophs were the predominant cell type and the pars distalis which contained
scattered, principally ACTH-expressing corticotrophs. The pars intermedia was
also strongly immunoreactive for the ACTH antibody which cross-reacts (100%)
with CLIP. Both these peptides are likely to contribute to this immunoreactivity in
the pars intermedia since ACTH is an intermediate in aMSH and CLIP synthesis
from POMC. The observation that ACTH is processed to yield aMSH in the pars
intermedia of the Soay pituitary gland is consistent with immunocytochemical
studies of the pars intermedia in the mouse (Marcinkiewicz et al., 1993), the rat
(Mains and Eipper, 1990) and the frog (Maruthainar et al., 1992).
The pars intermedia expresses both PCI and PC2, both of which are
necessary for the biosynthesis of aMSH (Castro and Morrison, 1997; Mains and
Eipper, 1990; Smith and Funder, 1988). The expression of both PCI and PC2 in
the pars intermedia implies that POMC is more extensively processed in this tissue
than in the corticotrophs of the pars distalis. The expression of both PCI and PC2
has been observed in the pars intermedia of the mouse (Marcinkiewicz et al.,
1993), the rat (Mains and Eipper, 1990) and the frog (Kurabuchi and Tanaka,
1997).
The principle POMC-derived product expressed by the corticotrophs of the
pars distalis was ACTH. aMSH immunoreactivity in the pars distalis was weak
compared to the pars intermedia and may be accounted for by the low
crossreactivity of the aMSH antiserum with ACTH (0.15%). The crossreactivity of
the ACTH antiserum for CLIP is not a relevant consideration in the pars distalis
given the weak immunoreactivity for aMSH observed in this tissue. As aMSH
and CLIP are both generated where ACTH is endoproteolytically cleaved, where a
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tissue lacks aMSH immunoreactivity it will also not express CLIP. Thus, the
corticotroph is unlikely to secrete significant amounts of aMSH in the Soay sheep.
Similarly, aMSH expression in the adult pars distalis is low in the mouse
(Marcinkiewicz et al., 1993), the rat (Mains and Eipper, 1990) and the frog
(Kurabuchi and Tanaka, 1997).
The pattern of PCI and PC2 expression in the pars distalis adds further
strength to the concept that the corticotroph does not secrete significant quantities of
aMSH. PCI is expressed in a small population of cells in the pars distalis with a
similar distribution to those expressing ACTH. A small population of cells of the
pars distalis stained weakly for PC2 but the intensity of staining was low compared
to the pars intermedia. These PC2-expressing cells of the pars distalis may not be
corticotrophs since in other species there are reports that PC2 is expressed in the
pars distalis by gonadotrophs (Marcinkiewicz et al., 1993). The low level of both
aMSH and PC2 in the corticotroph is indicative of less extensive POMC-
processing compared to the melanotroph in which aMSH and PC2 are strongly
expressed. The distribution of PCI and PC2 within the Soay pituitary gland is
consistent with that observed in the cow (Egger et al., 1994; Kirchmair et al.,
1992) and the mouse in which the precursor, POMC, is differentially processed in
these two pituitary compartments to produce a tissue-specific range of peptides
(Benjannet et al., 1991; Marcinkiewicz et al., 1993). In the mouse, in
corticotrophs POMC is cleaved into ACTH, (3LPH and possibly some (3END
through the proteolytic action of PCI. Scattered corticotrophs are found
throughout the pars distalis of the murine pituitary gland. However, PC2 and
aMSH are co-expressed at a low level by a proportion of these cells in the mouse.
The expression of PC2 and aMSH in the murine pars distalis is maximal in the
immature animal, but persists in the adult (Marcinkiewicz et al., 1993).
This study also identified an aMSH-secreting cell type in the pars tuberalis
not associated with the pars intermedia. Although occasional corticotrophs have
previously been observed in the pars tuberalis of the human pituitary (Baker,
1977), the cells observed in this study, unlike corticotrophs appear to produce
significant amounts of aMSH since they are much more readily immunoreactive
with the aMSH antiserum than are the corticotrophs of the pars distalis. These
cells are few in number compared to the melanotrophs of the pars intermedia and
are unlikely to contribute appreciably to peripheral levels of aMSH.
Overall, this study confirms the presence of two classic POMC-expressing
cell types in the pituitary gland of the Soay ram. The pattern of expression of
aMSH, a product of both PCI and PC2-mediated POMC cleavage and ACTH, a
product of PCl-mediated POMC cleavage alone, are consistent with the concept
that the melanotroph is the major source of circulating aMSH. The pituitary gland
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in the sheep expresses POMC at a level far exceeding that of any other tissue
(Smith and Funder, 1988) and this study demonstrates unequivocally that the pars
intermedia is the principle source of aMSH in the pituitary gland of the Soay
sheep. Therefore it is evident that the conspicuous seasonal cycle of circulating
aMSH previously observed in the Soay sheep is generated through the regulation
of the activity of the pars intermedia. The seasonal regulation of the activity of the
pars intermedia is the focus of the next study.
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Figure 3.1. Immunocytochemical characterisation of the rostral region of the
pituitary gland of the Soay ram in sagittal section using antisera for aMSH, ACTH,
LHp (LH) and prolactin (PRL). PI- pars intermedia, PD- pars distalis, ME- median
eminence, PT- pars tuberalis. The pars intermedia was highly immunoreactive for
aMSH (top left). Immunocytochemistry for ACTH (bottom left) revealed scattered
immunoreactive cells in the pars distalis, presumably corticotrophs. The pars
intermedia also stained positively for ACTH. LHp-immunoreactive gonadotrophs
were widely distributed and occurred singly throughout the pars distalis and
occassionally in the pars tuberalis and the margins of the pars intermedia.
Prolactin-immunoreactive lactotrophs (bottom right) were restricted to the pars
distalis where their distribution was strikingly lobular. In the pars distalis
lactotrophs occurred with a frequency greater than that of corticotrophs or
gonadotrophs.
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Figure 3.2. Immunocytochemical characterisation of the rostral pituitary gland
of the Soay ram through representative coronal sections. These sections were cut
sequentially at 2mm intervals caudally to the pars tuberalis (top) to the medial
pituitary gland (bottom). LH- LHp, PRL- prolactin, ME- Median eminence, 3V-
extension of third ventricle, PT- pars tuberalis, ZT- zona tuberalis, PN-pars
nervosa, PI- pars intermedia, PD- pars distalis. Most rostrally, the pars tuberalis
surrounded the median eminence. The pars tuberalis was rich in large sinusoidal
blood vessels (arrows). Note the presence of cells immunoreactive for LHp and
aMSH (*) associated with blood vessels in the pars tuberalis. The pars intermedia
expanded caudally from the pituitary stalk from a loose projection of aMSH-
staining cells (second row) into a V-shaped stucture surrounding the pars nervosa
(bottom row). The zona tuberalis which formed a caudal extension to the pars
tuberalis (second row) stained for LHp, but not prolactin (right) and contained a
few ACTH immunoreactive cells. The pars distalis, which stained heavily for
prolactin, increased in size caudally and was the predominant tissue of the medial
pituitary gland.
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ME - Median Eminence
PT - Pars Tuberalis
PN - Pars Nervosa
PI - Pars Intermedia
PD - Pars Distalis
Figure 3.3. The organisation of the Soay ram pituitary from the pars tuberalis
into the medial pituitary gland. This diagram is based on serial coronal sections of
pituitary glands from a number of Soay rams. The pars tuberalis enclosed the
median eminence which was continuous with the pars nervosa. The pars nervosa
extended back into the pituitary gland, first lying very superficially on top of the
dorsal surface before becoming progressively more embedded into the body of the
pituitary gland. The pars intermedia separated the pars nervosa from the pars
distalis except at its most rostral extent.
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Figure 3.4. Coronal sections through the pars nervosa (PN), pars intermedia
(PI) and pars distalis (PD) of the Soay ram.
Top panel; The pars intermedia immunocytochemically-stained for aMSH. The
pars intermedia formed a V-shaped collar around the ventral and lateral margins of
the pars nervosa along most of its length A clear residual lumen (*) is observed
between the pars intermedia and the pars distalis.
Bottom panel; The margin between the pars intermedia and pars distalis, double
immunocytochemically-stained for LHp (HRP-DAB method, brown) and aMSH
(APAAP-fast blue, blue). Immunocytochemical staining for aMSH in the pars
intermedia, but not in the pars distalis, was clearly observed. Gonadotrophs were
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Figure 3.5. The pars distalis (PD), pars intermedia (PI) and zona tuberalis (ZT)
of the Soay ram at greater magnification.
Top panel; The pars intermedia and pars distalis immunocytochemically stained for
prolactin (restricted to pars distalis) showing the boundary between these two
tissues. The pars intermedia was clearly distinct from the pars distalis and was
frequently separated from the pars distalis by the residual lumen of Rathke's pouch.
Bottom panel; In contrast, there was no clear boundary between the zona tuberalis
and the pars distalis. The zona tuberalis contained numerous sinusoidal blood
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Figure 3.6. The expression of POMC-derived peptides and their endoproteolytic
processing enzymes by the Soay ram melanotroph. Melanotrophs were strongly
immunoreactive for both aMSH and ACTH (top). Immunocytochemistry for the
processing enzymes PCI and PC2 demonstrated that both enzymes are expressed
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Figure 3.7. The expression of POMC-derived peptides and their endoproteolytic
processing enzymes by the Soay ram corticotroph. Corticotrophs expressed ACTH
and stained weakly for aMSH (top). PCI and PC2 (bottom) were also expressed
by scatttered cells of the pars distalis, presumed to be corticotrophs, although the









































































Seasonal regulation of pars intermedia POMC
expression and processing.
4.1 Introduction
In the Soay sheep, circulating aMSH and (3END show a pronounced seasonal cycle in
which aMSH is 3-20 fold higher in late summer and autumn than in winter and spring
(Ebling and Lincoln, 1987; Lincoln, 1991). This cycle occurs in males, females and
castrated males, and can be readily entrained by exposing animals to an artificial
lighting regimen indoors (Lincoln and Baker, 1995). While the general endocrinology
of this cycle has been described, the molecular and cellular events within the pars
intermedia which generate the seasonal cycle in aMSH secretion in the sheep are
unknown. Thus the aim of this study was to measure the differential expression of the
mRNAs for POMC, PCI and PC2 in the pars intermedia at different times of the year.
It was anticipated that seasonally coordinated changes in the expression of all three
genes would account for the observed changes in circulating concentrations of aMSH.
This is supported by observations in the rat, in which pharmacological activation and
inhibition of the pars intermedia induced changes in expression of POMC and the
associated endoproteolytic processing enzymes (Oyarce et al., 1996). To achieve these
aims, we utilised the partial ovine cDNA sequences for PCI and PC2 to characterise the
level of expression of these mRNAs in the pituitary gland and brain. This was further
confirmed by immunocytochemistry for the corresponding peptide products of these
mRNAs. Moreover, the possibility of proliferative and cellular changes in autumn
which result in hypertrophy of the pars intermedia and consequently the enhanced
aMSH secretion was investigated.
4.2 Experimental procedures
4.2.1 Animal treatments and collection of tissues
Animals used in the seasonal study were Soay ewes born the previous spring (eight to
nine months before commencing the experiment) and were maintained outdoors in
grass paddocks in Life, Scotland (56°N). The animals received supplementary feeding
of commercial sheep nuts and hay during the winter (December to April). The animals
were run with a ram from November to April and became pregnant around the
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beginning of the study (Table 4.1). Groups (n=5) were culled at four times of year;
approximately at the winter solstice (17th December, WS), the spring equinox (20th
March, SE), the summer solstice (20th June, SS), and the autumn equinox (24th
September, AE). The animals were transported to the Marshall Building near
Edinburgh where they were allowed to acclimatise for three days before being killed.
Immediately after death, the pituitary glands were separated, weighed and dissected into
rostral and caudal portions (section 2.3.1). Tissues from the rostral part were promptly
fixed for five hours in Bouins reagent and processed for histology as described in
section 2.4. The remaining tissue from the caudal part was dissected into pars
intermedia/pars nervosa and pars distalis and snap frozen and stored at -70°C until
RNA extraction (section 2.3). These tissues were utilised in RNase protection assays,
in situ hybridisation and immunocytochemistry.
Additional material from adult Scottish Blackface ewes held at the Moredun
Research Institute was obtained at different times of the year. The pituitary gland,
medio-basal hypothalamus (from the optic chiasm back to the mammilary bodies),
latero-ventral hippocampus and cerebellum were removed and snap frozen and stored at
-70°C until RNA extraction (section 2.3). These RNA were utilised in Northern blot
analyses, although the effect of season was not studied in these animals.
Table 4.1 Data on whole body, pituitary gland and ovary weight as well
as reproductive status in Soay ewes used in studies into the seasonal
regulation of circulating POMC-derived peptides.
Animal Body Wt (Kg) Pituitary Wt Ovary Wts Comments
(nig) (L/R; mg)
WS1 16.8 - 589/518 Pregnant-early
WS2 15.0 226 233/407 Pregnant-early
WS3 16.4 282 925/342 Pregnant-early
WS4 15.6 326 1183/353 Pregnant-early
WS5 15.8 273 730/215 Pregnant-early
SE6 15.2 312 785/343 Pregnant-late
SE7 19.4 281 297/827 Pregnant-late
SE8 16.4 351 278/974 Pregnant-late
SE9 16.3 295 178/788 Pregnant-late
SE10 18.2 335 178/827 Pregnant-late
SS11 19.3 436 372/384 Lactating-early
SS12 18.1 395 328/414 Lactating-early
SS 13 24.0 468 574/560 Lactating-early
SS14 20.0 432 278/528 Lactating-early
SS15 24.7 441 503/573 Non-lactating
AE16 25.0 400 468/522 Lactating-late
AE17 23.2 301 532/718 Lactating-late
AE18 25.0 333 415/313 Lactating-late
AE19 21.0 341 476/627 Lactating-late
AE20 24.0 337 574/610 Lactating-late
Abbreviations: WS, winter solstice group; SE, spring equinox group; SS, summer
solstice group; AE, autumn equinox group.
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4.2.2 RNase protection assay
RNase protection assays were carried out for POMC, PCI and PC2 mRNAs on 5pg
total pars intermedia RNA (section 2.13) using cRNA probes generated from the
subcloned ovine cDNA sequences described in detail in section 2.8. The size of the
protected fragments was assessed by comparison with RNA size standards (Ambion).
The relative optical density of POMC, PCI and PC2 RNA and 18S ribosomal standard
were determined on a phosphorimager (Molecular Dynamics) and the 18S ribosomal
standard was used to correct for loading variations in the RNA between individuals.
Differences between the relative density in the different treatment groups were evaluated
using ANOVA. Where ANOVA indicated that standard deviations differed between
treatments, the natural logarithms of data were used for parametric comparisons.
Pairwise comparisons between individual groups were carried out using the unpaired
student t-test.
4.2.3 In situ hybridisation
In situ hybridisation was carried out for POMC, PCI and PC2 mRNAs (section 2.12).
In situ hybridisation employed the same ovine cDNA sequences as RNase protection
assay (section 2.8). The tissue sections were exposed to photographic emulsions for a
period ranging from 1-2 days (POMC) to six weeks (PCI and PC2; section 2.11.6).
Semi-quantitative analyses were undertaken using computer-aided image analysis
(section 2.11). Analysis of variance was applied to grain density measurements
obtained by image analysis between treatments. As with RNase protection assay,
transformed data was used where the standard deviation differed between treatments.
4.2.4 Northern blot analysis
Northern blot analyses were carried out as described in section 2.10 using the ovine
cDNA sequences (section 2.8) and RNA collected from the Scottish Blackface ewes.
This gave general information on mRNA transcript sizes and extra-pituitary sites of
expression of POMC and the processing enzymes.
4.2.5 Immunocytochemistry
Immunocytochemical staining for aMSH, ACTH, PCI and PC2 was carried out on
3|jm coronal sections of each pituitary gland (Section 2.5.4). Where semi-quantitative
analysis of immunocytochemical staining intensity was made, sections were examined
without prior knowledge of treatment group and staining intensity was graded from
zero (antigen not detectable) to five (heavy immunostaining).
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To measure pars intermedia cellular proliferative activity, immunocytochemistry
for the proliferation marker, PCNA, was undertaken (Section 2.5.4). Percentage
positive nuclear-staining and cell density measurements were carried out simultaneously
by counting total and positively-staining nuclei within ten graticule units (Graticules
Ltd, Tonbridge, UK) in ten different areas of the tissue (total area in which cells were
counted was 0.032mm2). Counting of cells was made on slides without prior
knowledge of treatment group and comparisons between groups were made using
ANOVA. The cross-sectional area of the pars intermedia, pars distalis and pars
nervosa was measured using an image analysis program (Proplus software).
4.3 Results
4.3.1 Animals
Average whole body weight in the Soay ewes increased significantly (p<0.0001) from
winter (15.9±0.3kg; mean±SEM) to the following autumn (AE, 23.6±0.7kg).
Pituitary gland weight also increased from winter (WS, 277±21; SE, 315±13mg) to
summer (SS, 434±12 mg; p<0.0001) but then declined from summer (SS, 434±12
mg) to autumn (AE, 342±16mg; p<0.01).
4.3.2 POMC expression
POMC RNA transcripts of 1.2 and 2.8kb were detected in the pituitary gland. The
1.2kb transcript was the markedly predominant transcript. By comparison, only the
1.2kb transcript was detected in the mediobasal hypothalamus. No expression of
POMC was detected by Northern blot hybridisation in the hippocampus or the
cerebellum (Figure 4.1).
RNase protection assay (Figures 4.2 and 4.3) demonstrated significant seasonal
variation (P<0.01) in POMC mRNA expression in the pars intermedia. POMC mRNA
expression (Figure 4.3a) was lowest in winter (WS; 1.08110.215) and spring (SE;
0.24910.070) and increased in summer (SS; 1.25210.547) and autumn (AE-
3.16910.885; Optical density POMC protected fragment/18S protected fragment,
arbitary units). Similarly, semi-quantitative analysis by in situ hybridisation (Figure
4.4) demonstrated significant seasonal variation in POMC mRNA expression in the
pars intermedia (P<0.01). POMC expression was lowest in the winter (WS;
0.03210.001) and spring (SE; 0.03510.003) and increased in the summer (SS;
0.04510.005) and autumn (AE- 0.05010.003; Silver grain density, arbitary units;
Figures 4.4 and 4.5a). POMC mRNA was also detected in the pars distalis (Figure
4.6). However, no effect of season detected on the level of expression in the pars
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distalis (WS, 0.010±0.001; SE, 0.011±0.003; SS, 0.008±0.003; AE, 0.008±0.002;
Figures 4.5b and 4.6).
4.3.3 PCI expression
PCI mRNA transcripts of 2.5kb were detected in the pituitary gland, the mediobasal
hypothalamus, the hippocampus and the cerebellum. Additionally, minor transcripts of
1.8, 1.4 and 0.8kb were detected in the pituitary gland (Figure 4.7).
RNase protection assay confirmed expression of PCI in the ovine pars intermedia
(Figure 4.2). PCI mRNA expression was increased in the pars intermedia in autumn
compared to the rest of the year (Figure 4.3b; WS, 0.036±0.002; SE, 0.028±0.003;
SS, 0.033±0.003; AE, 0.066±0.007; Optical density PCI protected fragment/18S
protected fragment, arbitary units; p<0.001).
PCI mRNA was detectable by in situ hybridisation in both the pars intermedia
(Figure 4.4) and the pars distalis (Figure 4.6). PCI mRNA was undetectable in the
pars nervosa (Figure 4.4). In the pars intermedia, there was a tendency for increased
PCI mRNA expression in autumn although this did not reach statistical significance
(WS, 0.0176±0.0059; SE, 0.035710.0260; SS, 0.016210.0130; AE, 0.078110.0308;
Silver grain density, arbitary units; Figure 4.9a). The temporal pattern of PCI
expression indicated by in situ hybridisation was similar to that observed by RNase
protection assay.
PCI peptide was detectable by immunocytochemistry in the pars intermedia of all
animals (Figure 4.8). However, PCI immunoreactivity was present in lower
concentrations in the pars intermedia than in the adjacent pars nervosa. Again, there
was a tendency for increased PCl-immunostaining in the pars intermedia from winter
to the following autumn; however this did not reach statistical significance (WS,
0.410.2; SE, 0.610.2; SS, 0.810.2; AE, 1.510.5; Relative staining intensity, arbitrary
units; Figure 4.8). Individual cells of the pars distalis also showed PCI
immunoreactivity and similarly this showed an effect of season just short of
significance, with maximum staining intensity in animals killed at the spring equinox
(WS, 1.410.2; SE, 2.810.4; SS, 2.210.4; AE, 2.010.3; P=0.06). PCI staining in the
neural lobe was unaffected by season (WS, 3.010.6; SE, 2.0+0.3; SS, 2.610.5; AE,
1.810.4; Figure 4.8).
4.3.4 PC2 expression
PC2 mRNA transcripts of 2.7kb were detected in the pituitary gland, the mediobasal
hypothalamus and the hippocampus (Figure 4.10).
RNase protection assay confirmed the expression of PC2 mRNA in the pars
intermedia (Figure 4.2). There was no effect of season on pars intermedia PC2 mRNA
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expression (Figure 4.3; WS, 6.31±1.27; SE, 4.36±0.91; SS, 10.66±3.62; AE,
7.30±1.81; Optical density PC2 protected fragment/18S protected fragment, arbitary
units). PC2 expression was detectable also in the pars intermedia by in situ
hybridisation (Figure 4.4). There was a tendency for increased PC2 mRNA expression
in autumn; however, due to the large individual variation this did not reach statistical
significance (Figure 4.9b; WS, 0.0120±0.0058; SE, 0.004510.0035; SS,
0.012710.0110; AE, 0.049910.0385; Silver grain density, arbitary units). PC2
mRNA was not detected in the pars distalis (Figure 4.6).
PC2 peptide was detected in the pars intermedia of all animals studied (Figure
4.8). Additionally, some staining in the pars nervosa (Figure 4.8) and weak staining in
isolated cells of the pars distalis (as described in the previous chapter, Figure 3.7) was
observed. PC2 immunocytochemical staining intensity was unaffected by season in
any of the three pituitary compartments studied (Pars intermedia; WS, 3.610.2; SE,
2.810.4; SS, 2.610.4, AE; 2.510.5; Pars Distalis; WS, 0.410.2; SE, 0.610.2; SS,
0.210.2; AE, 0.210.2; Pars Nervosa; WS, 2.010.3; SE, 1.210.2; SS, 0.810.4; AE,
1.6+0.4; Relative staining intensity, arbitrary units).
4.3.5 Pars intermedia aMSH and ACTH expression
The POMC-derived peptide aMSH was detected in the pars intermedia by
immunocytochemistry at all times of the year (Figure 4.8). The intensity of aMSH
staining was not significantly affected by season (WS, 3.810.4; SE, 3.810.2; SS,
3.610.5; AE, 3.810.6; Relative staining intensity, arbitrary units). ACTH
immunoreactivity was also present in the pars intermedia with no differences between
seasons. In the pars distalis, both aMSH and ACTH were present, although ACTH
staining was more intense than aMSH as described in the previous chapter (Figure
3.7). The intensity of aMSH staining in the pars distalis was not altered with season.
4.3.6 Pars intermedia cell proliferation and morphology
Immunocytochemistry for PCNA revealed a significant increase in cell proliferation in
the pars intermedia from winter to the following autumn (Figure 4.11a; p<0.05). The
percentage of cells staining positively for PCNA increased from approximately 0.15%
to 0.50% from the winter solstice to the autumn equinox (WS, 0.13710.091; SE,
0.13910.075; SS, 0.38810.157; AE, 0.55610.089%).
Pars intermedia cell density showed a highly significant decline from winter to
the following autumn concomitant with the increase in PCNA expression (Figure
4.11b; WS, 1708148; SE, 11821126; SS, 1127190; AE, 945174 cells in 0.032mm2;
p<0.0001) indicative of an increase in cytoplasmic volume. In addition, there was a
parallel increase in pars intermedia cross-sectional area (WS, 428990197291; SE,
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446776±58342; SS, 796788±55552; AE, 751459±49918pm2; p<0.01). A increase in
the cross-sectional area of the pars distalis was detected from winter to summer (WS,
12109000±2031000; SE, 16072000±1923000; SS, 2357800013348000; AE,
2034300013348000pm2; p<0.05). No difference in cross sectional area between
seasons was detected in the pars nervosa (WS, 5775961173298; SE, 341766129199;
SS, 378840134579; AE, 379563131402)
4.4 Discussion
This study clearly demonstrates that there are seasonal changes in the expression of
POMC mRNA with an increase from spring to autumn in Soay ewes. In addition,
there is evidence for parallel changes in the mRNA expression of the processing
enzymes PCI and PC2 although these changes are not statistically significant for PC2
due to the large individual variations between animals. This general result is consistent
with the view that the seasonal cycle in aMSH secretion which is elevated in the late
summer and autumn (Lincoln, 1991; Lincoln and Baker, 1995) results from the
increased expression of the POMC precursor gene and the genes encoding the key
processing enzymes involved in endoproteolytic cleavage of the POMC precursor
molecule. The observation that both PCI and PC2 are expressed in the pars intermedia
is indicative of the notion that POMC is extensively processed in this tissue to yield
primarily aMSH (Castro and Morrison, 1997; Smith and Funder, 1988). In the rat,
experimental activation of the pars intermedia is associated with an increase in the
expression both of POMC and its processing enzymes, including PCI and PC2
(Oyarce et al., 1996). In addition, in the frog adaptation to dark background which
promotes aMSH secretion from the pars intermedia, is associated with up-regulation of
multiple genes involved in aMSH synthesis and processing (Ayoubi et al., 1992; Braks
et al., 1992; Maruthainar et al., 1992). Overall, this is consistent with the view that the
seasonal activation of the pars intermedia which results in increased circulating aMSH
at the onset of winter, involves the coordinated regulation of the POMC and processing
enzyme genes.
The results reported in this chapter also indicate that the seasonal variation POMC
expression and aMSH secretion are accompanied by a change in the cell size of the
proliferative activity of the pars intermedia. In autumn, when POMC mRNA
expression is maximal, and peak circulating aMSH concentrations are reported
(Lincoln and Baker, 1995), the pars intermedia undergoes hypertrophy and
hyperplasia. Moreover, the highest cross-sectional area of the pars intermedia, the
highest index of cell proliferation and the lowest cell density were all associated with
maximal POMC mRNA expression. In the rat, inhibition of aMSH secretion from the
pars intermedia using dopaminergic drugs is associated with a parallel decrease in the
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proliferative index of the pars intermedia (Chronwall et al., 1987). Moreover, in the
sheep, disconnection of the pituitary gland from the primarily inhibitory influence of the
hypothalamus results in an increase in aMSH secretion and hypertrophy of the pars
intermedia (Clarke et al., 1986). The study described here indicates that the pars
intermedia is a dynamic tissue in the intact sheep waxing and waning in activity with
season. The seasonal activation of the pars intermedia is likely to be a reversible effect
since dopaminergic drugs inhibit proliferative activity and gene expression of POMC
and its related processing enzymes as occurs in the winter (Chronwall et al., 1987;
Oyarce et al., 1996). This aspect is discussed in more detail in the following
experimental chapters.
The animals used in this study were juvenile at the onset of the study and thus the
experimental observations are confounded by the effect of age. The increase in
pituitary gland weight and the increase in the size of the pars intermedia (as indicated by
cross-sectional area) were associated with an increase in overall body weight. This may
be related to age rather than season since the pars intermedia of the sheep is reported to
increase from a thickness of 10 cells in the neonate to 15 cells deep in the adult (Perry et
al., 1982). The pars distalis also showed an increase in cross-sectional area from
winter to summer, probably also due to somatic growth. However, the weights of the
pituitary glands were decreased in the autumn compared with summer which indicates
an effect of season rather than age. This may be attributed to a decline in the size of the
pars distalis associated with regression of the activity of the lactotrophs (Lincoln and
Baker, 1995; Lincoln and Clarke, 1994). The treatment groups in this study do not
allow for more accurate dissection of the effect of season and age on the functional
activity of the pars intermedia. The data presented in this study may also be affected by
pregnancy and stress caused by transport three days before killing. Pregnancy and
lactation are known to delay the seasonal maximum in circulating aMSH concentrations
by approximately two months (Lincoln and Baker, 1995).
Northern blot analysis indicated that two POMC transcripts of 1.2kb and 2.8kb
were expressed in the ovine pituitary gland. The 1.2kb transcript was the more
dominant. Transcripts of 1.25 to 1.4 kb have been reported in the pituitary gland of the
fetal sheep (Merei et al., 1993). PCI mRNA transcripts of several sizes were detected.
Multiple transcription start sites are reported in the human PCI gene (Jansen et al.,
1995). However, the smaller of these (less than 2.0kb), which were only detected in
the pituitary gland, may be degradation products since they are likely to be too small to
code for functional PCI based on the cDNA sequences of other species (Bloomquist et
al., 1991).
This study describes the localisation of the mRNA for PCI and PC2 in the sheep
pituitary gland for the first time. The exposure times needed for detection of POMC
and PC1/PC2 signals in the in situ hybridisation studies suggest that either the POMC
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gene is comparatively a more heavily expressed gene and/or the POMC RNA is a more
stable transcript than that of the processing enzymes. POMC and PCI mRNA were
observed both in the pars intermedia and the pars distalis whereas PC2 mRNA was not
detectable in the pars distalis of any animals although immunocytochemistry indicated
that PC2 is expressed at low levels. These observations further substantiate the
findings in the previous chapter which indicated that PC2 is principally expressed by
the pars intermedia. Since PC2 is thought to be necessary for the efficient synthesis of
aMSH (Castro and Morrison, 1997; Smith and Funder, 1988), these observations
further implicate the pars intermedia as the principal source of circulating aMSH.
PCI and PC2 peptides were also detected in the pars nervosa of the Soay sheep.
PCI and PC2 have previously been reported in the bovine pars nervosa (Egger et al.,
1994). However, RNA transcripts for these enzymes were not detected in the pars
nervosa suggesting that these enzymes are transported to the axons and nerve terminals
of the pars nervosa from the cell bodies in the hypothalamus. These enzymes may be
involved in the endoproteolytic processing of secretogranin II to yield secretoneurin.
Secretogranin II mRNA is also restricted to the neuronal cell bodies in the
hypothalamus (Egger et al., 1994).
The novel ovine PCI and PC2 sequences generated for this study both show
considerable nucleotide and predicted peptide sequence homology to their murine and
human counterparts (Bloomquist et al., 1991; Dai et al., 1995; Seidah et al., 1992).
PCI and PC2 mRNA transcripts are expressed in tissues that do not express POMC,
such as the pars nervosa and the hippocampus, indicating that these endoproteases act
on a number of substrates. The diversity of substrates for the prohormone convertases
is illustrated by the multiple phenotypical effects of mutations of these enzymes.
Mutations in PCI have been reported in the human (O'Rahilly, 1998) and resulted in
multiple phenotypical effects which included early onset obesity (likely to be caused by
the failure to process insulin and possibly POMC) and abnormal pigmentation (likely to
be due to impaired POMC processing resulting in a lack of functional aMSH at the
melanocyte). The high conservation of sequences and widespread expression for these
enzymes reflects the fundamental role played by these enzymes in many physiological
systems.
This study has clearly demonstrated coordinate changes in the expression of the
mRNAs for POMC and at least one of its processing enzymes with season. However,
it is not clear how much of this apparently seasonal regulation of the expression of
these mRNAs is actually attributable to age and somatic growth. The effect of
photoperiod (which is the most widely used physiological indicator of season) on pars
intermedia function is the focus of the next study.
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Figure 4.1 Northern blot analysis on 5pg total RNA probed with radiolabeled
POMC cDNA. POMC mRNA transcripts of 1.2kb (major transcript) and 2.8kb
(minor transcript) were detected in RNA extracted from the pituitary gland (Pt).
The 1.2kb transcript is also expressed in RNA extracted from the mediobasal
hypothalamus (MBH). POMC does not appear to be expressed in the hippocampus
(Hp) or the cerebellum (Cb). Exposed to X-OMAT LS film for 4 days.
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Figure 4.2 RNase protection assays for POMC, PCI and PC2 mRNA extracted
from the pars intermedia. Protected cRNA probe/mRNA band (top) and 18s
(internal control) band (bottom). Exposed for 2 days (POMC) or 2 weeks (PCI




























Figure 4.3 Quantitative analysis (intensity of protected fragment divided by
intensity of 18s internal control) of POMC (a), PCI (b) and PC2 (c) RNase
protection assays on mRNA extracted from the pars intermedia. Both POMC and
PCI mRNA expression in the pars intermedia were significantly increased in the
autumn (POMC, p<0.01; PCI, p<0.001). No significant effect of season on the
expression of PC2 mRNA was detected. WS- Winter solstice, SE- Spring
eauinox. SS- Summer solstice. AE- Autumn eauinox.
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Figure 4.4 Representative sections of the pars intermedia taken (SS group)
subjected to in situ hybridisation with POMC (left), PCI (middle) and PC2 (right)
antisense (AS) and sense (S) cRNA probes and exposed for 2 days (POMC) or six
weeks (PCI and PC2). POMC, PCI and PC2 mRNA are expressed in the pars
intermedia but not the pars nervosa. Light field (LF) photomicrographs are also
shown.
 











































Figure 4.5 Semi-quantitative analysis of POMC in situ hybridisation in the pars
intermedia (a) and pars distalis (b). POMC mRNA expression in the pars
intermedia was significantly increased (by approximately 50%) from winter to
autumn (p<0.01, ANOVA). POMC mRNA expression in the pars distalis was not
affected by season. WS- Winter solstice, SE- Spring equinox, SS- Summer
solstice, AE- Autumn equinox.
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Figure 4.6 Representative sections of the pars distalis (SS group) subjected to in
situ hybridisation with POMC (left), PCI (middle) and PC2 (right) antisense (AS)
and sense (S) cRNA probes and exposed for three days (POMC) or six weeks
(PCI and PC2). POMC and PCI mRNA are both expressed in a scattered
population of cells in the pars distalis. PC2 mRNA was not detected in the pars
distalis. Light field (LF) photomicrographs are also shown.
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Figure 4.7 Northern blot analysis on 5|ag total RNA probed with radiolabeled
PCI cDNA. PCI mRNA transcripts of 2.5kb are detected in the pituitary gland
(Pt), the mediobasal hypothalamus (MBH), the hippocampus (Hp) and the
cerebellum (Cb). Additionally, minor transcripts of 1.8, 1.4 and 0.8kb are detected
in the pituitary gland. Exposed to X-OMAT LS film for 10 days.
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Figure 4.8 Representative examples of aMSH (top), PCI (middle) and PC2
(bottom) immunocytochemical staining in the pars intermedia of Soay ewes living
outdoors and killed at four points in the year (WS- Winter solstice, SE- Spring
equinox, SS- Summer solstice, AE- Autumn equinox). PCI staining intensity in
the pars intermedia tended to be increased in summer and autumn but this was not
quite statistically significant. Both aMSH and PC2 staining intensity in the pars
intermedia were unaffected by season.
 













Figure 4.9 Semi-quantitative analysis of PCI (a) and PC2 (b) in situ
hybridisation in the pars intermedia. Both PCI and PC2 mRNA expression in the
pars intermedia tended to be increased in the autumn but were highly variable
between individuals and were not statistically affected by season. WS- Winter
solstice, SE- Spring equinox, SS- Summer solstice, AE- Autumn equinox.
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Figure 4.10 Northern blot analysis on 5pg total RNA probed with radiolabeled
PC2 cDNA. PC2 mRNA transcripts of 2.7kB are detected in the pituitary gland
(Pt), the mediobasal hypothalamus (MBH) and the hippocampus (Hp). PC2





































WS SE SS AE
Figure 4.11 Histological analysis of melanotroph proliferation and density in the
pars intermedia, a) PCNA expression increased from winter to autumn (p<0.05,
ANOVA) indicating increased cellular proliferation, b) Melanotroph cell density
decreased siginificantly over time from winter to autumn (p<0.0001, ANOVA)
indicating pars intermedia hypertrophy over the experiment. WS- Winter solstice,
SE- Spring equinox, SS- Summer solstice, AE- Autumn equinox.
Chapter 5
Photoperiodic and hypothalamic regulation of pars
intermedia POMC expression and processing
5.1 Introduction
In the last chapter, evidence was presented that the seasonal cycle in circulating
ocMSH (Lincoln and Baker, 1995) is associated with corresponding seasonal
changes in the expression of POMC its endoproteolytic processing enzymes, PCI
and PC2, within the pars intermedia. Photoperiod is the principle environmental
cue dictating the timing of this cycle (Lincoln and Baker, 1995). This effect of
photoperiod is believed to be mediated by melatonin through its action within the
hypothalamus (Lincoln and Maeda, 1992a). The aims of the current experiment
were to measure the effect of the photoperiod and the role of the hypothalamus on
the expression of POMC mRNA and the mRNAs of the enzymes involved in the
endoproteolytic processing of the POMC peptide in the pars intermedia of the Soay
sheep. This was investigated in animals housed under an artificial light cycle
designed to drive the cycle in aMSH secretion and in animals in which the
hypothalamus was surgically disconnected from the pituitary gland. The prediction
was that the POMC, PCI and PC2 mRNA expression would be enhanced under
short days compared to long days and that this effect would be ablated following
hypothalamo-pituitary disconnection.
5.2 Experimental procedures
5.2.1 Animal treatments and collection of tissues
The animals used were adult Soay rams housed indoors under an artificial lighting
regime of alternating 16-weekly periods of long (LD; 16L:8D) and short (SD;
8L:16D) days. Animals were housed in individual pens with visual and tactile
contact between neighbours and were fed on a constant diet of dried grass nuts
with hay and water ad libitum (section 2.1.1).
The animals used in this study were intact and long term HPD Soay rams
(table 5.1). The HPD procedure was performed by Iain Clarke and Gerald Lincoln
approximately three years before killing as described by Clarke et al (1983). The
HPD surgical procedure removed the nerve terminals at the median eminence as
well as the axons innervating the pars nervosa while sparing the superior arterial
system supplying blood to the pituitary gland. A foil barrier was inserted between
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the hypothalamus and the pituitary gland to prevent the re-innervation of the
pituitary gland.
The animals were killed at seven weeks into the long or short day treatment
(section 2.1.2). Immediately after death, the pituitary glands were separated,
weighed and dissected into rostral and caudal portions (section 2.3.1). Tissues
from the rostral part were promptly fixed for five hours in Bouins reagent and
processed for histology as described in section 2.4. The remaining tissue from the
caudal part was dissected into pars intermedia/pars nervosa and pars distalis, snap
frozen and stored at -70°C until RNA extraction (section 2.3). These tissues were
utilised in RNase protection assays, in situ hybridisation and
immunocytochemi stry.
Animal Body weight (Kg) Pituitary Wt (mg) Treatment/
Photoperiod
S18 41 539 Intact/SD
S19 45 740 Intact/SD
S20 42 807 Intact/SD
S21 45 519 Intact/SD
S30 40 601 Intact/SD
S22 40 663 Intact/LD
S24 33 - Intact/LD
S25 34 691 Intact/LD
S26 33 658 Intact/LD
S74 36 392 HPD/SD
S75 42 356 HPD/SD
S77 50 487 HPD/SD
S66 39 266 HPD/LD
S67 40 317 HPD/LD
S73 39 550 HPD/LD
Table 5.1 Animal data at time of culling.
5.2.2 RNase protection assay
RNase protection assays were carried out for POMC, PCI and PC2 on 5pg total
pars intermedia RNA from intact LD and SD groups using cRNA probes generated
from the subcloned ovine cDNA sequences described in detail in section 2.8. The
size of the protected fragments was assessed by comparison with RNA size
standards (Ambion). All RNase protection assays protected partial transcipts of the
expected size. The relative optical density of POMC, PCI and PC2 RNA and 18S
ribosomal standard were determined on a phosphorimager (Molecular Dynamics)
and the 18S ribosomal standard was used to correct for loading variations in the
RNA between treatments. Differences between the relative density in the different
treatment groups were evaluated using the unpaired student t-test. Where the
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standard deviations differed between treatments, the natural logarithms of data were
used for parametric comparisons.
5.2.3 In situ hybridisation
In situ hybridisation was carried out for POMC, PCI and PC2 mRNA (section
2.12) on tissues from all animals. In situ hybridisation employed the same ovine
cDNA sequences as RNase protection assay (section 2.8). The tissue sections
were exposed to photographic emulsions for a period ranging from 1-2 days
(POMC) to six weeks (PCI and PC2; section 2.11.6). Semi-quantitative analyses
were undertaken using computer-aided image analysis (section 2.11). Analysis of
variance was applied to grain density measurements obtained by image analysis
between treatments. As with RNase protection assay, transformed data was used
where standard deviations differed between treatments.
5.2.4 Immunocytochemistry
Immunocytochemical staining for aMSH, ACTH, PCI and PC2 was carried out
on 3pm coronal sections of the pituitary gland of all animals (section 2.5.4).
Where semi-quantitative analysis of immunocytochemical staining intensity was
made, sections were examined without prior knowledge of treatment group and
staining intensity was graded from zero (antigen not detectable) to five (heavy
immunostaining).
To measure pars intermedia cellular proliferative activity,
immunocytochemistry for the proliferation marker PCNA was undertaken (section
2.5.4). Percentage positive staining and cell density measurements were carried
out simultaneously by counting total and positively-staining nuclei within ten
graticule units (Graticules Ltd, Tonbridge, UK) in ten different areas of the tissue
(total area in which cells were counted was 0.032mm2). Counting of cells was
made on slides without prior knowledge of treatment group and comparisons
between groups were made using ANOVA. The cross-sectional area of the pars




In intact animals, the body weight was significantly greater in the SD compared
with the LD treatment group (Intact SD, 42.6±1.0, Intact LD, 35.0±1.7kg;
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p<0.01) at the time of killing. The body weight in the HPD animals was not
affected by photoperiod and was not different from the mean body weights of the
intact animals (HPD SD, 42.7±4.1, HPD LD, 39.3±0.3kg).
5.3.2 POMC expression
In the intact animals, pars intermedia POMC mRNA expression, as measured by
RNase protection assay, tended to be higher in the intact SD group compared to
intact LD group, although this effect was not quite statistically significant (Figures
5.1 and 5.2a; Intact SD, 0.552±0.169, Intact LD, 0.146±0.020; p<0.1).
Similarly, in situ hybridisation indicated a similar trend in POMC mRNA
expression related to the photoperiod in the pars intermedia (Figures 5.3 and 5.4a;
Intact SD, 1.062±0.063, Intact LD, 0.599±0.216; p<0.1). However, in the HPD
rams, photoperiod had no effect on POMC mRNA expression in the pars
intermedia (Figures 5.7 and 5.8; HPD SD, 0.741±0.143, HPD LD,
0.610±0.135). POMC mRNA expression in HPD animals was similar to that in
intact animals exposed to LD treatment.
5.3.3 PCI expression
Pars intermedia PCI mRNA expression was significantly increased in intact SD
compared to intact LD animals as measured by in situ hybridisation (Figures 5.3
and 5.4b; Intact SD, 0.0202±0.0098, Intact LD, 0.0007±0.0004; p<0.05). RNase
protection assay also indicated a similar effect of photoperiod on the expression of
PCI in the pars intermedia of intact animals (Figure 5.1 and 5.2b; Intact SD,
1.40±0.29, Intact LD, 0.52±0.11; p<0.05). PCI peptide immunocytochemical
staining was detectable in the pars intermedia of all animals with increased staining
in intact SD compared to intact LD animals (Figure 5.5; Intact SD, 2.4±0.7, Intact
LD, 1.0±0.0). PCI immunocytochemical staining was also detected in the pars
distalis of all animals with no effect of photoperiod (Intact SD, 2.2+0.7, Intact LD,
3.0+0.4).
In the HPD animals pars intermedia PCI mRNA expression was unaffected
by photoperiod as measured by in situ hybridisation (Figures 5.7 and 5.8b, HPD
SD, 0.0005+0.0005, HPD LD, 0.0009+0.0005). However, PCI mRNA was
reduced in HPD animals compared to intact SD animals (Figures 5.7 and 5.8b
Intact SD, 0.0202+0.0098, Intact LD, 0.0007+0.0004, HPD SD, 0.0005+0.0005,
HPD LD, 0.0009+0.0005; p< 0.05). PCI peptide immunocytochemical staining
was detected in the pars intermedia of all HPD animals with no difference in
staining intensity with photoperiod or in comparison with intact animals (Figure
5.9, Intact SD, 2.4+1.0, Intact LD, 1.0+0.0, HPD SD, 3.0+0.6, HPD LD,
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2.0±0.6). In the pars nervosa PCI immunocytochemical staining was reduced in
HPD animals compared to intact controls (Intact SD, 3.2±0.4, Intact LD, 3.8±0.6,
HPD SD, 1.7±0.9, HPD LD, 0.7±0.7).
5.3.4 PC2 expression
No effect of photoperiod on pars intermedia PC2 mRNA expression was detectable
by RNase protection assay (Figures 5.1 and 5.2c; Intact SD, 1.0810.79, Intact
LD, 0.1610.02) or by in situ hybridisation (Figures 5.3 and 5.4c; Intact SD,
0.032810.0185, Intact LD, 0.005910.0039), although values obtained by both
techniques indicated that PC2 mRNA expression tended to be higher in SD than in
LD animals.
PC2 peptide was detectable in the pars intermedia, pars nervosa and weakly
in the pars distalis of all animals and was not affected by treatment in either the pars
intermedia (Figure 5.5; Intact SD, 2.210.4, Intact LD, 3.010.0) or pars distalis
(Intact SD, 0.410.2, Intact LD, 0.310.3).
In HPD animals, pars intermedia PC2 mRNA expression was unaffected by
photoperiod (Figures 5.7 and 5.8c; HPD SD, 0.017810.0097, HPD LD,
0.003610.0019). PC2 mRNA expression was also unaltered in HPD compared to
intact animals. Pars intermedia PC2 immunocytochemical staining was not affected
by photoperiod or HPD (Figure 5.9; Intact SD, 2.210.4, Intact LD, 3.010.0, HPD
SD, 3.710.3, HPD LD, 3.010.6). PC2 immunoreactivity was, however, reduced
in the pars nervosa of HPD compared to intact animals (Figure 5.9; Intact SD,
2.010.3, Intact LD, 2.310.3, HPD, 1.210.3).
5.3.5 Pars intermedia aMSH and ACTH expression
Strong aMSH-immunocytochemical staining was detected in the pars intermedia in
all animals (Figures 5.5 and 5.9). The staining intensity in the pars intermedia did
not vary with photoperiod in either intact or HPD animals (Figures 5.5 and 5.9;
Intact SD, 3.010.3, Intact LD 3.810.3, HPD SD, 3.011.0, HPD LD, 2.610.3).
Localised low levels of aMSH immunocytochemical staining were also detected in
the pars distalis and were unaffected by photoperiod (Intact SD, 1.210.8, Intact
LD, 1.010.0). Pars distalis aMSH staining intensity was, however, increased in
HPD compared to intact LD animals (Figures 5.5 and 5.9; Intact SD, 1.210.8,
Intact LD, 1.010.0, HPD SD, 1.710.3, HPD LD, 2.710.3). The pattern of
staining for ACTH was comparable to that of aMSH in the pars intermedia
whereas in the pars distalis ACTH immunocytochemical staining was localised to a
subpopulation of cells and where present was more intense than in the pars
intermedia. ACTH immunocytochemical staining intensity was unaffected by
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photoperiod and HPD in both tissues (Pars intermedia; Intact SD, 3.2±0.4, Intact
LD, 3.0±0.4, HPD SD, 3.3±0.3, HPD LD, 2.3±0.3; Pars distalis; Intact SD,
3.4+0.2, Intact LD, 3.8+0.3, HPD SD, 3.5+0.5, HPD LD, 4.0+0.0).
5.3.6 Pars intermedia cell proliferation and morphology
Cells expressing PCNA were infrequent and were only detected in intact LD
animals. The low numbers of PCNA expressing cells precluded the detection of an
effect of photoperiod on cell proliferation in the pars intermedia (Intact SD, 0.00,
Intact LD, 0.09+0.04%, Figure 5.6a). Cell density was also unaffected by
photoperiod or HPD (Intact SD, 1059+53, Intact LD, 1119+47 cells in 0.032mm2,
Figure 5.6b).
5.4 Discussion
The data presented in this chapter provides tentative support for the prediction that
POMC, PCI and PC2 mRNA expression is enhanced in the pars intermedia under
short days and that this effect is blocked by HPD. However, only the expression
of PCI mRNA was significantly increased in the intact Soay rams under short
days, while POMC and PC2 mRNA expression were increased, but this change
was not statistically significant. These relatively minor changes in mRNA
expression are in contrast with the predictably large changes in the circulating
concentrations of aMSH observed under similar conditions (Lincoln and Baker,
1995). This difference in mRNA expression and plasma peptide concentrations
may indicate that relatively small changes in gene expression result in relatively
large changes in peptide secretion if changes in the expresion of these genes have a
compounding or additive effect. Alternatively, this observed difference may be
largely due to the secretion of the aMSH peptide, unrelated to the expression of
these genes.
The immunocytochemical studies confirmed the presence of aMSH, PCI and
PC2 in the pars intermedia. Semi-quantitation of the immunocytochemical staining
revealed a significant increase in PCI protein under short days without a
corresponding change in PC2. This tends to support the view that increased
production of aMSH is associated with increased expression of at least one of the
POMC processing enzymes. However, the cellular content of the enzyme may not
reflect the rate of secretion of its product or its functional activity. The intensity of
immunocytochemical staining of the peptide product itself does not reflect the
pattern of its secretion, since there were no observed changes in the cellular content
of aMSH in the pars intermedia under short days when large difference in
circulating peptide would be predicted. Indeed, in the Siberian hamster,
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hypersecretion of aMSH results in a decrease in the cellular content of the protein
when release outstrips synthesis (Logan and Weatherhead, 1980).
In the HPD rams, there was no effect of photoperiod on the expression of
POMC, PCI and PC2. This is consistent with previous observations that pituitary
denervation blocks the photoperiodic control of the cycle in circulating aMSH
concentrations (Lincoln and Richardson, 1998) and supports the view that the
hypothalamus mediates the effect of photoperiod on the pars intermedia POMC
system. Furthermore, there is evidence in the short-tailed weasel, that the
seasonally-induced changes in pelage colour, likely to be influenced by aMSH, are
blocked where the pituitary gland is isolated from the hypothalamus by
autotransplantation to the kidney capsule (Rust and Meyer, 1968).
The HPD animals used in this study had received the surgery approximately
three years earlier and showed signs of permanent pituitary disconnection. This
included polyurea due to the atrophy of the pars nervosa and loss of PCI and PC2
immunoreactivity in the pars nervosa in the HPD animals. The level of expression
of PCI in the pars intermedia was decreased in HPD animals compared to intact
animals exposed to short days. Moreover, POMC and PC2 expression followed a
similar trend in HPD animals. Previous studies have reported that the expression
of POMC mRNA and content of aMSH were markedly increased following the
HPD procedure (Clarke et al., 1986). This inconsistency is largely explained by
the timing of the HPD operation. In the current study, the animals were chronically
disconnected, having received the operation approximately three years earlier,
while the study by Clarke et al was on short term HPD animals. Circulating
aMSH concentrations are reported to increase immediately following HPD and
then decline progressively in the long term (Lincoln and Richardson, 1998). These
changes appear to be reflected by long term parallel changes in POMC gene
expression. Thus, a functional hypothalamus is required to maintain normal
secretory activity of the pars intermedia.
The histology revealed that the pars intermedia in the HPD rams was
distorted in shape due to the regression of the pars nervosa with which it is usually
closely associated. The regression of the pars nervosa was associated with the loss
of PCI and PC2 immunoreactivity in this tissue, which was striking in intact
animals. The pars intermedia was also enlarged in cross-sectional area in HPD
animal, although it is not clear whether this is due to cellular proliferation or
hypertrophy since cellular proliferation was not detectable in long term HPD
animals. In the study of the short term HPD sheep, evidence was provided of a
clear hypertrophy of the pars intermedia (Clarke et al., 1986; Clarke et al., 1983).
These morphological changes appear to be the result of the removal in
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hypothalamic inhibition and further indicate that the hypothalamus regulates
multiple aspects of pars intermedia function.
One further feature of note in the HPD animals was the increase in aMSH
staining in the pars distalis, presumably associated with the corticotrophs. This
may be related to the stimulatory hypothalamic control of the corticotroph resulting
in a reduced release and increased storage of POMC-peptides with extended
processing to yield aMSH-immunoreactive peptides. This is consistent with the
observation that corticotrophs isolated from hypothalamic influence by
autotransplantation to the kidney capsule contain increased amounts of aMSH.
This effect in the rat is reversed by the administration of CRF (Iturriza and Ferese-
Spinelli, 1991).
In summary, these results provide some support for the concept that
photoperiod regulates the cyclical changes in circulating aMSH in the Soay ram by
influencing the level of expression of POMC, PCI and PC2 in the pars intermedia.
Short days are stimulatory and long days are inhibitory and these effects are
mediated by the hypothalamus. The potential importance of the hypothalamus as
an inhibitory regulator of the pars intermedia is further investigated in the next
chapter.
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Figure 5.1 RNase protection assays for POMC, PCI and PC2 mRNA in the pars
intermedia of intact Soay rams exposed to 7 weeks of short day (SD) or long day
(LD) photoperiods. Protected cRNA probe/mRNA band (top) and 18s (internal
control) band (bottom). Exposed for 2 days (POMC) or 2 weeks (PCI and PC2).
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Figure 5.2 Quantitative analysis (intensity of protected fragment divided by
intensity of 18s internal control) of POMC (a), PCI (b) and PC2 (c) RNase
protection assays in the pars intermedia of intact Soay rams exposed to 7 weeks of
short day (SD) and long day (LD) photoperiods. The expression of all of these
mRNA species tended to be decreased in animals exposed to LD photoperiod,
although a statistically significant effect of treatment was only detected for PCI.
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Figure 5.3 Representative sections of the pars intermedia of intact Soay rams
exposed to 7 weeks of long day (LD) and short day (SD) photoperiods subjected to
in situ hybridisation with POMC (top), PCI (middle) and PC2 (bottom) antisense
(AS) and sense (S) cRNA probes. Sections exposed for two days (POMC) or six
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Figure 5.4 Semi-quantitative analysis of POMC (a), PCI (b) and PC2 (c) in situ
hybridisation in the pars intermedia of Soay rams exposed to 7 weeks of short day
(SD) and long day (LD) photoperiods. PCI mRNA expression was significantly
reduced in LD compared to SD treatment (p<0.05, unpaired t-test, transformed
data) No significant effect of photoperiod on either POMC or PC2 mRNA
expression was detected although these tended to also be reduced in LD treatment.
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Figure 5.5 Representative examples of aMSH, PCI and PC2
immunocytochemical staining in the pars intermedia and pars nervosa of intact Soay
rams exposed to short day (SD) and long day (LD) photoperiod. PCI staining
intensity in the pars intermedia tended to be higher in SD than in LD treatment, but
this was not quite statistically significant (p<0.1, ANOVA). aMSH and PC2
staining intensity in the pars intermedia were not significantly affected by
photoperiod.
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a)
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Figure 5.6 Histological analysis of melanotrophs of the pars intermedia in
animals exposed to seven weeks of artificial short (SD) and long days (SD). a)
PCNA expression was only detected at a low level in LD animals, b) Melanotroph
cell density was unaffected by treatment.
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Figure 5.7 Representative sections of the pars intermedia of intact SD and HPD
SD Soay rams subjected to in situ hybridisation with POMC (top), PCI (middle)
and PC2 (bottom) antisense (AS) and sense (S) cRNA probes. Sections exposed































































































Figure 5.8 Semi-quantitative analysis of POMC (a), PCI (b) and PC2 (c) in situ
hybridisation in the pars intermedia of long term HPD and intact Soay rams
exposed to 7 weeks of short day (SD), long day (LD) photoperiod. POMC mRNA
expression was not significantly altered by treatment. PCI mRNA expression in
the pars intermedia was increased in the animals exposed to SD (transformed data,
p<0.05, ANOVA) compared to LD photoperiod and HPD animals in both of which
PCI mRNA was virtually undetectable. Similarly, PC2 mRNA expression tended
to be lower in both LD and HPD groups although a statistically significant effect of
treatment was not detected.
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Figure 5.9 Representative examples of aMSH, PCI and PC2
immunocytochemical staining in the pars intermedia of intact and long term HPD
Soay rams. aMSH, PCI and PC2 staining intensity in the pars intermedia were





Dopaminergic regulation of pars intermedia POMC
expression and processing
6.1 Introduction
The activity of the pars intermedia is regulated through direct innervation from the
hypothalamus. This hypothalamic regulation is principally inhibitory since the
removal of hypothalamic influence results in increased circulating aMSH (Lincoln
and Richardson, 1998). However, evidence was presented in the last chapter that
suggested that in the longer term the hypothalamus is necessary for the maintenance
of the secretory activity of the pars intermedia. One of the major components of
this hypothalamic innervation is likely to be dopaminergic since in other species
such as the rat dopamine agonists have profound inhibitory effects on the
expression of POMC and its processing enzymes (Lundblad and Roberts, 1988;
Oyarce et al., 1996). Moreover, long term treatment with dopamine agonists also
causes a reduction in the proliferative activity of the pars intermedia of the rat
(Chronwall et al., 1987). This study aimed to investigate the inhibitory effects of
dopamine on circulating concentrations of aMSH and prolactin (the secretion of
which from the pars distalis is also inhibited by dopamine), the expression of
POMC, PCI and PC2 mRNA and the cellular proliferative activity in the pars
intermedia in the adult Soay ram. These parameters were measured in animals in
which circulating aMSH was at its seasonal maximum, half of which received a
long-acting dopamine agonist which was chronically administered over nearly six
weeks.
6.2 Experimental procedures
6.2.1 Animal treatments and collection of tissues
Animals used in this study were six adult Soay rams living outdoors in Fife,
Scotland (56°N), exposed to natural photoperiod in July/August when circulating
aMSH is at its seasonal maximum (Ebling and Lincoln, 1987; Lincoln and Baker,
1995). Animals were maintained in grass paddocks and received supplementary
feeding of commercial sheep nuts. The dopamine agonist, parlodel LA was
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administered chronically (16.7mg/animal, administered five times over 39 days) to
rams (n=3); three untreated rams were used as controls. When dopamine agonist
was administered, blood samples were collected into heparinised tubes and plasma
was obtained by centrifugation and stored at -20°C until subsequent analysis.
At the end of the experiment, animals were killed and body weight was
recorded. Immediately after death, the pituitary glands were separated, weighed
and dissected into rostral and caudal portions (section 2.3.1). Tissues from the
rostral part were promptly fixed for five hours in Bouins reagent and processed for
histology as described in section 2.4. The remaining tissue from the caudal part
was dissected into pars intermedia/pars nervosa and pars distalis and snap frozen
and stored at -70°C until RNA extraction (section 2.3). These tissues were utilised
in RNase protection assays, in situ hybridisation and immunocytochemistry.
Animal Body Wt (kg) Pituitary wt Treatment
(g)
S101 36.5 768 Control
S102 28.5 354 Control
S103 33.0 532 Control
S104 31.0 473 Dopamine
S105 28.0 415 Dopamine
S106 28.0 573 Dopamine
Table 6.1 Data on animals used in studies into the dopaminergic regulation
of circulating POMC-derived peptides.
6.2.2 RNase protection assay
RNase protection assays were carried out for POMC, PCI and PC2 on 5pg total
pars intermedia RNA (section 2.13) using cRNA probes generated from the
subcloned ovine cDNA sequences described in detail in section 2.8. The size of the
protected fragments was assessed by comparison with RNA size standards
(Ambion). The relative optical density of POMC, PCI and PC2 RNA and 18S
ribosomal standard were determined on a phosphorimager and the 18S ribosomal
standard was used to correct for loading variations in the RNA between treatments.
Differences between the relative density in the different treatment groups were
evaluated using the unpaired student t-test. Where the standard deviations differed
between treatments, the natural logarithms of data were used for parametric
analysis.
6.2.3 In situ hybridisation
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In situ hybridisation was carried out for POMC, PCI and PC2 (section 2.12). In
situ hybridisation employed the same ovine cDNA sequences as RNase protection
assay (section 2.8). The tissue sections were exposed to photographic emulsions
for a period ranging from 1-2 days (POMC) to six weeks (PCI and PC2; section
2.11.6). Semi-quantitative analyses were undertaken using computer-aided image
analysis (section 2.11). The unpaired student t-test was applied to grain density
measurements obtained by image analysis between treatments. As with RNase
protection assay, transformed data was used where appropriate.
6.2.4 Immunocytochemistry
Immunocytochemical staining for aMSH, ACTH, PCI and PC2 was carried out
on 3|am coronal sections of the pituitary gland (Section 2.5.4). Where semi¬
quantitative analysis of immunocytochemical staining intensity was made, sections
were examined without prior knowledge of treatment group and staining intensity
was graded from zero (antigen not detectable) to five (heavy immunostaining).
To measure pars intermedia cellular proliferative activity,
immunocytochemistry for the proliferation marker PCNA was undertaken (Section
2.5.4). Percentage positive staining and cell density measurements were carried
out simultaneously by counting total and positively-staining nuclei within ten
graticule units (Graticules Ltd, Tonbridge, UK) in ten different areas of the tissue
(total area in which cells were counted was 0.032mm2). Counting of cells was
made on slides without prior knowledge of treatment group and comparisons
between groups were made using the unpaired student t-test. The cross-sectional
area of the pars intermedia, pars distalis and pars nervosa was measured using an
image analysis program (Proplus software).
6.2.5 Plasma hormone radioimmunoassay
Radioimmunoassays for aMSH, prolactin and FSH were carried out as described
in section 2.13 on the plasma samples. Pairwise comparisons between groups




Whole body or pituitary gland weights were unaffected by chronic treatment with
dopamine agonist.
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6.3.2 Plasma hormone profiles
Treatment with dopamine agonist resulted in a sustained 70% reduction in
circulating aMSH concentrations compared with control rams (Control,
94.6±14.6, Dopamine agonist, 34.0±8.7pmol/litre at end (39 days) of dopamine
agonist treatment; p<0.05; Figure 6.7a). Chronic treatment with dopamine agonist
also resulted in a sustained 90% reduction in plasma prolactin (Control,
47.5±13.0, Dopamine agonist, 4.7±0.2ng/ml, P<0.01, transformed data, Figure
6.7b). Circulating FSH was not significantly affected by treatment with dopamine
agonist (Control, 2.74±0.18, Dopamine agonist, 3.02±0.93ng/ml).
6.3.3 POMC expression
POMC RNase protection assay protected a smaller than expected POMC mRNA
fragment of approximately 200bp. The intensity of this protected fragment
indicated that expression of POMC mRNA was reduced in dopamine agonist-
treated rams (Control, 16.92±12.55, Dopamine agonist, 0.97+0.33; P<0.05,
Figures 6.1 and 6.2a). However, in situ hybridisation detected no significant
effect of the dopamine agonist on POMC mRNA expression in the pars intermedia
(Control, 0.896±0.183, Dopamine agonist, 0.600±0.141; Figures 6.3 and 6.4) or
the pars distalis (Control, 0.98+0.10, Dopamine agonist, 0.91+0.33).
6.3.4 PCI expression
In situ hybridisation indicated that pars intermedia PCI mRNA expression was
reduced by treatment with dopamine agonist (Control, 0.0805+0.0372, Dopamine
agonist, 0.0027+0.0012; p<0.05; Figure 6.4b), although RNase protection assay
detected no differences in PCI mRNA expression between the control (2.00+2.51)
and dopamine agonist-treated (0.22+0.25) rams due to high individual variation
(Figures 6.1 and 6.2b).
PCI peptide was weakly detected in the pars intermedia in both treatments by
imuunocytochemistry but no effect of treatment on staining intensity was detected
(Control, 1.0+0.0, Dopamine agonist, 1.3+0.3; Figure 6.5).
6.3.5 PC2 expression
RNase protection assay indicated that pars intermedia PC2 mRNA expression was
significantly reduced by treatment with dopamine agonist (Control, 1.60+0.26,
Dopamine agonist, 0.62+0.22; P<0.01, Figures 6.1 and 6.2c). However, in situ
hybridisation, which detected PC2 only weakly (Figure 6.3), detected no effect of
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dopamine agonist on PC2 mRNA expression in the pars intermedia (Control,
0.0053±0.0035, Dopamine agonist, 0.0046±0.0037; Figure 6.4c).
Immunocytochemistry for PC2 confirmed its presence in the pars intermedia
in all animals without detecting an effect of treatment on staining intensity (Control,
2.3±0.9, Dopamine agonist, 3.7±0.3; Figure 6.5).
6.3.6 Pars intermedia aMSH and ACTH expression
Immunocytochemistry for the POMC-derived peptides, aMSH and ACTH (Figure
6.5) revealed that both peptides are present in the pars intermedia in animals from
both treatment groups. The intensity of immunological staining for either peptide
was not affected by treatment with dopamine agonist (aMSH; Control, 4.0±0.0,
Dopamine agonist, 3.310.3; Figure 6.5; ACTH; Control, 1.310.3; Dopamine
agonist, 1.710.3).
6.3.6 Pars intermedia cell proliferation and morphology
Immunocytochemistry for the marker of proliferation, PCNA (Figure 6.6a)
suggested that pars intermedia cell proliferation was reduced in dopamine agonist-
treated animals, although was just short of statistical significance (Control,
0.3610.12, Dopamine agonist, 0.0710.04%, p<0.1). Treatment with dopamine
agonist resulted in hypotrophy of melanotrophs as assessed by cell density
measurements using a graticule (Control 10711131, Dopamine agonist, 1595196
nuclei per 0.032 mm2, p<0.05, unpaired t-test, Figure 6.6b).
This hypotrophy of the pars intermedia was further supported by the
observation that a general reduction in the cross-sectional areas of both the pars
intermedia and the pars distalis occurred in dopamine agonist-treated rams,
although this was short of statisitical significance (Pars intermedia; Control,
10582051286919, Dopmine agonist, 740641143139pm2; Pars distalis; Control,
1545270111654970, Dopamine agonist, 1070479515044597pm2, both p<0.2).
6.4 Discussion
The aim of this study was to investigate whether dopamine plays a major role in the
regulation of the expression of POMC, PCI and PC2 in the pars intermedia of the
Soay ram. The prediction was that the administration of dopamine agonist at the
peak of the aMSH cycle would suppress the mRNA expression of POMC and its
associated endoproteolytic processing enzymes. The results presented in this
chapter indicate that dopamine agonist treatment caused a marked reduction in PCI
and PC2 mRNA expression but only a marginal effect for POMC. This was
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associated with a large decrease in plasma concentrations of aMSH. This is
consistent with the general hypothesis that dopamine acts to inhibit the secretion of
aMSH and the expression of PCI, PC2 and possibly POMC mRNA. As in the
previous study, the changes in POMC mRNA are relatively minor based on the
results obtained by in situ hybridisation but marked based on RNase protection
assay. The results for the RNase protection assay are equivocal since the
procedure protected a mRNA fragment which was smaller than predicted. This
may be associated with strong secondary structures occurring where hybridisation
conditions were not optimal. Using the results obtained by in situ hybridisation as
evidence for the level of POMC mRNA expression, the treatment with dopamine
agonist over nearly six weeks induced only a small decrease in POMC mRNA
expression. This is consistent with the observations made in the previous chapter
where relatively minor changes in POMC gene expression were associated with
predicted large changes in circulating aMSH. However, in this case the expression
of PCI and PC2 mRNAs were markedly suppressed implying that the regulation of
the processing enzymes is particularly important in the regulation of aMSH
secretion. Immunocytochemistry failed to demostrate clear changes in stored
peptide levels for aMSH, PCI and PC2 in the pars intermedia under this treatment,
which further shows the limitation in this technique in detecting changes in
secretion and peptide activity. Studies in the rat pars intermedia have demonstrated
that dopamine agonists inhibit, and dopamine antagonists stimulate, the expression
of mRNAs for POMC, PCI and PC2, indicating stronger effects on POMC mRNA
expression than those observed in the current study (Oyarce et al., 1996).
Besides the effects of dopamine agonist on the POMC system, there was a
clear, signifiant decrease in cell volume by up to 50 percent in the pars intermedia.
This compares with the reverse effect of short term HPD which induces
hypertrophy of the melanotrophs (Clarke et al., 1986; Clarke et al., 1983). The
decrease in cell size after treatment with dopamine agonist was associated with a
trend towards reduced cell proliferation which was just short of significance. This
provides some support for the view that where dopamine levels are low, the pars
intermedia increases in size due to both hypertrophy and hyperplasia and that these
effects are reversed by dopamine which also suppresses aMSH secretion.
In summary, while the animal numbers used where very low, this chapter
provides clear evidence that dopamine plays a prominent role in the regulation of
aMSH secretion through the inhibitory control of PCI, PC2 and possibly POMC
mRNA expression in the Soay ram. The inference is that in autumn, hypothalamic
dopamine activity is reduced which permits the activiation of POMC peptide
secretion. This seasonal effect is readily reversed by the administration of
exogenous dopamine. Thus, it is likely that photoperiod acts, at least in part,
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through dopamine to regulate the seasonal cycle in aMSH secretion in the Soay
ram.
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Figure 6.1 RNase protection assays for POMC, PCI and PC2 mRNA in the pars
intermedia of chronic parlodel treated (dopamine agonist; DA) and untreated control
(C) Soay rams. Protected cRNA probe/mRNA band (top) and 18s (internal






















Figure 6.2 Quantitative analysis (intensity of protected fragment divided by
intensity of 18s internal control) of POMC (a), PCI (b) and PC2 (c) RNase
protection assays in the pars intermedia of chronic parlodel treated (dopamine
agonist; DA) and untreated control (C) Soay rams. POMC and PC2 mRNA
expression were both reduced in the pars intermedia of DA-treated compared to
control animals (p<0.05 and p<0.01 respectively, unpaired t-test, transformed
data). PCI mRNA expression also tended to be lower in DA-treated animals but
did not reach statistical significance.
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Figure 6.3 Representative sections of the pars intermedia of chronic parlodel
treated (dopamine agonist; DA) and untreated control (C) Soay rams subjected to in
situ hybridisation with POMC (top), PCI (middle) and PC2 (bottom) antisense and
sense control (S) cRNA probes. Sections were exposed for two days (POMC) or
six weeks (PCI and PC2).
 






Figure 6.4 Semi-quantitative analysis of POMC (a), PCI (b) and PC2 (c) in situ
hybridisation in the pars intermedia of chronic parlodel treated (dopamine agonist;
DA) and untreated control (C) Soay rams. PCI mRNA expression was
significantly reduced in DA-treated compared to control (p<0.05, unpaired t-test,
transformed data) No significant effect of photoperiod on either POMC or PC2
mRNA expression was detected.
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Figure 6.5 Representative examples of aMSH, PCI and PC2
immunocytochemical staining in the pars intermedia and pars nervosa of chronic
parlodel treated (dopamine agonist; DA) and untreated control (C) Soay rams.
Arrows indicate areas of more intense PCI staining. aMSH, PCI and PC2
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Figure 6.6 Histological analysis of melanotrophs of the pars intermedia in
chronic parlodel-treated (dopamine agonist; DA) and control (C) Soay rams, a)
PCNA expression tended to be decreased in DA animals but no significant effect of
DA was detected, b) Melanotroph cell density was increased by treatment with
parlodel suggesting cellular hypotrophy.









Figure 6.7 Mean plasma hormone concentrations at time of culling (animals
killed in August where maximal circulating aMSH concentrations were predicted)
in chronic parlodel-treated (dopamine agonist; DA) and untreated control (C) Soay
rams. Parlodel reduced circulating levels of both aMSH (a; p<0.05, unpaired t-
test) and prolactin (b; p<0.01).
Chapter 7. General Discussion
In the highly seasonally responsive Soay ram a conspicuous seasonal cycle in
circulating aMSH and (3END occurs in which circulating concentrations are
maximal in autumn (Ebling and Lincoln, 1987; Lincoln, 1991). Most circulating
POMC-derived peptides are derived principally from the pituitary gland (Autelitano
et al., 1989; Lundblad and Roberts, 1988; Smith and Funder, 1988). The first aim
of this thesis was to confirm that most of the aMSH in circulation in the Soay
sheep is secreted by the pars intermedia. Immunocytochemistry revealed that all the
cells in the pars intermedia were strongly immunoreactive for aMSH whereas only
minimal staining associated with the cortictroph was detected in the pars distalis.
Furthermore, both PC2 peptide and mRNA were detected in the pars intermedia but
not the pars distalis. Since PC2 is associated with the endoproteolytic processing
of POMC to aMSH, these observations indicate that most of the aMSH in
circulation is secreted by the pars intermedia as predicted in other breeds of sheep
and other species (Engler et al., 1989). Moreover, the general changes in
morphology and POMC expression in the pars intermedia seasonally and after HPD
and dopamine administration (see below) are associated with predicted and
observed changes respectively in circulating aMSH concentrations. A similar
distribution of expression of PCI and PC2 mRNAs and immunoreactivities have
recently been reported in the fetal ovine pituitary gland (Bell et al., 1998). Having
established that the pars intermedia is the principle source of circulating aMSH in
the Soay sheep, this thesis then aimed to study the molecular events in the pars
intermedia which underpin the seasonal cycle in circulating concentrations of
aMSH and to identify the environmental cues which entrain this cycle.
This thesis has provided evidence that the seasonal cycle in circulating aMSH
is generated by seasonal changes in the activity of the pars intermedia. Such
seasonal changes in activity were characterised by the seasonal regulation of the
expression of the mRNA for the aMSH precursor molecule, POMC. Furthermore,
the mRNA expression of the prohormone convertases, PCI and possibly PC2,
which endoproteolytically cleave the aMSH peptide from the POMC precursor, are
also regulated seasonally in a similar way to POMC mRNA expression. These
changes in mRNA expression are likely to be attributable to changes in gene
expression but may also be due to changes in RNA stability since the techniques
used do not directly measure the rate of gene transcription. Therefore, the seasonal
cycle in circulating aMSH in the Soay sheep is characterised by coordinate seasonal
changes in the level of mRNA expression of POMC and its processing enzymes
126
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PCI and PC2. Moreover, pars intermedia cellular proliferation and cellular volume
are also profoundly affected by season and where aMSH-synthetic and secretory
activity are maximal, proliferation and cytoplasmic volume are also increased. The
failure to detect changes in aMSH immunoreactivity in the tissue may be a
limitation of the technique. It is also probable that stored peptide concentrations do
not accurately reflect peptide secretion. This is emphasised by studies in the
Siberian hamster in which stored aMSH in the pituitary gland is depleted where
aMSH secretion into the circulation is increased (Logan and Weatherhead, 1980).
In the natural state this cycle in circulating aMSH is entrained by
environmental factors. Photoperiod varies greatly and predictably in latitudes more
than 30° from the equator and as such is the most reliable and widely used indicator
of season. A role for photoperiod as the principle environmental cue underlying the
effect of season on the activity of the pars intermedia is substantiated by the
observation that artificial photoperiod can drive a cycle in circulating aMSH in
Soay rams housed indoors in which circulating aMSH is maximal under short days
(Lincoln and Baker, 1995). This thesis provides some evidence that this artificial
cycle is characterised by coordinate changes in the mRNA expression of POMC
and both PCI and PC2, although a statistically significant effect of photoperiod
was only detected for PCI mRNA. An effect of photoperiod on the proliferative
activity of the pars intermedia was not detectable. The effect of photoperiod on the
pars intermedia was the least robust effect of the experimental regimes. The
measurements of cell proliferation and POMC, PCI and PC2 mRNA expression
were only made at two time points which may not have coincided with the
maximum effects of photoperiod. The effect of photoperiod on circulating aMSH
concentrations is characterised by the rapid development of refractoriness (Lincoln
and Baker, 1995) which makes the timing of such measurements critical. Short
days are only found to be stimulatory to circulating concentrations of aMSH for
approximately eight weeks and similarly long days only exert a powerful inhibitory
effect on circulating aMSH for a similar duration (Lincoln and Baker, 1995).
However, the results presented in this thesis are consistent with a role for
photoperiod as the driving environmental factor behind the seasonal changes in the
expression of POMC and its processing enzymes. The observation that seasonally,
aMSH concentrations are diminished from autumn to winter further demonstrates
that pars intermedia quickly becomes refractory to the effect of short days (Lincoln
and Baker, 1995).
This thesis illustates that the effect of photoperiod on the activity of the pars
intermedia is mediated through the hypothalamus. This is based on the absence of
an effect of photoperiod on the expression of POMC, PCI and PC2 mRNAs or
cellular proliferation in the pars intermedia of HPD animals. These results are
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consistent with previous studies which demonstrate that the removal of direct
hypothalamic innervation of the pars intermedia by HPD abolishes the ability of
photoperiod to entrain the cycle in circulating aMSH (Lincoln and Richardson,
1998). Furthermore, no effect of photoperiod on aMSH immunocytochemical
staining in the pars intermedia was detected in HPD animals although increased
aMSH immunoreactivity was detected in the corticotroph in all HPD, compared to
intact animals. This effect of HPD may be due to increased processing of POMC-
derived peptides resulting from the longer term storage of POMC-derived peptides
in the corticotroph associated with the removal of stimulatory hypothalamic
influences. It is possible that basal secretion of such aMSH immunoreactive
peptides from the corticotroph contributes to the increased circulating
concentrations of aMSH observed in the HPD animal (Lincoln and Richardson,
1998). However, this increase in circulating aMSH after HPD is likely to be
principally due to the increased activity of the pars intermedia and suggests that the
regulation of the pars intermedia by the hypothalamus is principally inhibitory. In
the longer term, however, circulating aMSH is reported to decline in the HPD
animal (Lincoln and Richardson, 1998). The results presented in this thesis show a
general long term decline in the expression of mRNAs for POMC, PCI and PC2
compared to intact SD animals, although this was only statistically significant for
PCI mRNA. This long term decline in activity suggests that the pars intermedia
requires hypothalamic influence for normal function in the long term.
In spite of the low number of animals studied, this thesis has presented
evidence that a large component of the inhibitory influence which is exerted on the
pars intermedia by the hypothalamus is dopaminergic. This is based on observation
that the administration of dopamine agonist to Soay sheep at the peak of the aMSH
cycle resulted in marked decline not only in circulating concentrations of aMSH,
but also in the mRNA expression of PCI and PC2. Dopamine agonist also had an
impact on pars intermedia cellular morphology (reduced cytoplasmic volume) and
proliferation (reduced). Given the low sample size used in this study, the effect of
dopamine on the pars intermedia was the most robust experimental regime observed
in this thesis. The effect of dopamine on the ovine pars intermedia is similar to that
reported in the rat where dopamine agonists are inhibitory to both the mRNA
expression of POMC, PCI and PC2 (Oyarce et al., 1996) and the cellular
proliferative activity in the pars intermedia (Chronwall et al., 1987). The large
decrease in circulating aMSH following treatment with dopamine agonist was not
associated with any changes in pars intermedia aMSH immunoreactivity. This
further indicates that immunocytochemistry for aMSH is a poor indicator of
secretory activity in the pars intermedia.
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The only other well studied example of a long term regulation of the activity
of the pars intermedia in response to changes in the external environment is that
observed in the amphibia, where aMSH has a role in the regulation of skin colour
in background adaptation. The ability to respond to changing, visually perceived
environmental conditions by alterations in skin colour is achieved through long
term changes in pars intermedia activity and circulating concentrations of aMSH
(Tonosaki et al., 1995). The amphibian pars intermedia is innervated by
dopaminergic neurons originating in the hypothalamus (Tonosaki et al., 1995), as
in the sheep (Gayrard et al., 1995). Also as in the sheep, isolation of the
amphibian pars intermedia from the hypothalamus results in hypersecretion of
aMSH as indicated by inappropriate black pigmentation and the failure to respond
to changes in background colour (Etkin, 1935). The changes in activity of the pars
intermedia under such changes in environmental lighting conditions are, as in the
Soay sheep, characterised by changes in the expression of the genes for POMC and
its processing enzymes with a 20 to 30 fold increase in POMC mRNA expression
in frogs adapted to black background conditions (Ayoubi et al., 1992). Not only
POMC, but PC2 and 7B2, a molecular chaperone associated with PC2 maturation,
are coordinately regulated with POMC in the amphibian pars intermedia in this
model (Braks et al., 1992). Furthermore, the degree of acetylation of aMSH is
also altered in a coordinated way by these environmental changes which is
associated with an increase in the biological activity of aMSH (Maruthainar et al.,
1992). Moreover, hypothalamically-mediated adaptation to background elicits not
only changes in gene expression, but also changes in POMC RNA stability
(Ayoubi et al., 1992). Taken together these observations suggest that the
regulation of circulating POMC-derived peptides occurring in the amphibian is
regulated at the levels of gene transcription, RNA degradation and post-
transcriptional modification.
The data presented here allows us to construct a hypothetical model of the
events which generate the seasonal cycle in the activity of the pars intermedia
(Figure 7.1). In this model it is proposed that the effects of season are mediated
primarily due to the annual cycle in photoperiod. The effects of photoperiod are
mediated through changes in melatonin secretion which generates a humoral signal
that encodes photoperiod and acts at specific sites in the hypothalamus to influence
the activity of dopaminergic neuronal systems that innervate the pars intermedia.
Light transmitted from the retina by the retino-hypothalamic tract, a non visual
neural pathway to the hypothalamus. The light has two effects. The first is that it
acts to entrain the endogenous circadian rhythm generating system in the
suprachiasmatic nucleus which governs daily cyclicity inducing the rhythmic
secretion of melatonin. Secondly, light acts via the sympathetic innervation of the
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Figure 7,1 Schematic model showing the proposed regulation of the activity of
the pars intermedia by photoperiod.
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pineal gland to inhibit melatonin secretion, the consequence of which is that
melatonin is secreted only at night and so the duration of melatonin secretion
reflects the length of the dark phase. The evidence that melatonin mediates the
effects of photoperiod is based on the observation that the administration of
continuous melatonin (through subcutaneous implants) to Soay sheep exposed to
long days results in increased circulating aMSH, so mimicking to effects of short
days (Lincoln, 1991). More specifically, the administration of microimplants of
melatonin directly to the medial-basal hypothalamus activates the activity of the pars
intermedia (as judged by the measurement of circulating pEND), demonstrating that
the medial-basal hypothalamus is the site of action of melatonin in influencing the
photoperiodic relay system to the hypothalamus (Lincoln and Maeda, 1992a).
Under short days, the long duration melatonin signal results in inhibition of
dopamine activity and disinhibits the function of the pars intermedia resulting in
increased aMSH and pEND secretion. The photoperiodic regulation of the pars
intermedia is associated with the coordinated activiation of POMC mRNA and its
associated endoproteolytic enzymes which are involved in the production of the
fully mature hormone. Conversely, under long days the short duration melatonin
signal acts in the hypothalamus to promote dopamine secretion resulting in the
inhibition of the complex internal cellular machinery responsible for generating the
mature aMSH peptide. In this model, the control of mRNA expression and post-
translational processing enzymes contribute to the production of aMSH. It is also
probable, as has been demonstrated in the frog, that the processing of the POMC
molecule to aMSH is controlled further by the regulation of acetylation as well as
exoproteolytic processing and a-amidation.
Seasonal cycles in aMSH and pEND is unlikely to be restricted to the Soay
sheep since the pituitary content of aMSH also varies seasonally in the Siberian
hamster (Logan and Weatherhead, 1980). Similar cycles are likely to occur in other
sheep breeds but may be attenuated in domestic breeds as a result of selective
breeding. The Soay sheep is a feral breed and like wild sheep the Soay displays
particularly robust seasonally-regulated changes in pelage and food intake as well
as reproduction (Argo and Smith, 1983; Lincoln, 1991). The seasonal changes in
these physiological parameters are characterised by seasonal cycles in circulating
levels of other pituitary hormones such as prolactin and FSH and represent
important adaptations for survival in a predictably seasonally-changing
environment.
With respect to the functional significance of the aMSH system, there is an
extensive literature indicating that aMSH and pEND have a role in the regulation of
appetite and body weight (Davis et ah, 1983; Deutch and Martin, 1983; Genazzani
et al., 1986; Huszar et al., 1997; Margules et al., 1978; Mountjoy and Wong,
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1997). Most of this literature describes the effects of central rather than circulating
aMSH, which may not be able to pass through the blood-brain barrier. While
aMSH is known to have a role in the regulation of appetite in the hypothalamus
(Huszar et al., 1997; Mountjoy and Wong, 1997), the physiological functions of
peripheral aMSH in the sheep are poorly understood. However, the seasonal
cycles of aMSH and pEND correlate closely with voluntary food intake and body
weight in the Soay sheep (Ebling and Lincoln, 1987; Lincoln and Baker, 1995;
Lincoln and Richardson, 1998), which are maximal in late summer (July, August
and September) and fall to a minimum in winter and spring (December to April). In
contrast to the localised effects of aMSH in the hypothalamus, the secretion of
aMSH and pEND from the pars intermedia represents a conspicuous signal to
many peripheral tissues which possess receptors for these peptides. A role for
aMSH in the regulation of carbohydrate metabolism is also implicated by the
distribution of these receptors. While it is not clear whether the pEND secreted by
the pars intermedia is bioactive, five subtypes of aMSH receptors have been
described, two of which are expressed in adipose tissue (Mountjoy and Wong,
1997). One of these is the type one melanocortin receptor (MC1-R) which occurs
in the pigment cells of the skin and is thought to mediate the effects of aMSH in the
regulation of pigmentation. However, this receptor is also expressed in adipose
tissue and in macrophages (Mountjoy and Wong, 1997). The second receptor type
(MC2-R) is principally an ACTH receptor, but also has a low affinity for aMSH.
MC2-R mediates the stimulatory effects of ACTH on the adrenal cortex but is also
expressed in adipose tissue and the adrenal gland (Mountjoy and Wong, 1997).
The third receptor subtype (MC3-R) is expressed centrally and in the placenta,
duodenum, the pancreas and the stomach while the type four receptor (MC4-R) is
expressed centrally in the brain, spinal cord, sympathetic nervous system and
muscle (Mountjoy and Wong, 1997). MC4-R is implicated in the central control of
appetite since its inactivation in the mouse results in hyperphagia and obesity
(Huszar et al., 1997). The fifth receptor (MC5-R) has a more widespread pattern
of peripheral expression than any of the other melanocortin receptor subtypes and is
particularly highly expressed in exocrine tissues (van der Kraan et al., 1998).
Many ungulates show robust seasonal cycles in voluntary food intake and
body weight particularly in semi domesticated and wild animals such as the Soay
sheep and the red deer (Ebling and Lincoln, 1987; Loudon and Jabbour, 1994).
This seasonally modified behaviour, which is characterised by fat storage and
hyperphagia while food is abundant, has evolved to anticipate and exploit seasonal
changes in environment and optimise physiology to cope with the deprivations of
winter. This type of adaptation to seasonal food availability is taken to extremes in
hibernators such as ground squirrels which display conspicuous seasonal cycles in
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body weight characterised by hyperphagia and fat deposition in summer and
autumn followed by winter anorexia and weight loss (Davis, 1976; Mrosovsky and
Sherry, 1980). The cyclical changes in voluntary food intake and metabolism are
associated with a wide range of physiological changes including adipose tissue
sensitivity to insulin (Castex and Sutter, 1981b; Feist et al., 1986; Florant and
Greenwood, 1986) alterations in pancreatic function (Castex et al., 1979; Castex
and Sutter, 1981a; Florant et al., 1985) and variations in circulating thyroid
hormones which may seasonally elevate metabolic energy expenditure (Jallageas
and Assenmacher, 1983; Rickart, 1986; Young, 1984). Such peripheral seasonal
alterations in adipose and pancreatic activity are likely to be associated with
seasonal cycles in peripheral humoral factors, such as aMSH and (3END.
The results obtained in the course of this study were often subject to a high
degree of variability. The comparative difficulty inherent in the maintenance of
large animals such as the sheep precludes the use of large numbers of animals.
Moreover, as well as contributing to high statistical variance, the low sample sizes
used in the experiments prevents sampling at many time points. Since the Soay
sheep is a feral breed, animals are subject to high genetic polymorphism, and so
may behave differently to each other in terms of the magnitude and timing of their
response to the experimental regimens imposed on them. Future studies may
require larger sample sizes and sampling at more time points to unequivocally
establish the effects of season and photoperiod on the activity of the pars intermedia
POMC system. The persistence of seasonal changes in the activity in the pars
intermedia of the Soay sheep implies a physiological function for the secretory
products of this tissue. Future work would therefore focus on the physiological
significance of the seasonal cycle in aMSH. To establish the physiological
significance of the seasonal cycle in aMSH and its target tissues, receptor studies
could be undertaken to map the distribution of the receptor subtypes and invetigate
whether the expression of any of these receptor populations are regulated
seasonally, as their endocrine ligands are. This may also help to establish whether
the normal ligands for these receptors are endocrine rather than paracrine.
This thesis demonstrates that the seasonal cycle in circulating aMSH is
associated with changes in pars intermedia activity and morphology in the Soay
sheep. This seasonal cycle in the activity of the pars intermedia is characterised by
changes in gene expression of POMC, PCI and PC2 and cellular proliferative
activity and is driven by photoperiod, the effect of which is transduced through the
inhibitory regulation of the pars intermedia by the hypothalamus. Dopamine is a
major component, possibly the principle component of the regulation of the pars
intermedia by the hypothalamus which conveys the effect of season to the pars
intermedia. The physiological significance of the seasonal cycle in circulating
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aMSH concentrations generated by the changes in activity of the pars intermedia
described in this thesis is poorly understood, but is likely to be an important
mechanism which has evolved to anticipate and optimise survival in an environment
in which food availability changes seasonally.
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